% AUTO-GENERATED FILE - DO NOT EDIT
% Generated from knowledge/references.qmd (single source of truth)

% This file contains BibTeX entries for ALL citations in references.qmd
% For editing citations, add/modify entries in knowledge/references.qmd

% Extracted citation data: author, year, source, URL, and notes.
% Re-generate by running: python scripts/generate-everything-parameters-variables-calculations-references.py

@article{166-billion-compounds,
  title = {166 billion potential treatments remain untested},
  author = {Nature},
  year = {2017},
  journal = {Nature},
  url = {https://www.nature.com/articles/549445a},
  urldate = {2025-01-20},
}

@legislation{21st-century-cures-act-2016,
  title = {21st Century Cures Act (2016)},
  institution = {U.S. Congress},
  year = {2016},
  url = {https://www.congress.gov/bill/114th-congress/house-bill/34},
  urldate = {2025-01-20},
  note = {Congress.gov, H.R.34 - 21st Century Cures Act | FDA, 21st Century Cures Act},
}

@article{3-5-rule,
  title = {3.5\% participation tipping point},
  author = {Harvard Kennedy School},
  year = {2020},
  journal = {Harvard Kennedy School},
  url = {https://www.hks.harvard.edu/centers/carr/publications/35-rule-how-small-minority-can-change-world},
  urldate = {2025-01-20},
  note = {Harvard Kennedy School, The '3.5\% rule': How a small minority can change the world | Chenoweth Research Paper (2020) | BBC Future, 2019, 'The 3.5\% rule' | Wikipedia, 3.5\% rule},
}

@report{5-million-annual-child-deaths,
  title = {Annual child deaths statistic},
  institution = {UNICEF},
  year = {2024},
  publisher = {UNICEF},
  url = {https://data.unicef.org/resources/levels-and-trends-in-child-mortality-2024/},
  urldate = {2025-01-20},
  note = {4.8 million children under 5 died in 2023},
}

@report{53-percent-preventable-deaths,
  title = {Percentage of preventable deaths},
  institution = {CDC},
  year = {2024},
  publisher = {MMWR},
  volume = {73},
  url = {https://www.cdc.gov/mmwr/volumes/73/ss/ss7302a1.htm},
  urldate = {2025-01-20},
  note = {53.8\% figure is for unintentional injury deaths; overall 20-40\% of deaths from leading causes are preventable},
}

@article{95-pct-diseases-no-treatment,
  title = {95\% of diseases have no effective treatment},
  author = {GAO},
  year = {2025},
  journal = {GAO},
  url = {https://www.gao.gov/products/gao-25-106774},
  urldate = {2025-01-20},
  note = {GAO, 2025, Rare Disease Drugs: FDA Has Steps Underway to Strengthen Coordination | Global Genes, RARE Disease Facts | Note: Only 5\% of 7,000+ rare diseases have FDA-approved treatments},
}

@article{acled-active-combat-deaths,
  title = {Active combat deaths annually},
  author = {ACLED},
  year = {2024},
  journal = {ACLED: Global Conflict Surged 2024},
  url = {https://acleddata.com/2024/12/12/data-shows-global-conflict-surged-in-2024-the-washington-post/},
  urldate = {2025-01-20},
  note = {ACLED: Global Conflict Surged 2024 | Washington Post via ACLED | ACLED Conflict Index},
}

@article{administrative-procedure-act,
  title = {Administrative Procedure Act (APA)},
  author = {National Archives},
  year = {},
  journal = {National Archives},
  url = {https://www.archives.gov/federal-register/laws/administrative-procedure},
  urldate = {2025-01-20},
  note = {National Archives, Administrative Procedure Act (5 U.S.C. Subchapter II) | Cornell Law, 5 U.S.C. § 551},
}

@article{affordable-care-act-passage,
  title = {Passage of the Affordable Care Act and Pelosi quote},
  author = {Congress.gov},
  year = {},
  journal = {Congress.gov},
  url = {https://www.congress.gov/bill/111th-congress/house-bill/3590/text},
  urldate = {2025-01-20},
  note = {Congress.gov, H.R.3590 - Patient Protection and Affordable Care Act | Snopes, Did Nancy Pelosi Say Obamacare Must be Passed to 'Find Out What Is in It'? | Note: Full quote was "we have to pass the ...},
}

@article{afghanistan-war-annual-cost-300b,
  title = {Annual cost of Afghanistan War: $300 billion},
  author = {Brown University Costs of War Project},
  year = {2021},
  journal = {Brown University Costs of War Project},
  url = {https://www.brown.edu/news/2021-09-01/costsofwar},
  urldate = {2025-01-20},
  note = {Brown University Costs of War Project, 2021, Costs of the 20-year war on terror | Note: $300 million per day × 365 days ≈ $109.5 billion/year; total war cost was $2.3 trillion over 20 years},
}

@article{aging-reversal-mammals-yamanaka,
  title = {Aging reversal demonstrated in mammals using Yamanaka factors},
  author = {PMC},
  year = {2023},
  journal = {PMC: Chemically Induced Reprogramming to Reverse Aging},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC10373966/},
  urldate = {2025-01-20},
  note = {PMC: Chemically Induced Reprogramming to Reverse Aging | Nature: Long Road of Reprogramming-Induced Rejuvenation | Liebertpub: Gene Therapy Extends Lifespan 109\% | Clinical Epigenetics: Cellular R...},
}

@article{alphabet-rd-spending-40b,
  title = {Alphabet R\&D spending: $40 billion},
  author = {Statista},
  year = {},
  journal = {Statista: Alphabet R\&D Costs},
  url = {https://www.statista.com/statistics/507858/alphabet-google-rd-costs/},
  urldate = {2025-01-20},
  note = {Statista: Alphabet R\&D Costs | MacroTrends: Alphabet R\&D},
}

@article{alzheimers-deaths-2-6m-annually,
  title = {Annual deaths from Alzheimer's and other dementias},
  author = {Alzheimer's Association},
  year = {2024},
  journal = {Alzheimer's Association},
  url = {https://www.alz.org/alzheimers-dementia/facts-figures},
  urldate = {2025-01-20},
  note = {Alzheimer's Association, 2024, Alzheimer's Facts and Figures Report | CDC, 2021, FastStats - Alzheimers Disease | Note: 119,399 deaths in US in 2021; global dementia deaths estimated at 2.6M annually},
}

@article{amazon-rd-spending-85b,
  title = {Amazon R\&D spending: $85 billion},
  author = {RD World},
  year = {2023},
  journal = {RD World: Amazon R\&D Spending},
  url = {https://www.rdworldonline.com/top-30-rd-spending-leaders-2023-big-tech-firms-hit-new-heights/},
  urldate = {2025-01-20},
  note = {RD World: Amazon R\&D Spending | MacroTrends: Amazon R\&D},
}

@article{amr-10m-2050,
  title = {Antimicrobial resistance deaths projection},
  author = {Review on Antimicrobial Resistance},
  year = {2016},
  journal = {Review on Antimicrobial Resistance},
  url = {https://amr-review.org/sites/default/files/160525_Final\%20paper_with\%20cover.pdf},
  urldate = {2025-01-20},
  note = {Review on Antimicrobial Resistance, 2016, Final Report},
}

@article{animal-diseases-eradicated-by-vets,
  title = {Animal diseases eradicated by veterinary science},
  author = {Our World in Data},
  year = {},
  journal = {Our World in Data: Rinderpest Eradication},
  url = {https://ourworldindata.org/how-rinderpest-was-eradicated},
  urldate = {2025-01-20},
  note = {Our World in Data: Rinderpest Eradication | WOAH: Rinderpest},
}

@article{annual-drug-combinations-tested,
  title = {Number of potential drug combinations tested annually},
  author = {PMC},
  year = {},
  journal = {PMC: DrugCombDB},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC7145671/},
  urldate = {2025-01-20},
  note = {PMC: DrugCombDB | PubMed: Drug Combination Prediction},
}

@article{annual-pet-food-sales-150b,
  title = {Annual pet food sales: $150 billion},
  author = {Statista},
  year = {},
  journal = {Statista: Pet Food Market},
  url = {https://www.statista.com/topics/7429/pet-food-market-worldwide/},
  urldate = {2025-01-20},
  note = {Statista: Pet Food Market | IMARC: Pet Food Market Report},
}

@article{annual-rd-savings-potential-50b,
  title = {Annual R\&D savings potential of $50.0B},
  author = {CBO},
  year = {},
  journal = {CBO: Pharma R\&D},
  url = {https://www.cbo.gov/publication/57126},
  urldate = {2025-01-20},
  note = {CBO: Pharma R\&D | Accenture: Transforming Pharma R\&D | Clarivate: Pharma R\&D Efficiency},
}

@article{anti-aging-cream-market-50b,
  title = {Global anti-aging cream market: $50 billion},
  author = {Data Bridge Market Research},
  year = {},
  journal = {Data Bridge Market Research},
  url = {https://www.databridgemarketresearch.com/reports/global-anti-ageing-products-market},
  urldate = {2025-01-20},
  note = {Data Bridge Market Research | Grand View Research},
}

@article{antidepressant-failure-rate-stard,
  title = {Antidepressant failure rates: Two-thirds fail to achieve remission},
  author = {Psychiatric Services},
  year = {2009},
  journal = {Psychiatric Services: STAR*D Results},
  url = {https://psychiatryonline.org/doi/10.1176/ps.2009.60.11.1439},
  urldate = {2025-01-20},
  note = {Psychiatric Services: STAR*D Results | PMC: STAR*D Reexamination | Wikipedia: STAR*D},
}

@article{antidepressant-trial-exclusion-rates,
  title = {Antidepressant clinical trial exclusion rates},
  author = {NIH},
  year = {2015},
  journal = {Zimmerman et al.},
  url = {https://pubmed.ncbi.nlm.nih.gov/26276679/},
  urldate = {2025-01-20},
  note = {Zimmerman et al., Mayo Clinic Proceedings, 2015 | Preskorn et al., Journal of Psychiatric Practice, 2015 | Wolters Kluwer: Antidepressant Trials Exclude Most Real World Patients},
}

@article{apple-inc-market-cap,
  title = {Market capitalization of Apple Inc.},
  author = {Companies Market Cap},
  year = {},
  journal = {Companies Market Cap: Apple},
  url = {https://companiesmarketcap.com/apple/marketcap/},
  urldate = {2025-01-20},
  note = {Companies Market Cap: Apple | Yahoo Finance: Apple $4T Milestone},
}

@article{apple-rd-spending-32b,
  title = {Apple R\&D spending: $32 billion},
  author = {Statista},
  year = {},
  journal = {Statista: Apple R\&D Expenditure},
  url = {https://www.statista.com/statistics/273006/apple-expenses-for-research-and-development/},
  urldate = {2025-01-20},
  note = {Statista: Apple R\&D Expenditure | MacroTrends: Apple R\&D},
}

@article{appointments-clause,
  title = {U.S. Constitution Appointments Clause},
  author = {Constitution Annotated},
  year = {2021},
  journal = {Constitution Annotated: Appointments Clause},
  url = {https://constitution.congress.gov/browse/essay/artII-S2-C2-3-1/ALDE_00013092/},
  urldate = {2025-01-20},
  note = {Constitution Annotated: Appointments Clause | Justia: Appointments Clause | SCOTUSblog: Arthrex Remedy},
}

@article{arms-trade-treaty-2013,
  title = {Arms Trade Treaty (2013) - Campaign and Adoption},
  author = {UN Legal},
  year = {},
  journal = {UN Legal},
  url = {https://legal.un.org/avl/ha/att/att.html},
  urldate = {2025-01-20},
  note = {UN Legal, Arms Trade Treaty | Control Arms, ATT Overview | Oxfam America, The International Arms Trade Treaty | Arms Control Association, ATT At a Glance},
}

@article{arpa-h-site,
  title = {ARPA‑H official site},
  author = {ARPA‑H},
  year = {},
  journal = {ARPA‑H},
  url = {https://arpa-h.gov/},
  urldate = {2025-01-20},
  note = {ARPA‑H, About},
}

@article{astrology-belief-poll,
  title = {Poll on belief in astrology in the U.S.},
  author = {Pew Research},
  year = {2025},
  journal = {Pew Research: Astrology Survey},
  url = {https://www.pewresearch.org/religion/2025/05/21/3-in-10-americans-consult-astrology-tarot-cards-or-fortune-tellers/},
  urldate = {2025-01-20},
  note = {Pew Research: Astrology Survey | YouGov: Astrology Belief},
}

@article{australia-medical-research-spending-900m,
  title = {Australia medical research spending: $900 million},
  author = {NHMRC},
  year = {2024},
  journal = {NHMRC Budget 2024-25},
  url = {https://www.nhmrc.gov.au/about-us/news-centre/budget-2024-25},
  urldate = {2025-01-20},
  note = {NHMRC Budget 2024-25 | MRFF Overview},
}

@misc{average-reading-speed,
  title = {Average reading speed},
  author = {Educational psychology literature},
  year = {},
  note = {Educational psychology literature},
}

@article{average-us-hourly-wage,
  title = {Average US hourly wage},
  author = {BLS},
  year = {2024},
  journal = {BLS},
  url = {https://www.bls.gov/news.release/pdf/ocwage.pdf},
  urldate = {2025-01-20},
  note = {BLS, Occupational Employment and Wages May 2024},
}

@article{average-us-senate-campaign-cost,
  title = {Average cost of a competitive U.S. Senate campaign},
  author = {Issue One},
  year = {},
  journal = {Issue One: 118th Congress Fundraising},
  url = {https://issueone.org/articles/the-118th-congress-fundraising-treadmill/},
  urldate = {2025-01-20},
  note = {Issue One: 118th Congress Fundraising | OpenSecrets: Most Expensive Races},
}

@article{ballot-measure-signature-costs-2024,
  title = {2024 ballot initiative petition signature gathering costs},
  author = {Ballotpedia},
  year = {2024},
  journal = {Ballotpedia},
  url = {https://ballotpedia.org/Ballot_measure_signature_costs,_2024},
  urldate = {2025-01-20},
  note = {Ballotpedia, Ballot measure signature costs, 2024 | Ballotpedia News, 2024 initiatives reach record-high cost per signature},
}

@article{barro2011,
  title = {Macroeconomic Effects from Government Purchases and Taxes},
  author = {Barro, Robert J. and Redlick, Charles J.},
  year = {2011},
  journal = {The Quarterly Journal of Economics},
  volume = {126},
  number = {1},
  pages = {51-102},
  doi = {10.1093/qje/qjq002},
  note = {Estimates defense spending multiplier less than 1.0},
}

@article{barta2024,
  title = {The Logic of Credit: How and Why Credit Rating Agencies Exercise Power within Global Governance},
  author = {Barta, Zsófia},
  year = {2024},
  journal = {MPIfG Discussion Paper},
}

@article{batini2021,
  title = {Building Back Better: How Big Are Green Spending Multipliers?},
  author = {Batini, Nicoletta and Di Serio, Mario and Fragetta, Matteo and Melina, Giovanni and Waldron, Anthony},
  year = {2021},
  journal = {Ecological Economics},
  volume = {193},
  pages = {107305},
  doi = {10.1016/j.ecolecon.2021.107305},
  note = {Finds renewable energy multipliers (1.1-1.7) are significantly higher than fossil fuel multipliers (0.4-0.7)},
}

@article{beta-blocker-drug-lag-deaths,
  title = {Estimated deaths due to FDA delay in approving beta blockers},
  author = {FDAReview.org},
  year = {2011},
  journal = {FDAReview.org: FDA Harm},
  url = {https://www.fdareview.org/issues/theory-evidence-and-examples-of-fda-harm/},
  urldate = {2025-01-20},
  note = {FDAReview.org: FDA Harm | Orange County Register: Death by FDA Delay},
}

@article{bio-clinical-development-2021,
  title = {BIO Clinical Development Success Rates 2011-2020},
  author = {Biotechnology Innovation Organization (BIO)},
  year = {2021},
  journal = {Biotechnology Innovation Organization (BIO)},
  url = {https://go.bio.org/rs/490-EHZ-999/images/ClinicalDevelopmentSuccessRates2011_2020.pdf},
  urldate = {2025-01-20},
  note = {Biotechnology Innovation Organization (BIO), 2021, Clinical Development Success Rates and Contributing Factors 2011-2020},
}

@article{biological-immortality-in-nature,
  title = {Examples of Biological Immortality and Extreme Longevity in Nature},
  author = {Wikipedia},
  year = {},
  journal = {Wikipedia: Biological Immortality},
  url = {https://en.wikipedia.org/wiki/Biological_immortality},
  urldate = {2025-01-20},
  note = {Wikipedia: Biological Immortality | PMC: Molecular Signatures of Longevity},
}

@article{bloom-ideas-getting-harder-2020,
  title = {Research productivity declining over time},
  author = {Bloom, Nicholas, Charles I. Jones, John Van Reenen, and Michael Webb},
  year = {2020},
  journal = {Bloom},
  url = {https://www.aeaweb.org/articles?id=10.1257/aer.20180338},
  urldate = {2025-01-20},
  note = {Bloom, Nicholas, Charles I. Jones, John Van Reenen, and Michael Webb, 2020, Are Ideas Getting Harder to Find? American Economic Review 110 (4): 1104–44 | Originally NBER Working Paper 23782 (2017)},
}

@article{boeing-defense-annual-revenue-26b,
  title = {Boeing Defense annual revenue},
  author = {Statista},
  year = {2024},
  journal = {Statista: Boeing Defense Revenue},
  url = {https://www.statista.com/statistics/268999/sales-in-defense-of-boeing/},
  urldate = {2025-01-20},
  note = {Statista: Boeing Defense Revenue | Boeing Q4 2024 Results},
}

@article{bradley-terry-pagerank-models,
  title = {Bradley-Terry and PageRank Models for Ranking},
  author = {arXiv},
  year = {},
  journal = {arXiv: PageRank and Bradley-Terry Model},
  url = {https://arxiv.org/abs/2402.07811},
  urldate = {2025-01-20},
  note = {arXiv: PageRank and Bradley-Terry Model | Wikipedia: Bradley-Terry | ScienceDirect: Improving PageRank with Sports Results},
}

@article{brazil-medical-research-spending-600m,
  title = {Brazil medical research spending: $600 million},
  author = {PMC},
  year = {},
  journal = {PMC: Brazil Biomedical Research Funding},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC10953608/},
  urldate = {2025-01-20},
  note = {PMC: Brazil Biomedical Research Funding | DWIH: Brazil Research Funding},
}

@article{brian-armstrong-health-tech-investor,
  title = {Brian Armstrong's investments in health tech},
  author = {MIT Tech Review},
  year = {2025},
  journal = {MIT Tech Review: Armstrong CRISPR Investment},
  url = {https://www.technologyreview.com/2025/06/05/1117909/crypto-billionaire-brian-armstrong-is-ready-to-invest-in-crispr-baby-tech/},
  urldate = {2025-01-20},
  note = {MIT Tech Review: Armstrong CRISPR Investment | Yahoo Finance: ResearchHub Funding},
}

@article{brightid-social-verification-network,
  title = {BrightID social identity verification network},
  author = {BrightID},
  year = {2020},
  journal = {BrightID},
  url = {https://www.brightid.org/},
  urldate = {2025-01-20},
  note = {BrightID | Frontiers: Sybil-Resistance in Proof of Personhood},
}

@book{buchanan1962,
  title = {The Calculus of Consent: Logical Foundations of Constitutional Democracy},
  author = {Buchanan, James M. and Tullock, Gordon},
  year = {1962},
  publisher = {University of Michigan Press},
  address = {Ann Arbor},
}

@article{california-ballot-proposition-overload,
  title = {California direct democracy and ballot proposition overload},
  author = {Carnegie Endowment},
  year = {2024},
  journal = {Carnegie Endowment: California Direct Democracy},
  url = {https://carnegieendowment.org/posts/2024/11/california-2024-election-propositions-direct-democracy},
  urldate = {2025-01-20},
  note = {Carnegie Endowment: California Direct Democracy | Davis Political Review: Hijacking the Ballot},
}

@article{canada-bill-c-76,
  title = {Canada Bill C-76 foreign influence restrictions},
  author = {Wikipedia},
  year = {2019},
  journal = {Elections Modernization Act (Wikipedia)},
  url = {https://en.wikipedia.org/wiki/Bill_C-76},
  urldate = {2025-01-20},
  note = {Elections Modernization Act (Wikipedia) | Canada: Combatting Foreign Interference | McCarthy: Canada's Election Laws Changing},
}

@article{canada-expenditure-reporting-500,
  title = {Canadian election expenditure reporting threshold over $500},
  author = {Elections Canada},
  year = {},
  journal = {Elections Canada: Expense Limits},
  url = {https://www.elections.ca/content.aspx?section=pol\&dir=limits\&document=index\&lang=e},
  urldate = {2025-01-20},
  note = {Elections Canada: Expense Limits | Elections Canada: Political Financing},
}

@article{canada-medical-research-spending-1-5b,
  title = {Canada medical research spending: $1.5 billion},
  author = {CIHR},
  year = {2024},
  journal = {CIHR: Budget 2024},
  url = {https://cihr-irsc.gc.ca/e/53894.html},
  urldate = {2025-01-20},
  note = {CIHR: Budget 2024 | CIHR Grants Expenditures},
}

@article{cancer-30-50-percent-preventable,
  title = {30-50\% of cancer is currently preventable; 90-95\% has environmental/lifestyle roots},
  author = {PMC},
  year = {},
  journal = {PMC: Cancer is a Preventable Disease},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC2515569/},
  urldate = {2025-01-20},
  note = {PMC: Cancer is a Preventable Disease | IARC: Environment and Lifestyle Epidemiology | AACR Cancer Progress Report: Risk Factors},
}

@article{cancer-deaths-10m-annually,
  title = {Annual deaths from cancer (10 million)},
  author = {The Lancet},
  year = {2023},
  journal = {The Lancet: Global Cancer Deaths 2023},
  url = {https://www.hematologyadvisor.com/news/globally-18-5-million-incident-cancer-cases-and-10-4-million-deaths-reported-in-2023/},
  urldate = {2025-01-20},
  note = {The Lancet: Global Cancer Deaths 2023 | WHO/IARC, 2024, Global cancer burden growing},
}

@report{cbo2015,
  title = {Estimated Impact of the American Recovery and Reinvestment Act on Employment and Economic Output in 2014},
  institution = {Congressional Budget Office},
  year = {2015},
  url = {https://www.cbo.gov/publication/49958},
  urldate = {2025-01-20},
}

@article{ccpa-cpra-compliance,
  title = {California Consumer Privacy Act (CCPA) and California Privacy Rights Act (CPRA)},
  author = {CA Attorney General},
  year = {},
  journal = {CA Attorney General: CCPA},
  url = {https://oag.ca.gov/privacy/ccpa},
  urldate = {2025-01-20},
  note = {CA Attorney General: CCPA | California Privacy Protection Agency | Bloomberg: CCPA \& CPRA},
}

@article{cdc-covid-test-contamination-2020,
  title = {Contamination of early CDC COVID-19 tests in 2020},
  author = {NPR},
  year = {2020},
  journal = {NPR: CDC Test Flawed},
  url = {https://www.npr.org/2020/11/06/929078678/cdc-report-officials-knew-coronavirus-test-was-flawed-but-released-it-anyway},
  urldate = {2025-01-20},
  note = {NPR: CDC Test Flawed | CNN: CDC Contamination},
}

@article{cellular-turnover-rates,
  title = {Cellular Turnover and Repair Rates in the Human Body},
  author = {Scientific American},
  year = {},
  journal = {HowStuffWorks: Body Replace Every 7 Years},
  url = {https://www.scientificamerican.com/article/our-bodies-replace-billions-of-cells-every-day/},
  urldate = {2025-01-20},
  note = {HowStuffWorks: Body Replace Every 7 Years | Live Science: Cell Replacement | Sanitas: Body Regeneration},
}

@article{ceo-compensation,
  title = {CEO compensation},
  author = {EPI},
  year = {2024},
  journal = {EPI},
  url = {https://www.epi.org/blog/ceo-pay-increased-in-2024-and-is-now-281-times-that-of-the-typical-worker-new-epi-landing-page-has-all-the-details/},
  urldate = {2025-01-20},
  note = {EPI, CEO Pay 2024},
}

@article{cfr-21-312-8-charging-for-investigational-drugs,
  title = {FDA regulations for charging for investigational drugs (21 CFR 312.8)},
  author = {FDA},
  year = {},
  journal = {21 CFR 312.8},
  url = {https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-312/subpart-A/section-312.8},
  urldate = {2025-01-20},
  note = {21 CFR 312.8 | FDA Guidance: Charging for Investigational Drugs},
}

@article{chan-zuckerberg-initiative-funding,
  title = {Chan Zuckerberg Initiative Funding/Pledge},
  author = {Washington Post},
  year = {2015},
  journal = {Washington Post: Zuckerberg $45B Pledge},
  url = {https://www.washingtonpost.com/news/the-switch/wp/2015/12/01/mark-zuckerberg-will-give-away-99-percent-of-his-facebook-stock/},
  urldate = {2025-01-20},
  note = {Washington Post: Zuckerberg $45B Pledge | Philanthropy: CZI Pledge},
}

@article{chance-of-dying-from-terrorism-1-in-30m,
  title = {Chance of dying from terrorism statistic},
  author = {Cato Institute},
  year = {},
  journal = {Cato Institute: Terrorism and Immigration Risk Analysis},
  url = {https://www.cato.org/policy-analysis/terrorism-immigration-risk-analysis},
  urldate = {2025-01-20},
  note = {Cato Institute: Terrorism and Immigration Risk Analysis | NBC News: Lightning vs Terrorism},
}

@article{chemical-space-size,
  title = {Total drug-like chemical space (10^23 - 10^60)},
  author = {Reymond, J. L.},
  year = {2015},
  journal = {Reymond},
  url = {https://pubs.acs.org/doi/10.1021/ar500432k},
  urldate = {2025-01-20},
  note = {Reymond, J. L., 2015, The Chemical Space Project},
}

@article{child-population-percentage,
  title = {Global population percentage of children},
  author = {World Bank},
  year = {},
  journal = {World Bank: Population Ages 0-14},
  url = {https://data.worldbank.org/indicator/SP.POP.0014.TO.ZS},
  urldate = {2025-01-20},
  note = {World Bank: Population Ages 0-14 | UNICEF: Children in the World},
}

@article{childhood-vaccination-economic-benefits,
  title = {Childhood vaccination economic benefits},
  author = {CDC MMWR},
  year = {1994},
  journal = {CDC MMWR},
  url = {https://www.cdc.gov/mmwr/volumes/73/wr/mm7331a2.htm},
  urldate = {2025-01-20},
  note = {CDC MMWR, Childhood Immunizations 1994-2023 | The Lancet, 50 Years of Expanded Programme on Immunization00850-X/fulltext)},
}

@article{childhood-vaccination-roi,
  title = {Childhood Vaccination (US) ROI},
  author = {CDC},
  year = {2017},
  journal = {CDC},
  url = {https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6316a4.htm},
  urldate = {2025-01-20},
  note = {CDC, Link | Vaxopedia, Link},
}

@article{childhood-vaccinations-prevent-deaths,
  title = {Childhood vaccinations prevent deaths and hospitalizations},
  author = {CDC},
  year = {2023},
  journal = {CDC},
  url = {https://www.cdc.gov/mmwr/volumes/73/wr/mm7331a2.htm},
  urldate = {2025-01-20},
  note = {CDC, 2023, Morbidity and Mortality Weekly Report},
}

@article{china-biopharma-rd-2023,
  title = {China biopharma R\&D spending 2023},
  author = {DrugPatentWatch},
  year = {},
  journal = {DrugPatentWatch},
  url = {https://www.drugpatentwatch.com/blog/the-dragon-awakes-charting-the-unstoppable-growth-of-chinese-pharmaceuticals-in-the-global-market/},
  urldate = {2025-01-20},
  note = {DrugPatentWatch, Chinese Pharmaceuticals Growth},
}

@article{china-health-rd-share-2-2pct,
  title = {China's health/medical share of R\&D},
  author = {UNESCO},
  year = {},
  journal = {UNESCO: R\&D Spending by Country},
  url = {https://uis.unesco.org/apps/visualisations/research-and-development-spending/},
  urldate = {2025-01-20},
  note = {UNESCO: R\&D Spending by Country | PMC: China Health Expenditure Analysis | Statista: China Pharma R\&D},
}

@article{china-leading-trial-location-2024,
  title = {China as leading trial location},
  author = {Pharmaceutical Technology},
  year = {2024},
  journal = {Pharmaceutical Technology},
  url = {https://www.pharmaceutical-technology.com/analyst-comment/large-pharma-drug-licensing-china-2024/},
  urldate = {2025-01-20},
  note = {Pharmaceutical Technology, China Drug Licensing},
}

@article{china-licensing-deals-2024,
  title = {China pharmaceutical licensing deals 2024},
  author = {Pharmaceutical Technology},
  year = {2024},
  journal = {Pharmaceutical Technology},
  url = {https://www.pharmaceutical-technology.com/analyst-comment/large-pharma-drug-licensing-china-2024/},
  urldate = {2025-01-20},
  note = {Pharmaceutical Technology, China Licensing Analysis 2024 | LabioTech, China Biotech Industry},
}

@article{china-medical-research-spending-15b,
  title = {China's medical research spending (2024): ~$15 billion},
  author = {China National Statistics},
  year = {2024},
  journal = {China National Statistics: R\&D 2024},
  url = {https://www.stats.gov.cn/english/PressRelease/202502/t20250207_1958579.html},
  urldate = {2025-01-20},
  note = {China National Statistics: R\&D 2024 | Global Times: China R\&D Growth},
}

@article{china-military-parade-cost,
  title = {Cost of China's military parades},
  author = {Wikipedia},
  year = {2015},
  journal = {Wikipedia: 2015 China Victory Day Parade},
  url = {https://en.wikipedia.org/wiki/2015_China_Victory_Day_Parade},
  urldate = {2025-01-20},
  note = {Wikipedia: 2015 China Victory Day Parade | NBC News: 2025 China Parade Cost},
}

@article{china-rd-annual-growth,
  title = {China annual R\&D expenditure growth},
  author = {PMC},
  year = {},
  journal = {PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC12280122/},
  urldate = {2025-01-20},
  note = {PMC, China Innovative Drug Development},
}

@misc{china-rd-growth-2015-2023,
  title = {China R\&D growth 2015-2023},
  author = {Multiple industry sources},
  year = {2024},
  note = {Multiple industry sources, 2024},
}

@article{china-surveillance-vs-medicine-spending,
  title = {China spending on surveillance vs. medicine},
  author = {Nikkei Asia},
  year = {},
  journal = {Nikkei Asia: China Public Security},
  url = {https://asia.nikkei.com/static/vdata/infographics/china-spends-more-on-controlling-its-1-dot-4bn-people-than-on-defense/},
  urldate = {2025-01-20},
  note = {Nikkei Asia: China Public Security | Jamestown: China Domestic Security Analysis},
}

@article{china-total-rd-spending-668b,
  title = {China's total R\&D spending},
  author = {China National Statistics},
  year = {2024},
  journal = {China National Statistics: R\&D 2024},
  url = {https://www.stats.gov.cn/english/PressRelease/202502/t20250207_1958579.html},
  urldate = {2025-01-20},
  note = {China National Statistics: R\&D 2024 | Global Times: China R\&D $495B | Statista: China R\&D Spending},
}

@article{china-trial-advantages,
  title = {China clinical trial advantages},
  author = {BioSpace},
  year = {},
  journal = {BioSpace},
  url = {https://www.biospace.com/business/china-still-go-to-source-for-new-drugs-despite-tariff-minefield},
  urldate = {2025-01-20},
  note = {BioSpace, China Drug Development},
}

@article{china-trial-share-2024,
  title = {China clinical trials market share 2024},
  author = {FDD Analysis},
  year = {2025},
  journal = {FDD Analysis},
  url = {https://www.fdd.org/analysis/2025/06/03/china-races-ahead-in-biotech-trials-is-the-u-s-stuck-in-second-place/},
  urldate = {2025-01-20},
  note = {FDD Analysis, China Races Ahead in Biotech Trials},
}

@article{china-vs-us-researcher-salary,
  title = {Chinese vs. American researcher salary comparison},
  author = {PayScale},
  year = {},
  journal = {PayScale: China Research Scientist},
  url = {https://www.payscale.com/research/CN/Job=Research_Scientist/Salary},
  urldate = {2025-01-20},
  note = {PayScale: China Research Scientist | Glassdoor: US Research Scientist},
}

@article{chocolate-milk-from-brown-cows,
  title = {Survey on American adults' knowledge of agriculture},
  author = {Washington Post},
  year = {2017},
  journal = {Washington Post: Chocolate Milk Survey},
  url = {https://www.washingtonpost.com/news/wonk/wp/2017/06/15/seven-percent-of-americans-think-chocolate-milk-comes-from-brown-cows-and-thats-not-even-the-scary-part/},
  urldate = {2025-01-20},
  note = {Washington Post: Chocolate Milk Survey | CJR: Survey Analysis},
}

@article{chronic-illness-workforce-productivity-loss,
  title = {Chronic illness workforce productivity loss},
  author = {Integrated Benefits Institute},
  year = {2024},
  journal = {Integrated Benefits Institute 2024},
  url = {https://www.ibiweb.org/resources/chronic-conditions-in-the-us-workforce-prevalence-trends-and-productivity-impacts},
  urldate = {2025-01-20},
  note = {Integrated Benefits Institute 2024, Chronic Conditions in US Workforce | One Medical 2024, Study on Chronic Conditions | de Beaumont Foundation 2025, Poll on Chronic Health Conditions},
}

@article{churchill-democracy-quote,
  title = {Winston Churchill quote on democracy},
  author = {UK Parliament},
  year = {1947},
  journal = {UK Parliament},
  url = {https://api.parliament.uk/historic-hansard/commons/1947/nov/11/parliament-bill},
  urldate = {2025-01-20},
  note = {UK Parliament, Hansard, November 11, 1947 | International Churchill Society, The Worst Form of Government | Full quote: "Indeed, it has been said that democracy is the worst form of Government exce...},
}

@article{citizens-united-ruling,
  title = {Impact of Citizens United Supreme Court decision on campaign finance},
  author = {Supreme Court of the United States},
  year = {},
  journal = {Citizens United v. FEC},
  url = {https://supreme.justia.com/cases/federal/us/558/310/},
  urldate = {2025-01-20},
  note = {Citizens United v. FEC, 558 U.S. 310 | Brennan Center: Citizens United Explained},
}

@misc{citizensunited2010,
  title = {Citizens United v. Federal Election Commission},
  author = {Supreme Court of the United States},
  year = {2010},
  note = {558 U.S. 310},
}

@article{civic-literacy-survey-congress-function,
  title = {Survey of American civic literacy (Congress's function)},
  author = {Annenberg},
  year = {},
  journal = {Annenberg: Americans' Civic Knowledge},
  url = {https://www.annenbergpublicpolicycenter.org/americans-know-surprisingly-little-about-their-government-survey-finds/},
  urldate = {2025-01-20},
  note = {Annenberg: Americans' Civic Knowledge | US Chamber Foundation: Civic Literacy Study},
}

@article{civic-literacy-survey-congressman,
  title = {Survey of American civic literacy (naming representatives)},
  author = {Haven Insights},
  year = {},
  journal = {Haven Insights: Name Your Representative},
  url = {https://medium.com/haven-insights/just-37-of-americans-can-name-their-representative-8d3ca402993b},
  urldate = {2025-01-20},
  note = {Haven Insights: Name Your Representative | MRCTV: Only 37\% Can Name Congressman},
}

@article{clean-water-sanitation-roi,
  title = {Clean Water \& Sanitation (LMICs) ROI},
  author = {UN News},
  year = {2014},
  journal = {UN News},
  url = {https://news.un.org/en/story/2014/11/484032},
  urldate = {2025-01-20},
  note = {UN News, Link | WaterAid, Link},
}

@article{climate-bonds-gss-plus,
  title = {Climate Bonds: GSS+ debt \$5.5T cumulative},
  author = {Climate Bonds Initiative},
  year = {2024},
  journal = {Climate Bonds Initiative},
  url = {https://www.climatebonds.net/publications.html},
  urldate = {2025-01-20},
  note = {Climate Bonds Initiative, 2024, State of the Market},
}

@misc{clinical-trial-abandonment-rate,
  title = {Clinical trial abandonment},
  author = {Industry estimates},
  year = {},
  note = {Industry estimates},
}

@misc{clinical-trial-completion-rate,
  title = {Clinical trial completion},
  author = {Industry estimates},
  year = {},
  note = {Industry estimates},
}

@article{clinical-trial-cost-breakdown,
  title = {Cost breakdown of traditional clinical trials},
  author = {JAMA Internal Medicine},
  year = {},
  journal = {JAMA Internal Medicine: Clinical Trial Costs Study},
  url = {https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2702287},
  urldate = {2025-01-20},
  note = {JAMA Internal Medicine: Clinical Trial Costs Study},
}

@article{clinical-trial-cost-per-patient,
  title = {Clinical trial cost per patient (traditional Phase III)},
  author = {ProRelix Research},
  year = {},
  journal = {ProRelix Research},
  url = {https://prorelixresearch.com/phase-by-phase-clinical-trial-costs-what-every-sponsor-needs-to-know/},
  urldate = {2025-01-20},
  note = {ProRelix Research, Phase-by-Phase Clinical Trial Costs | WithPower, Clinical Trial Cost Per Patient | JAMA, Cost of Bringing a New Drug},
}

@article{clinical-trial-eligibility-rate,
  title = {Clinical trial eligibility},
  author = {Applied Clinical Trials},
  year = {},
  journal = {Applied Clinical Trials},
  url = {https://www.appliedclinicaltrialsonline.com/view/rebooting-the-statistic-that-5-of-eligible-patients-participate-in-clinical-trials},
  urldate = {2025-01-20},
  note = {Applied Clinical Trials},
}

@article{clinical-trial-enrollment-timelines,
  title = {Clinical trial enrollment timelines},
  author = {Clinical Trials Arena},
  year = {},
  journal = {Clinical Trials Arena},
  url = {https://www.clinicaltrialsarena.com/marketdata/featureclinical-trial-patient-recruitment/},
  urldate = {2025-01-20},
  note = {Clinical Trials Arena, Link},
}

@article{clinical-trial-geographic-barriers,
  title = {Clinical trial geographic access barriers},
  author = {JCO Oncology Practice},
  year = {2024},
  journal = {JCO Oncology Practice: Geographic Access to Cancer Trials},
  url = {https://ascopubs.org/doi/10.1200/OP.24.00261},
  urldate = {2025-01-20},
  note = {JCO Oncology Practice: Geographic Access to Cancer Trials, 2024 | PMC: Geographic Disparities in Clinical Trials | PMC: Travel Burden in Cancer Clinical Trials | Elligo Health Research: 67 Miles Av...},
}

@article{clinical-trial-market-size,
  title = {Global clinical trials market size},
  author = {Fortune Business Insights, May},
  year = {2024},
  journal = {Fortune Business Insights},
  url = {https://www.fortunebusinessinsights.com/clinical-trials-market-106930},
  urldate = {2025-01-20},
  note = {Fortune Business Insights, May 2024, Clinical Trials Market Size, Share \& Industry Analysis | Global Market Insights, Feb 2024, Clinical Trials Market – Global Forecast 2024-2034},
}

@article{clinical-trial-patient-participation-rate,
  title = {Clinical trial patient participation rate},
  author = {ACS CAN},
  year = {},
  journal = {ACS CAN: Barriers to Clinical Trial Enrollment},
  url = {https://www.fightcancer.org/policy-resources/barriers-patient-enrollment-therapeutic-clinical-trials-cancer},
  urldate = {2025-01-20},
  note = {ACS CAN: Barriers to Clinical Trial Enrollment | HINTS: Clinical Trial Participation},
}

@article{clinical-trial-spending,
  title = {\$61 billion global annual clinical trial expenditure},
  author = {Fortune Business Insights},
  year = {2024},
  journal = {Fortune Business Insights},
  url = {https://www.fortunebusinessinsights.com/clinical-trials-market-106930},
  urldate = {2025-01-20},
  note = {Fortune Business Insights, May 2024 | Global Market Insights, Feb 2024},
}

@article{clinical-trial-spending-dfda-baseline,
  title = {Annual global clinical trial spending},
  author = {Fortune Business Insights},
  year = {},
  journal = {Fortune Business Insights},
  url = {https://www.fortunebusinessinsights.com/clinical-trials-market-106930},
  urldate = {2025-01-20},
  note = {Fortune Business Insights, Clinical Trials Market | Global Market Insights, Clinical Trials Market Forecast},
}

@article{clinical-trials-cost-per-approved-drug,
  title = {Total clinical trial costs per approved drug},
  author = {CBO},
  year = {},
  journal = {CBO},
  url = {https://www.cbo.gov/publication/57126},
  urldate = {2025-01-20},
  note = {CBO, Pharmaceutical Industry R\&D},
}

@article{clinical-trials-market-projection-2030,
  title = {Clinical trials market projections for 2030},
  author = {Global Market Insights},
  year = {2025},
  journal = {Global Market Insights},
  url = {https://www.gminsights.com/industry-analysis/clinical-trials-market},
  urldate = {2025-01-20},
  note = {Global Market Insights, Clinical Trials Market 2025-2034 | Research and Markets, 2024},
}

@article{clinical-trials-market-projection-2034,
  title = {Clinical trials market projections for 2034},
  author = {Precedence Research},
  year = {2024},
  journal = {Precedence Research},
  url = {https://www.precedenceresearch.com/clinical-trials-market},
  urldate = {2025-01-20},
  note = {Precedence Research, Clinical Trials Market Forecast | Towards Healthcare, 2024},
}

@article{clinical-trials-market-range-2024,
  title = {Clinical trials market size range 2024},
  author = {Towards Healthcare},
  year = {},
  journal = {Towards Healthcare},
  url = {https://www.towardshealthcare.com/insights/innovation-in-drug-development-calls-for-clinical-trials},
  urldate = {2025-01-20},
  note = {Towards Healthcare, Clinical Trials Market | Straits Research, Clinical Trials Market Analysis},
}

@article{clinical-trials-puzzle-interactome,
  title = {Only ~12\% of human interactome targeted},
  author = {PMC},
  year = {2023},
  journal = {PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC10749231/},
  urldate = {2025-01-20},
  note = {PMC, 2023, The Clinical Trials Puzzle},
}

@article{clinicaltrials-gov-enrollment-data-2025,
  title = {ClinicalTrials.gov cumulative enrollment data (2025)},
  author = {Direct analysis via},
  year = {},
  journal = {Direct analysis via ClinicalTrials.gov API v2},
  url = {https://clinicaltrials.gov/data-api/api},
  urldate = {2025-01-20},
  note = {Direct analysis via ClinicalTrials.gov API v2},
}

@article{cluster-munitions-convention-2008,
  title = {Convention on Cluster Munitions (2008) - Oslo Process},
  author = {Convention on Cluster Munitions},
  year = {},
  journal = {Convention on Cluster Munitions},
  url = {https://www.clusterconvention.org/oslo-process/},
  urldate = {2025-01-20},
  note = {Convention on Cluster Munitions, Oslo Process | UNIDIR, Unacceptable Harm: History of the Treaty | CMC, Global Cluster Munition Ban},
}

@article{cmmi-overview,
  title = {CMS Innovation Center (CMMI) Overview},
  author = {CMS},
  year = {},
  journal = {CMS},
  url = {https://www.cms.gov/priorities/innovation/about},
  urldate = {2025-01-20},
  note = {CMS, CMMI Overview},
}

@article{cognitive-limit-seven-items,
  title = {Cognitive Limit in Short-Term Memory (Miller's Law)},
  author = {George A. Miller},
  year = {1956},
  journal = {George A. Miller},
  url = {https://doi.org/10.1037/h0043158},
  urldate = {2025-01-20},
  note = {George A. Miller, 1956, The Magical Number Seven, Plus or Minus Two: Some Limits on Our Capacity for Processing Information, Psychological Review, Vol. 63, No. 2},
}

@article{congress-time-spent-fundraising,
  title = {Percentage of time members of Congress spend fundraising},
  author = {CBS 60 Minutes},
  year = {},
  journal = {CBS 60 Minutes: Congressional Telemarketers},
  url = {https://www.cbsnews.com/news/60-minutes-are-members-of-congress-becoming-telemarketers/},
  urldate = {2025-01-20},
  note = {CBS 60 Minutes: Congressional Telemarketers | HuffPost: Call Time},
}

@article{congress-unrequested-defense-spending,
  title = {Congress adding funds to defense budget not requested by the Pentagon},
  author = {Military.com},
  year = {2025},
  journal = {Military.com: $15B Unrequested Weapons},
  url = {https://www.military.com/daily-news/2025/04/03/capitol-hill-wants-15-billion-weapons-pentagon-didnt-seek-report.html},
  urldate = {2025-01-20},
  note = {Military.com: $15B Unrequested Weapons | Roll Call: $100B+ Unrequested Since 2022},
}

@article{congressional-committee-price-list,
  title = {Congressional committee assignments have explicit fundraising price tags},
  author = {Issue One},
  year = {2017},
  journal = {Issue One: The Price of Power},
  url = {https://www.issueone.org/wp-content/uploads/2017/05/price-of-power-final.pdf},
  urldate = {2025-01-20},
  note = {Issue One: The Price of Power | The Intercept: DCCC Committee Dues | Brookings: Committee Tax in Congress | Roll Call: Committee Gavels Don't Come Cheap},
}

@article{congressman-salary,
  title = {Salary of a U.S. Congressman},
  author = {U.S. Senate},
  year = {},
  journal = {U.S. Senate: Salaries},
  url = {https://www.senate.gov/senators/SenateSalariesSince1789.htm},
  urldate = {2025-01-20},
  note = {U.S. Senate: Salaries | Congressional Research Service Report},
}

@article{conscious-vs-unconscious-decisions-5-pct,
  title = {Conscious mind controls ~5\% of decisions},
  author = {ScienceDaily},
  year = {2008},
  journal = {ScienceDaily: Unconscious Decision Making},
  url = {https://www.sciencedaily.com/releases/2008/04/080414145705.htm},
  urldate = {2025-01-20},
  note = {ScienceDaily: Unconscious Decision Making | PMC: The Unconscious Mind},
}

@article{contracts-2-02t,
  title = {Defense Contracts (2001-2021)},
  author = {Responsible Statecraft},
  year = {2021},
  journal = {Responsible Statecraft},
  url = {https://responsiblestatecraft.org/2021/09/02/top-defense-firms-see-2t-return-on-1b-investment-in-afghan-war/},
  urldate = {2025-01-20},
  note = {Responsible Statecraft, 2021, Top defense firms see \$2T return on \$1B investment in Afghan war},
}

@article{control-arms-coalition,
  title = {Control Arms Coalition - Arms Trade Treaty Campaign},
  author = {Wikipedia},
  year = {},
  journal = {Wikipedia},
  url = {https://en.wikipedia.org/wiki/Control_Arms_Campaign},
  urldate = {2025-01-20},
  note = {Wikipedia, Control Arms Campaign | Oxfam, How did a global campaign bring about a UN Arms Trade Treaty? | Oxfam Policy, Power and Change: The Arms Trade Treaty},
}

@report{copenhagenconsensus2023,
  title = {Halftime for SDGs: Child Immunization},
  institution = {Copenhagen Consensus},
  year = {2023},
  url = {https://copenhagenconsensus.com/publication/halftime-sdgs-child-immunization},
  urldate = {2025-01-20},
  note = {Analysis calculating benefit-cost ratio of 101:1 for childhood immunization programs in low- and middle-income countries, 2023-2030},
}

@article{coppa-compliance,
  title = {Children's Online Privacy Protection Act (COPPA)},
  author = {FTC},
  year = {},
  journal = {FTC: COPPA Rule},
  url = {https://www.ftc.gov/legal-library/browse/rules/childrens-online-privacy-protection-rule-coppa},
  urldate = {2025-01-20},
  note = {FTC: COPPA Rule | Wikipedia: COPPA | eCFR: 16 CFR Part 312},
}

@article{corporate-lobbying-spending-2023,
  title = {Corporate lobbying spending in 2023},
  author = {Statista},
  year = {2023},
  journal = {Statista: Total Lobbying Spending 2023},
  url = {https://www.statista.com/statistics/257337/total-lobbying-spending-in-the-us/},
  urldate = {2025-01-20},
  note = {Statista: Total Lobbying Spending 2023 | OpenSecrets: Federal Lobbying},
}

@article{cost-of-political-influence,
  title = {How campaign contributions influence politicians},
  author = {ScienceDirect},
  year = {2010},
  journal = {ScienceDirect: Campaign Contributions \& Legislative Behavior},
  url = {https://www.sciencedirect.com/science/article/pii/S0047272725000179},
  urldate = {2025-01-20},
  note = {ScienceDirect: Campaign Contributions \& Legislative Behavior | Slate: Cost to Buy a Vote | OpenSecrets: Cost of Election | Issue One: Congressional Fundraising},
}

@article{cost-of-universal-healthcare,
  title = {Estimated cost of providing universal healthcare globally},
  author = {WHO},
  year = {2030},
  journal = {WHO: Cost of Reaching Global Health Targets by 2030},
  url = {https://www.who.int/news/item/17-07-2017-who-estimates-cost-of-reaching-global-health-targets-by-2030},
  urldate = {2025-01-20},
  note = {WHO: Cost of Reaching Global Health Targets by 2030 | WHO: UHC Fact Sheet)},
}

@article{costa-rica-no-military,
  title = {Costa Rica abolished its army in 1949},
  author = {UNESCO Memory of the World},
  year = {},
  journal = {UNESCO Memory of the World: Abolition of Army},
  url = {https://en.unesco.org/memoryoftheworld/registry/209},
  urldate = {2025-01-20},
  note = {UNESCO Memory of the World: Abolition of Army | Wikipedia: Article 12 Costa Rica Constitution},
}

@article{covid-deaths-vs-us-war-deaths,
  title = {Comparison of U.S. deaths from COVID-19 vs. major wars},
  author = {Statista},
  year = {},
  journal = {Statista: COVID vs War Deaths},
  url = {https://www.statista.com/chart/24252/us-covid-19-deaths-compared-to-deaths-in-major-wars/},
  urldate = {2025-01-20},
  note = {Statista: COVID vs War Deaths | Snopes: COVID vs Foreign Conflicts},
}

@article{covid-economic-damage-16t,
  title = {Economic Damage of COVID-19 Pandemic},
  author = {JAMA},
  year = {2020},
  journal = {JAMA: The $16 Trillion Virus},
  url = {<https://jamanetwork.com/journals/jama/fullarticle/2771764>},
  urldate = {2025-01-20},
  note = {JAMA: The $16 Trillion Virus | Harvard Gazette: COVID Cost},
}

@article{covid-therapeutics-accelerator,
  title = {COVID-19 Therapeutics Accelerator},
  author = {Gates Foundation},
  year = {2020},
  journal = {Gates Foundation},
  url = {https://www.gatesfoundation.org/ideas/media-center/press-releases/2020/03/covid-19-therapeutics-accelerator-awards-$20-million-in-initial-grants-to-fund-clinical-trials},
  urldate = {2025-01-20},
  note = {Gates Foundation, COVID-19 Therapeutics Accelerator},
}

@misc{covid-therapeutics-initial-grants,
  title = {COVID-19 Therapeutics Accelerator initial grants},
  author = {Gates Foundation},
  year = {2020},
  note = {Gates Foundation, March 2020},
}

@report{creditsuisse2023,
  title = {Global Wealth Report 2023},
  institution = {UBS and Credit Suisse},
  year = {2023},
  url = {https://www.ubs.com/global/en/family-office-uhnw/reports/global-wealth-report-2023.html},
  urldate = {2025-01-20},
  note = {Reports global household wealth of USD 454.4 trillion in 2023; first joint UBS-Credit Suisse wealth report},
}

@article{crispr-discovery-yogurt-bacteria,
  title = {Discovery of CRISPR in yogurt bacteria research},
  author = {Nature},
  year = {2012},
  journal = {Nature},
  url = {https://www.nature.com/articles/d41586-020-02765-9},
  urldate = {2025-01-20},
  note = {Nature, Pioneers of revolutionary CRISPR gene editing win chemistry Nobel | Science, 2012, A Programmable Dual-RNA-Guided DNA Endonuclease | Note: Doudna \& Charpentier discovered CRISPR/Cas9 while...},
}

@article{cs-global-wealth-report-2023,
  title = {Credit Suisse Global Wealth Report 2023},
  author = {Credit Suisse/UBS},
  year = {2023},
  journal = {Credit Suisse/UBS},
  url = {https://www.ubs.com/global/en/family-office-uhnw/reports/global-wealth-report-2023.html},
  urldate = {2025-01-20},
  note = {Credit Suisse/UBS, 2023, Global Wealth Report 2023},
}

@article{current-median-household-wealth-100k,
  title = {Current median household wealth of ~\$100,000},
  author = {DQYDJ},
  year = {2024},
  journal = {DQYDJ: Net Worth Percentiles},
  url = {https://dqydj.com/net-worth-percentiles/},
  urldate = {2025-01-20},
  note = {DQYDJ: Net Worth Percentiles | Census: Home Equity \& Net Worth},
}

@article{cvd-80-percent-preventable,
  title = {80\% of cardiovascular disease is preventable},
  author = {WHO},
  year = {2021},
  journal = {WHO: Cardiovascular diseases (CVDs))},
  url = {https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds},
  urldate = {2025-01-20},
  note = {WHO: Cardiovascular diseases (CVDs)) | World Heart Federation: CVD Prevention | Cleveland Clinic: 90\% Preventable | PMC: Strategy to Reduce CVD by 80\%},
}

@article{cybercrime-economy-10-5t,
  title = {Cybercrime economy projected to reach $10.5 trillion},
  author = {Cybersecurity Ventures},
  year = {2016},
  journal = {Cybersecurity Ventures: $10.5T Cybercrime},
  url = {<https://cybersecurityventures.com/hackerpocalypse-cybercrime-report-2016/>},
  urldate = {2025-01-20},
  note = {Cybersecurity Ventures: $10.5T Cybercrime | Boise State: Cybercrime Costs},
}

@article{cybercrimes-unpunished-96-pct,
  title = {96\% of cybercrimes go unpunished},
  author = {CSO Online},
  year = {},
  journal = {CSO Online: Why Internet Crime Goes Unpunished},
  url = {https://www.csoonline.com/article/2618598/why-internet-crime-goes-unpunished.html},
  urldate = {2025-01-20},
  note = {CSO Online: Why Internet Crime Goes Unpunished | Information Security Buzz: 1\% Prosecuted},
}

@article{daily-death-toll-by-region,
  title = {Daily death toll statistics by geographic region},
  author = {PMC},
  year = {},
  journal = {PMC: Heart of the World - CVD Regional Burden},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC10809869/},
  urldate = {2025-01-20},
  note = {PMC: Heart of the World - CVD Regional Burden | Lancet: CVD in Americas00287-4/fulltext)},
}

@article{dao-multisig-vulnerabilities,
  title = {DAO multisig vulnerabilities to technical and social exploits},
  author = {Quorum},
  year = {},
  journal = {Quorum: Auditing Social Layer of DAO},
  url = {https://mirror.xyz/quorumnewsletter.eth/U5lYFUe5oavRiwdRisH9DnejpvRJhteObB7tpV5Kw_E},
  urldate = {2025-01-20},
  note = {Quorum: Auditing Social Layer of DAO | BlockScience: DAO Vulnerabilities | Consensys: State of DAO Security},
}

@article{dct-cost-reductions-evidence,
  title = {Decentralized Clinical Trials (DCT) cost reduction evidence},
  author = {Rogers et al.},
  year = {2022},
  journal = {Rogers et al.},
  url = {https://discovery.dundee.ac.uk/ws/files/72718478/Brit_J_Clinical_Pharma_2022_Rogers_A_systematic_review_of_methods_used_to_conduct_decentralised_clinical_trials.pdf},
  urldate = {2025-01-20},
  note = {Rogers et al., 2022, Systematic review of methods used to conduct decentralised clinical trials | Valachis \& Lindman, 2024, Lessons learned from an unsuccessful DCT in Oncology},
}

@article{dct-platform-funding-medable,
  title = {Medable DCT platform funding},
  author = {HIT Consultant, Oct},
  year = {2021},
  journal = {HIT Consultant},
  url = {https://hitconsultant.net/2021/10/26/medable-dct-series-d-funding/},
  urldate = {2025-01-20},
  note = {HIT Consultant, Oct 2021, Medable Raises $304M Series D | Informa Connect, Medable raises another $300M},
}

@article{dct-platform-funding-others,
  title = {Other DCT platform company funding},
  author = {MobiHealthNews, Aug},
  year = {2020},
  journal = {MobiHealthNews},
  url = {https://www.mobihealthnews.com/news/exo-raises-40m-handheld-ultrasound-decentralized-trial-platforms-raise-nearly-100m-and-more},
  urldate = {2025-01-20},
  note = {MobiHealthNews, Aug 2020, DCT Platforms Raise Nearly $100M | Pharma Almanac, Apr 2022, uMotif Announces $25.5M Investment},
}

@article{death-causes-vs-fear,
  title = {Death Causes vs Fear (Heart Disease vs Terrorism)},
  author = {IHME},
  year = {2023},
  journal = {IHME: CVD Deaths 2023},
  url = {https://www.healthdata.org/news-events/newsroom/news-releases/report-cardiovascular-diseases-caused-1-3-global-deaths-2023},
  urldate = {2025-01-20},
  note = {IHME: CVD Deaths 2023 | World Heart Federation Report 2023},
}

@article{deaths-from-treatable-diseases-15m,
  title = {Annual deaths from treatable diseases},
  author = {PMC},
  year = {2025},
  journal = {PMC: Mortality Due to Low-Quality Health Systems},
  url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238021/},
  urldate = {2025-01-20},
  note = {PMC: Mortality Due to Low-Quality Health Systems | WHO: Avoidable NCD Deaths},
}

@article{defense-pension-funds-assets,
  title = {Assets Under Management by Defense Contractor Pension Funds},
  author = {Pensions \& Investments},
  year = {},
  journal = {Pensions \& Investments: Defense Contractor Pension Assets},
  url = {https://www.pionline.com/article/20130204/PRINT/302049981/defense-contractor-pension-assets-eyed},
  urldate = {2025-01-20},
  note = {Pensions \& Investments: Defense Contractor Pension Assets | GAO: Pension Costs on DOD Contracts},
}

@article{defense-vs-nih-salary-comparison,
  title = {Salary comparison between defense industry and NIH},
  author = {Glassdoor},
  year = {},
  journal = {Glassdoor: Raytheon Salaries},
  url = {https://www.glassdoor.com/Salary/Raytheon-Salaries-E3300024.htm},
  urldate = {2025-01-20},
  note = {Glassdoor: Raytheon Salaries | Glassdoor: NIH Salaries},
}

@article{delaware-corporate-population,
  title = {Delaware has more corporate entities than residents},
  author = {Delaware Division of Corporations},
  year = {2020},
  journal = {Delaware Division of Corporations: 2020 Annual Report},
  url = {https://corp.delaware.gov/stats/2020-annual-report/},
  urldate = {2025-01-20},
  note = {Delaware Division of Corporations: 2020 Annual Report | Princeton Press: What's the Matter with Delaware?},
}

@article{depression-leading-cause-disability,
  title = {Depression is the leading cause of disability worldwide},
  author = {WHO},
  year = {2017},
  journal = {WHO: Depression Let's Talk (2017)},
  url = {https://www.who.int/news/item/30-03-2017--depression-let-s-talk-says-who-as-depression-tops-list-of-causes-of-ill-health},
  urldate = {2025-01-20},
  note = {WHO: Depression Let's Talk (2017) | UN News: Leading Cause of Disability | JAMA: Depression Leading Cause},
}

@article{depression-prevalence-280m,
  title = {Global prevalence of depression: 280 million},
  author = {WHO},
  year = {},
  journal = {WHO: Depression Fact Sheet},
  url = {https://www.who.int/news-room/fact-sheets/detail/depression},
  urldate = {2025-01-20},
  note = {WHO: Depression Fact Sheet | Our World in Data: Mental Health},
}

@report{desa2023,
  title = {Credit Rating Agencies and Sovereign Debt: Four Proposals to Support Achievement of the SDGs},
  institution = {United Nations Department of Economic and Social Affairs},
  year = {2023},
  number = {131},
  url = {https://desapublications.un.org/policy-briefs/un-desa-policy-brief-no-131},
  urldate = {2025-01-20},
}

@article{deworming-cost-per-daly,
  title = {Cost per DALY for Deworming Programs},
  author = {GiveWell},
  year = {},
  journal = {GiveWell: Cost-Effectiveness in $/DALY for Deworming},
  url = {https://www.givewell.org/international/technical/programs/deworming/cost-effectiveness},
  urldate = {2025-01-20},
  note = {GiveWell: Cost-Effectiveness in $/DALY for Deworming},
}

@article{dfda-roi-463-to-1,
  title = {dFDA ROI: 4,990:1 (recommended) to 8,542:1 (full impact)},
  author = {dFDA},
  year = {},
  journal = {dFDA: Cost Benefit Analysis},
  url = {https://wiki.dfda.earth/en/economic-models/dfda-cost-benefit-analysis},
  urldate = {2025-01-20},
  note = {dFDA: Cost Benefit Analysis | dFDA Wiki},
}

@article{diabetes-deaths-2m-annually,
  title = {Annual deaths from diabetes},
  author = {International Diabetes Federation},
  year = {2024},
  journal = {International Diabetes Federation},
  url = {https://diabetesatlas.org/},
  urldate = {2025-01-20},
  note = {International Diabetes Federation, 2024, IDF Diabetes Atlas | WHO, 2021, Diabetes Fact Sheet | Note: 3.4 million deaths in 2024 (IDF), including direct and indirect deaths from diabetes complications},
}

@article{disease-advocacy-lobbying-roi,
  title = {Lobbying spending and returns for disease advocacy groups},
  author = {NYU Stern},
  year = {2024},
  journal = {NYU Stern: Lobbying Influences NIH Funding},
  url = {https://www.stern.nyu.edu/experience-stern/news-events/new-research-finds-special-interest-lobbying-does-influence-nih-research-funding},
  urldate = {2025-01-20},
  note = {NYU Stern: Lobbying Influences NIH Funding | Nature: Lobbying Sways NIH Grants | Alzheimer's Association: $100M Increase},
}

@article{disease-burden-as-pct-of-gdp,
  title = {Global disease burden as a percentage of global GDP},
  author = {McKinsey},
  year = {},
  journal = {McKinsey: Poor Health Reduces GDP 15%},
  url = {https://www.mckinsey.com/mgi/overview/in-the-news/poor-health-reduces-global-gdp-by-15-percent-each-year},
  urldate = {2025-01-20},
  note = {McKinsey: Poor Health Reduces GDP 15\% | WEF: Global Economic Burden of NCDs},
}

@article{disease-cost-alzheimers-1300b,
  title = {Annual global economic burden of Alzheimer's and other dementias},
  author = {WHO},
  year = {2019},
  journal = {WHO: Dementia Fact Sheet},
  url = {https://www.who.int/news-room/fact-sheets/detail/dementia},
  urldate = {2025-01-20},
  note = {WHO: Dementia Fact Sheet | Alzheimer's \& Dementia: Worldwide Costs 2019},
}

@article{disease-cost-cancer-1800b,
  title = {Annual global economic burden of cancer},
  author = {JAMA Oncology},
  year = {2020},
  journal = {JAMA Oncology: Global Cost 2020-2050},
  url = {https://jamanetwork.com/journals/jamaoncology/fullarticle/2801798},
  urldate = {2025-01-20},
  note = {JAMA Oncology: Global Cost 2020-2050 | Nature: $25T Over 30 Years},
}

@article{disease-cost-diabetes-1500b,
  title = {Annual global economic burden of diabetes},
  author = {Diabetes Care},
  year = {},
  journal = {Diabetes Care: Global Economic Burden},
  url = {https://diabetesjournals.org/care/article/41/5/963/36522/Global-Economic-Burden-of-Diabetes-in-Adults},
  urldate = {2025-01-20},
  note = {Diabetes Care: Global Economic Burden | Lancet: Diabetes Economic Burden30100-6/abstract)},
}

@article{disease-cost-heart-disease-2100b,
  title = {Annual global economic burden of heart disease},
  author = {Int'l Journal of Cardiology},
  year = {2050},
  journal = {Int'l Journal of Cardiology: Global Heart Failure Burden02238-9/abstract)},
  url = {https://www.internationaljournalofcardiology.com/article/S0167-5273(13},
  urldate = {2025-01-20},
  note = {Int'l Journal of Cardiology: Global Heart Failure Burden02238-9/abstract) | AHA: US CVD Costs to 2050},
}

@article{disease-cost-kidney-disease-600b,
  title = {Annual global economic burden of kidney disease},
  author = {PMC},
  year = {},
  journal = {PMC: Inside CKD Global Economic Burden},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC10499937/},
  urldate = {2025-01-20},
  note = {PMC: Inside CKD Global Economic Burden | Lancet eClinicalMedicine: CKD Projections00194-9/fulltext)},
}

@article{disease-cost-mental-illness-1600b,
  title = {Annual global economic burden of mental illness},
  author = {PMC},
  year = {},
  journal = {PMC: Economic Costs of Mental Disorders},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC5007565/},
  urldate = {2025-01-20},
  note = {PMC: Economic Costs of Mental Disorders | eClinicalMedicine: Quantifying Mental Disorder Burden00405-9/fulltext)},
}

@article{disease-cost-respiratory-900b,
  title = {Annual global economic burden of respiratory diseases},
  author = {Lancet Respiratory Medicine},
  year = {2017},
  journal = {Lancet Respiratory Medicine: GBD 2017 CRDs30105-3/fulltext)},
  url = {https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20},
  urldate = {2025-01-20},
  note = {Lancet Respiratory Medicine: GBD 2017 CRDs30105-3/fulltext) | Frontiers in Medicine: CRD Burden 2019 | CDC MMWR: US Worker Costs},
}

@misc{disease-economic-burden-109t,
  title = {\$109 trillion annual global disease burden},
  author = {Calculated from IHME Global Burden of Disease (2.55B DALYs) and global GDP per capita valuation},
  year = {},
  note = {Calculated from IHME Global Burden of Disease (2.55B DALYs) and global GDP per capita valuation},
}

@article{disease-network-overlap,
  title = {Disease network overlap (network medicine)},
  author = {Barabási et al.},
  year = {2011},
  journal = {Barabási et al.},
  url = {https://www.nature.com/articles/nrg2918},
  urldate = {2025-01-20},
  note = {Barabási et al., 2011, Network medicine: a network-based approach to human disease},
}

@article{disease-prevalence-2-billion,
  title = {Global prevalence of chronic disease},
  author = {ScienceDaily},
  year = {2015},
  journal = {ScienceDaily: GBD 2015 Study},
  url = {https://www.sciencedaily.com/releases/2015/06/150608081753.htm},
  urldate = {2025-01-20},
  note = {ScienceDaily: GBD 2015 Study | PMC: Burden of Chronic Disease | PMC: Multiple Chronic Conditions},
}

@article{diseases-cured-since-2014,
  title = {Number of diseases cured since 2014},
  author = {PMC},
  year = {},
  journal = {PMC: Hepatitis C Elimination},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC8112794/},
  urldate = {2025-01-20},
  note = {PMC: Hepatitis C Elimination | Military Medical Research: HCV to Clinical Cure | WHO: Hepatitis C Fact Sheet},
}

@report{disley2011,
  title = {Lessons Learned from the Planning and Early Implementation of the Social Impact Bond at HMP Peterborough},
  institution = {Disley, Emma and Rubin, Jennifer and Scraggs, Emily and Burrowes, Nina and Culley, Deirdre},
  year = {2011},
}

@article{disparity-ratio-weapons-vs-cures,
  title = {36:1 disparity ratio of spending on weapons over cures},
  author = {SIPRI},
  year = {2016},
  journal = {SIPRI: Military Spending},
  url = {https://www.sipri.org/commentary/blog/2016/opportunity-cost-world-military-spending},
  urldate = {2025-01-20},
  note = {SIPRI: Military Spending | PMC: Military vs Healthcare Crowding Out | Congress.gov: Global R\&D Landscape},
}

@article{dot-vsl-13-6m,
  title = {DOT Value of Statistical Life (\$13.6M)},
  author = {DOT},
  year = {2024},
  journal = {DOT: VSL Guidance 2024},
  url = {https://www.transportation.gov/office-policy/transportation-policy/revised-departmental-guidance-on-valuation-of-a-statistical-life-in-economic-analysis},
  urldate = {2025-01-20},
  note = {DOT: VSL Guidance 2024 | DOT: Economic Values Used in Analysis},
}

@misc{drug-development-cost,
  title = {Cost of drug development},
  author = {Tufts CSDD},
  year = {},
  note = {Tufts CSDD | IQVIA | Deloitte},
}

@article{drug-development-success-rate-0-01pct,
  title = {Drug development success rate: 0.01\%},
  author = {PMC},
  year = {2006},
  journal = {PMC: Approval Success Rates},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC8212735/},
  urldate = {2025-01-20},
  note = {PMC: Approval Success Rates | PMC: Why 90\% Fail | ScienceDirect: Benchmarking R\&D Success 2006-2022},
}

@article{drug-development-timeline-17-years,
  title = {Time to develop one drug: 17 years},
  author = {Drugs.com},
  year = {},
  journal = {Drugs.com},
  url = {https://www.drugs.com/fda-approval-process.html},
  urldate = {2025-01-20},
  note = {Drugs.com, FDA Drug Approval Process | FDAReview.org, The Drug Development and Approval Process | Note: 12-15 years average from preclinical to FDA approval},
}

@article{drug-price-competition-act-1984,
  title = {Drug Price Competition and Patent Term Restoration Act of 1984},
  author = {Wikipedia},
  year = {},
  journal = {Wikipedia: Hatch-Waxman Act},
  url = {https://en.wikipedia.org/wiki/Drug_Price_Competition_and_Patent_Term_Restoration_Act},
  urldate = {2025-01-20},
  note = {Wikipedia: Hatch-Waxman Act | Congress.gov: H.R.3605 | CRS: Hatch-Waxman Primer},
}

@article{drug-repurposing-hub-collection,
  title = {Drug Repurposing Hub (Broad Institute)},
  author = {Broad Institute},
  year = {2017},
  journal = {Broad Institute},
  url = {https://www.broadinstitute.org/drug-repurposing-hub},
  urldate = {2025-01-20},
  note = {Broad Institute, Drug Repurposing Hub | Corsello et al., Nature Medicine (2017)},
}

@article{drug-repurposing-rate,
  title = {Drug Repurposing Rate (~30\%)},
  author = {Nature Medicine},
  year = {2024},
  journal = {Nature Medicine},
  url = {https://www.nature.com/articles/s41591-024-03233-x},
  urldate = {2025-01-20},
  note = {Nature Medicine, 2024, Drug Repurposing Trends},
}

@article{drug-trial-success-rate-12-pct,
  title = {Drug trial success rate from Phase I to approval},
  author = {Nature Reviews Drug Discovery},
  year = {2016},
  journal = {Nature Reviews Drug Discovery: Clinical Success Rates},
  url = {https://www.nature.com/articles/nrd.2016.136},
  urldate = {2025-01-20},
  note = {Nature Reviews Drug Discovery: Clinical Success Rates | PMC: Estimating Success Rates | Oxford Academic: Clinical Trial Success},
}

@article{dtra-alliance,
  title = {Decentralized Trials \& Research Alliance (DTRA)},
  author = {Decentralized Trials \& Research Alliance (DTRA)},
  year = {},
  journal = {DTRA Official Site},
  url = {https://www.dtra.org/},
  urldate = {2025-01-20},
  note = {DTRA Official Site | Wikipedia: DTRA | VA News: Decentralized Trials},
}

@article{dunbar-number,
  title = {Dunbar's Number},
  author = {Dunbar, R.I.M.},
  year = {1992},
  journal = {Dunbar},
  url = {<https://doi.org/10.1016/0047-2484(92},
  urldate = {2025-01-20},
  note = {Dunbar, R.I.M., 1992, Neocortex size as a constraint on group size in primates90081-J>)},
}

@article{eclinicalmedicine-statins-polypill,
  title = {Statins and polypill cost-effectiveness},
  author = {eClinicalMedicine},
  year = {2022},
  journal = {eClinicalMedicine},
  url = {https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(22},
  urldate = {2025-01-20},
  note = {eClinicalMedicine, 2022, The Lancet eClinicalMedicine00155-2/fulltext)},
}

@article{education-investment-economic-multiplier,
  title = {Education investment economic multiplier (2.1)},
  author = {EPI},
  year = {},
  journal = {EPI: Public Investments Outside Core Infrastructure},
  url = {https://www.epi.org/publication/bp348-public-investments-outside-core-infrastructure/},
  urldate = {2025-01-20},
  note = {EPI: Public Investments Outside Core Infrastructure | World Bank: Returns to Investment in Education | Freopp: Education ROI Framework},
}

@article{england-trial-participants-2023-24,
  title = {England clinical trial participants 2023/24},
  author = {NIHR},
  year = {2023},
  journal = {NIHR},
  url = {https://www.nihr.ac.uk/about-us/who-we-are/reports-and-performance/annual-statistics},
  urldate = {2025-01-20},
  note = {NIHR, Annual Statistics 2023/24},
}

@article{environmental-cost-of-war,
  title = {Environmental cost of war (\$100B annually)},
  author = {Brown Watson Costs of War},
  year = {},
  journal = {Brown Watson Costs of War: Environmental Cost},
  url = {https://watson.brown.edu/costsofwar/costs/social/environment},
  urldate = {2025-01-20},
  note = {Brown Watson Costs of War: Environmental Cost | Earth.Org: Environmental Impact of Wars | Transform Defence: Military Spending \& Climate},
}

@article{eo-13944-essential-medicines,
  title = {Executive Order 13944 (2020) on Essential Medicines},
  author = {Trump White House Archives},
  year = {2020},
  journal = {Trump White House Archives: EO 13944},
  url = {https://trumpwhitehouse.archives.gov/presidential-actions/executive-order-ensuring-essential-medicines-medical-countermeasures-critical-inputs-made-united-states/},
  urldate = {2025-01-20},
  note = {Trump White House Archives: EO 13944 | Federal Register: EO 13944 | FDA: EO 13944 List},
}

@article{eo-14158,
  title = {Executive Order 14158 (DOGE)},
  author = {White House},
  year = {2025},
  journal = {White House},
  url = {https://www.federalregister.gov/documents/2025/01/29/2025-02005/establishing-and-implementing-the-presidents-department-of-government-efficiency},
  urldate = {2025-01-20},
  note = {White House, 2025, EO 14158},
}

@article{eo-14210,
  title = {Executive Order 14210 (DOGE Workforce Optimization)},
  author = {White House},
  year = {2025},
  journal = {White House},
  url = {https://www.federalregister.gov/documents/2025/02/14/2025-02762/implementing-the-presidents-department-of-government-efficiency-workforce-optimization-initiative},
  urldate = {2025-01-20},
  note = {White House, 2025, EO 14210},
}

@article{eo-14222,
  title = {Executive Order 14222 (DOGE Cost Efficiency)},
  author = {White House},
  year = {2025},
  journal = {White House},
  url = {https://www.whitehouse.gov/presidential-actions/2025/02/implementing-the-presidents-department-of-government-efficiency-cost-efficiency-initiative/},
  urldate = {2025-01-20},
  note = {White House, 2025, EO 14222},
}

@article{epa-vsl-9-6m,
  title = {EPA Value of Statistical Life (\$9.6M)},
  author = {EPA},
  year = {2017},
  journal = {EPA: Mortality Risk Valuation},
  url = {https://www.epa.gov/environmental-economics/mortality-risk-valuation},
  urldate = {2025-01-20},
  note = {EPA: Mortality Risk Valuation | RFF: Revisiting EPA's VSL | EPA: VSL White Paper},
}

@article{erectile-dysfunction-drug-market-3b,
  title = {Erectile dysfunction drug market size: $3 billion/year},
  author = {Grand View Research},
  year = {2034},
  journal = {Grand View Research: ED Drugs Market},
  url = {https://www.grandviewresearch.com/industry-analysis/erectile-dysfunction-drugs-market},
  urldate = {2025-01-20},
  note = {Grand View Research: ED Drugs Market | Cognitive Market Research: ED Drug Market | Precedence Research: ED Market to 2034},
}

@article{estonia-eresidency-stats,
  title = {Estonia e-Residency statistics},
  author = {e-Residency},
  year = {2024},
  journal = {e-Residency},
  url = {https://www.e-resident.gov.ee/dashboard/},
  urldate = {2025-01-20},
  note = {e-Residency, 2024, Statistics},
}

@article{estonia-government-on-blockchain,
  title = {Estonia's digital governance model},
  author = {e-Estonia},
  year = {},
  journal = {e-Estonia: KSI Blockchain},
  url = {https://e-estonia.com/solutions/cyber-security/ksi-blockchain/},
  urldate = {2025-01-20},
  note = {e-Estonia: KSI Blockchain | Medium: Estonia's Blockchain Success | Oxford Academic: Blockchain at Government Level},
}

@article{estonia-internet-voting,
  title = {Estonia internet voting lessons},
  author = {Academic and official analyses, e.g.},
  year = {},
  journal = {Academic and official analyses},
  url = {https://e-estonia.com/solutions/e-governance/e-democracy/},
  urldate = {2025-01-20},
  note = {Academic and official analyses, e.g., e-estonia.com},
}

@article{estonia-x-road,
  title = {Estonia's X-Road blockchain-based health system},
  author = {e-Estonia},
  year = {},
  journal = {e-Estonia: Estonian e-Health Records},
  url = {https://e-estonia.com/solutions/e-health-2/e-health-records/},
  urldate = {2025-01-20},
  note = {e-Estonia: Estonian e-Health Records | Invest in Estonia: e-Health | GovInsider: Estonia Blockchain Health Records},
}

@misc{eu-annual-health-research-budget,
  title = {EU annual health research budget},
  author = {Calculated from total health budget allocation},
  year = {},
  note = {Calculated from total health budget allocation},
}

@article{eu-compassionate-use-program,
  title = {EU Compassionate Use program for experimental drugs},
  author = {EMA},
  year = {},
  journal = {EMA: Compassionate Use},
  url = {https://www.ema.europa.eu/en/human-regulatory-overview/research-development/compassionate-use},
  urldate = {2025-01-20},
  note = {EMA: Compassionate Use | PMC: Overview of Compassionate Use in EU | EURORDIS: Early Access to Promising Medicines},
}

@article{eu-eidas-network,
  title = {EU eIDAS network for electronic identification},
  author = {EU Digital Strategy},
  year = {2014},
  journal = {EU Digital Strategy: eIDAS Regulation},
  url = {https://digital-strategy.ec.europa.eu/en/policies/eidas-regulation},
  urldate = {2025-01-20},
  note = {EU Digital Strategy: eIDAS Regulation | EUR-Lex: Regulation 910/2014 | Wikipedia: eIDAS},
}

@article{eu-horizon-health-budget-8-2b,
  title = {Horizon Europe Health Budget (2021-2027): €8.2 billion},
  author = {HRB},
  year = {},
  journal = {HRB: Horizon Europe Health Information},
  url = {https://www.hrb.ie/funding/funding-opportunities/eu-funding-support/horizon-europe-information/},
  urldate = {2025-01-20},
  note = {HRB: Horizon Europe Health Information | HaDEA: Horizon Europe Health | Health-NCP-Net: Horizon Europe},
}

@article{eu-mica,
  title = {EU MiCA transparency and disclosure},
  author = {EUR‑Lex},
  year = {2023},
  journal = {EUR‑Lex},
  url = {https://eur-lex.europa.eu/eli/reg/2023/1114/oj},
  urldate = {2025-01-20},
  note = {EUR‑Lex, 2023, MiCA Regulation},
}

@misc{eu4health-2024-budget,
  title = {EU4Health 2024 annual budget},
  author = {European Commission resources},
  year = {},
  note = {European Commission resources},
}

@article{eu4health-budget,
  title = {EU4Health programme budget},
  author = {European Commission},
  year = {},
  journal = {European Commission},
  url = {https://research-and-innovation.ec.europa.eu/research-area/health_en},
  urldate = {2025-01-20},
  note = {European Commission, EU4Health},
}

@article{european-drug-approval-timeline,
  title = {Average drug approval timeline in Europe},
  author = {EMA},
  year = {},
  journal = {EMA: From Lab to Patient Timeline},
  url = {https://www.ema.europa.eu/en/from-lab-to-patient-timeline},
  urldate = {2025-01-20},
  note = {EMA: From Lab to Patient Timeline | PMC: FDA vs EMA Cancer Therapy Timings | Value in Health: US vs EU Authorization Timelines00160-0/fulltext)},
}

@article{evolutionary-mismatch,
  title = {Evolutionary Mismatch and Modern Disease},
  author = {Lieberman, Daniel},
  year = {2013},
  journal = {Lieberman},
  url = {https://www.penguinrandomhouse.com/books/206671/the-story-of-the-human-body-by-daniel-e-lieberman/},
  urldate = {2025-01-20},
  note = {Lieberman, Daniel, 2013, The Story of the Human Body: Evolution, Health, and Disease},
}

@article{excess-deaths-fda-covid-response,
  title = {Estimated excess deaths attributed to FDA's COVID-19 response},
  author = {PMC},
  year = {},
  journal = {PMC: EUAs vs FDA Approval Implications},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC8101583/},
  urldate = {2025-01-20},
  note = {PMC: EUAs vs FDA Approval Implications | PMC: FDA \& COVID Political Economy | Yale Law Journal: Deadly Delay FDA Role},
}

@article{executive-orders-regulatory-reform,
  title = {Executive Orders on Regulatory Reform},
  author = {Wikipedia},
  year = {2025},
  journal = {Wikipedia: EO 13771},
  url = {https://en.wikipedia.org/wiki/Executive_Order_13771},
  urldate = {2025-01-20},
  note = {Wikipedia: EO 13771 | White House: 10-to-1 Deregulation | Skadden: Rolling Back Administrative State},
}

@article{f35-cost-vs-rare-disease-research,
  title = {F-35 cost compared to global rare disease research funding},
  author = {Responsible Statecraft},
  year = {},
  journal = {Responsible Statecraft: F-35 Cost $2T},
  url = {<https://responsiblestatecraft.org/f35-cost/>},
  urldate = {2025-01-20},
  note = {Responsible Statecraft: F-35 Cost $2T | Statista: Rare Diseases Funding NIH | Arms Control Center: F-35 Costs \& Challenges},
}

@article{f35-program-details,
  title = {F-35 program cost details and manufacturing locations},
  author = {New Atlas},
  year = {2015},
  journal = {New Atlas: $400K Helmet},
  url = {<https://newatlas.com/aircraft/f-35-lightning-gen-3-hdms-helmet-cost/>},
  urldate = {2025-01-20},
  note = {New Atlas: $400K Helmet | Air Force Times: F-35 Helmet | POGO: F-35 and Captured State},
}

@article{f35-program-lifetime-cost-1-7t,
  title = {F-35 program lifetime cost: $1.7 trillion},
  author = {GAO},
  year = {2024},
  journal = {GAO: F-35 Sustainment Costs},
  url = {https://www.gao.gov/products/gao-24-106703},
  urldate = {2025-01-20},
  note = {GAO: F-35 Sustainment Costs | Breaking Defense: F-35 Lifetime Cost},
}

@article{fda-annual-drug-approvals,
  title = {Average annual new drug approvals by FDA},
  author = {FDA},
  year = {2023},
  journal = {FDA: New Drug Therapy Approvals 2023},
  url = {https://www.fda.gov/media/175253/download},
  urldate = {2025-01-20},
  note = {FDA: New Drug Therapy Approvals 2023 | PMC: FDA Drug Approvals 2023},
}

@article{fda-approval-timeline-10-years,
  title = {FDA drug approval timeline},
  author = {Drugs.com},
  year = {},
  journal = {Drugs.com: FDA Drug Approval Process},
  url = {https://www.drugs.com/fda-approval-process.html},
  urldate = {2025-01-20},
  note = {Drugs.com: FDA Drug Approval Process | FDAReview.org: Drug Development \& Approval | PMC: Drugs, Devices, FDA Overview},
}

@article{fda-approved-drugs-total,
  title = {Total number of FDA-approved drugs},
  author = {PMC},
  year = {2023},
  journal = {PMC: FDA Drug Approvals 2023},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC10856271/},
  urldate = {2025-01-20},
  note = {PMC: FDA Drug Approvals 2023 | Statista: CDER Drug Approvals 2008-2023 | DrugBank: Statistics},
}

@article{fda-approved-products-20k,
  title = {FDA-approved prescription drug products (20,000+)},
  author = {FDA},
  year = {},
  journal = {FDA},
  url = {https://www.fda.gov/media/143704/download},
  urldate = {2025-01-20},
  note = {FDA, Facts About Generic Drugs},
}

@article{fda-budget-modernization-fy24,
  title = {FDA FY24 Budget Request for Modernization},
  author = {FDA},
  year = {2024},
  journal = {FDA: FY2024 Budget Summary},
  url = {https://www.fda.gov/about-fda/budgets/2024-budget-summary},
  urldate = {2025-01-20},
  note = {FDA: FY2024 Budget Summary | FDA: FY24 CJ Online Version},
}

@article{fda-covid-test-delay,
  title = {FDA delay in approving rapid COVID-19 tests},
  author = {CNN},
  year = {2020},
  journal = {CNN: How Government Delayed Testing},
  url = {https://www.cnn.com/2020/04/09/politics/coronavirus-testing-cdc-fda-red-tape-invs/index.html},
  urldate = {2025-01-20},
  note = {CNN: How Government Delayed Testing | Yale Law Journal: Deadly Delay | HHS OIG: FDA EUA Adaptations},
}

@article{fda-cure-id,
  title = {FDA Cure-ID Program},
  author = {CURE ID},
  year = {},
  journal = {CURE ID: About},
  url = {https://cure.ncats.io/about},
  urldate = {2025-01-20},
  note = {CURE ID: About | C-Path: CDRC and CURE ID FAQs | FDA: CURE ID Automated Data Collection},
}

@misc{fda-drug-lag-deaths-estimate,
  title = {fda-drug-lag-deaths-estimate},
  note = {See https://warondisease.org/knowledge/references.html\#fda-drug-lag-deaths-estimate},
  url = {https://warondisease.org/knowledge/references.html\#fda-drug-lag-deaths-estimate},
}

@article{fda-gras-list-count,
  title = {FDA GRAS List Count (~570-700)},
  author = {FDA},
  year = {},
  journal = {FDA},
  url = {https://www.fda.gov/food/generally-recognized-safe-gras/gras-notice-inventory},
  urldate = {2025-01-20},
  note = {FDA, GRAS Notice Inventory},
}

@article{fda-new-drug-approvals,
  title = {FDA new drug approvals annually},
  author = {FDA},
  year = {2022},
  journal = {FDA},
  url = {https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2022},
  urldate = {2025-01-20},
  note = {FDA, Novel Drug Approvals 2022},
}

@article{fda-phase-4-requirements,
  title = {FDA Phase 4 trial requirements},
  author = {FDA},
  year = {},
  journal = {FDA},
  url = {https://www.fda.gov/drugs/data-standards-manual-monographs/phase-4-commitment-category},
  urldate = {2025-01-20},
  note = {FDA, Phase 4 Commitment Category},
}

@article{fda-pre-1962-mandate,
  title = {FDA mandate pre-1962 focused on safety, not efficacy},
  author = {Wikipedia},
  year = {},
  journal = {Wikipedia: Kefauver-Harris Amendment},
  url = {https://en.wikipedia.org/wiki/Kefauver–Harris_Amendment},
  urldate = {2025-01-20},
  note = {Wikipedia: Kefauver-Harris Amendment | FDA: Promoting Safe \& Effective Drugs 100 Years | PMC: Kefauver-Harris Amendments at 50},
}

@article{fda-public-health-advancement-mandate,
  title = {FDA Mandate to Accelerate Innovation (21 U.S.C. § 393(b)(2)(B))},
  author = {United States Code},
  year = {2012},
  journal = {21 U.S.C. § 393},
  url = {https://www.law.cornell.edu/uscode/text/21/393},
  urldate = {2025-01-20},
  note = {21 U.S.C. § 393 | Public Law 112-144 (FDASIA 2012)},
}

@article{fda-regulatory-capture-evidence,
  title = {Evidence of FDA regulatory capture by pharmaceutical industry},
  author = {CRS},
  year = {},
  journal = {CRS: FDA Human Medical Product User Fees},
  url = {https://www.congress.gov/crs-product/R44750},
  urldate = {2025-01-20},
  note = {CRS: FDA Human Medical Product User Fees | ASPE: FDA User Fees Issue Brief | PMC: PDUFA - More Than User Fees},
}

@article{fda-reviewer-count,
  title = {Number of key FDA drug reviewers},
  author = {Wikipedia},
  year = {},
  journal = {Wikipedia: Center for Drug Evaluation and Research},
  url = {https://en.wikipedia.org/wiki/Center_for_Drug_Evaluation_and_Research},
  urldate = {2025-01-20},
  note = {Wikipedia: Center for Drug Evaluation and Research | NCBI: FDA Advisory Committee System},
}

@article{fda-sentinel-initiative,
  title = {FDA Sentinel Initiative},
  author = {FDA},
  year = {},
  journal = {FDA: Sentinel Initiative},
  url = {https://www.fda.gov/safety/fdas-sentinel-initiative},
  urldate = {2025-01-20},
  note = {FDA: Sentinel Initiative | PMC: Sentinel - Learning Health System | Wikipedia: Sentinel Initiative},
}

@article{fda-trial-launch-timeline,
  title = {FDA clinical trial launch timeline},
  author = {FDA},
  year = {2012},
  journal = {FDA: IND Application Procedures},
  url = {https://www.fda.gov/drugs/investigational-new-drug-ind-application/ind-application-procedures-overview},
  urldate = {2025-01-20},
  note = {FDA: IND Application Procedures | Drugs.com: FDA Approval Process | PMC: FDA's Expedited Programs 2012-2016},
}

@article{fda-trial-patient-exclusion-criteria,
  title = {FDA trial patient exclusion criteria},
  author = {FDA},
  year = {},
  journal = {FDA: Evaluating Inclusion \& Exclusion Criteria},
  url = {https://www.fda.gov/media/134754/download},
  urldate = {2025-01-20},
  note = {FDA: Evaluating Inclusion \& Exclusion Criteria | ScienceDirect: Eligibility Criteria FDA Perspective | ASCO: Transforming Eligibility Criteria},
}

@article{fda-vs-oxford-paperwork,
  title = {Paperwork comparison between FDA trials and RECOVERY trial},
  author = {PMC},
  year = {},
  journal = {PMC: Making Trials Part of Good Clinical Care - RECOVERY},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC8285150/},
  urldate = {2025-01-20},
  note = {PMC: Making Trials Part of Good Clinical Care - RECOVERY | PMC: Establishing COVID-19 Trials at Scale - RECOVERY | FDA: Form 1572},
}

@article{fdaaa-2007,
  title = {FDA Amendments Act (FDAAA) of 2007},
  author = {Wikipedia},
  year = {2007},
  journal = {Wikipedia: FDAAA 2007},
  url = {https://en.wikipedia.org/wiki/Food_and_Drug_Administration_Amendments_Act_of_2007},
  urldate = {2025-01-20},
  note = {Wikipedia: FDAAA 2007 | NEJM: FDAAA Effects a Decade Later | Congress.gov: H.R.3580},
}

@article{fdama-1997,
  title = {FDA Modernization Act of 1997 (FDAMA)},
  author = {Wikipedia},
  year = {1997},
  journal = {Wikipedia: FDAMA 1997},
  url = {https://en.wikipedia.org/wiki/Food_and_Drug_Administration_Modernization_Act_of_1997},
  urldate = {2025-01-20},
  note = {Wikipedia: FDAMA 1997 | Congress.gov: S.830 | GovInfo: Public Law 105-115},
}

@article{fdasia-2012,
  title = {FDA Safety and Innovation Act (FDASIA) of 2012},
  author = {FDA},
  year = {2012},
  journal = {FDA: FDASIA},
  url = {https://www.fda.gov/regulatory-information/selected-amendments-fdc-act/food-and-drug-administration-safety-and-innovation-act-fdasia},
  urldate = {2025-01-20},
  note = {FDA: FDASIA | Wikipedia: FDASIA | PMC: User Fees and Beyond - FDASIA 2012},
}

@article{fec-foreign-national-restrictions,
  title = {FEC Foreign National Restrictions},
  author = {52 U.S.C. § 30121(a)(1)(A)},
  year = {},
  journal = {52 U.S.C. § 30121(a)(1)(A)},
  url = {https://www.fec.gov/updates/foreign-nationals/},
  urldate = {2025-01-20},
  note = {52 U.S.C. § 30121(a)(1)(A), FEC Guidelines},
}

@article{fec-foreign-nationals,
  title = {FEC Foreign Nationals Guidance},
  author = {Federal Election Commission},
  year = {},
  journal = {Federal Election Commission},
  url = {https://www.fec.gov/updates/foreign-nationals/},
  urldate = {2025-01-20},
  note = {Federal Election Commission, Foreign Nationals},
}

@article{feca-violation-penalties,
  title = {FECA violation penalties},
  author = {Wiley},
  year = {2020},
  journal = {Wiley: FEC Increases Civil Penalties},
  url = {https://www.wiley.law/newsletter-709},
  urldate = {2025-01-20},
  note = {Wiley: FEC Increases Civil Penalties | USSC: Amendment 648 | Inside Political Law: Criminal Campaign Finance},
}

@article{fhir-standard,
  title = {Fast Healthcare Interoperability Resources (FHIR) Standard},
  author = {HL7},
  year = {},
  journal = {HL7: FHIR Overview},
  url = {https://www.hl7.org/fhir/overview.html},
  urldate = {2025-01-20},
  note = {HL7: FHIR Overview | Wikipedia: FHIR | HealthIT.gov: HL7 FHIR},
}

@article{fintech-identity-verification-conversion-2024,
  title = {Fintech identity verification conversion rates and costs (2024)},
  author = {Regula (BusinessWire)},
  year = {},
  journal = {Regula (BusinessWire)},
  url = {https://www.businesswire.com/news/home/20241217060846/en/ABA-Bank-Boosts-Conversion-Rate-and-Cuts-Acquisition-Costs-by-65-with-Regula-Identity-Verification-Solution},
  urldate = {2025-01-20},
  note = {Regula (BusinessWire), ABA Bank Boosts Conversion Rate | Biometric Update, Identity verification scale to push costs down},
}

@article{food-abundance-stats,
  title = {Food Abundance in Modern Society},
  author = {USDA Economic Research Service},
  year = {2019},
  journal = {USDA Economic Research Service},
  url = {https://www.ers.usda.gov/data-products/food-availability-per-capita-data-system/},
  urldate = {2025-01-20},
  note = {USDA Economic Research Service, 2019, Food Availability and Consumption},
}

@article{fossil-fuel-lobbying-roi,
  title = {Fossil Fuel Lobbying ROI},
  author = {Rep. Omar \& Sen. Sanders},
  year = {2024},
  journal = {Rep. Omar \& Sen. Sanders},
  url = {https://omar.house.gov/media/press-releases/rep-omar-and-sen-sanders-introduce-legislation-end-corporate-welfare-fossil-0},
  urldate = {2025-01-20},
  note = {Rep. Omar \& Sen. Sanders, 2024, End Polluter Welfare Act},
}

@article{fossil-fuel-subsidies,
  title = {Fossil Fuel Subsidies (\$7T, 2022)},
  author = {IMF},
  year = {2023},
  journal = {IMF},
  url = {https://www.imf.org/en/Blogs/Articles/2023/08/24/fossil-fuel-subsidies-surged-to-record-7-trillion},
  urldate = {2025-01-20},
  note = {IMF, 2023, Fossil Fuel Subsidies Surged to Record $7 Trillion},
}

@article{fowler2020,
  title = {Quid Pro Quo? Corporate Returns to Campaign Contributions},
  author = {Fowler, Anthony and Garro, Haritz and Spenkuch, Jörg L.},
  year = {2020},
  journal = {The Journal of Politics},
  volume = {82},
  number = {3},
  pages = {844-858},
}

@article{france-medical-research-spending-4b,
  title = {France medical research spending: ~$4 billion/year},
  author = {French Healthcare},
  year = {2030},
  journal = {French Healthcare: Health Innovation Plan 2030},
  url = {https://frenchhealthcare.com/frances-attractiveness/health-innovation-plan-2030-e7-5-billion-to-return-france-to-its-position-as-leader-in-healthcare-in-europe/},
  urldate = {2025-01-20},
  note = {French Healthcare: Health Innovation Plan 2030 | Campus France: France 2030 Boost Health Research},
}

@article{friends-cancer-research-fda-approvals,
  title = {FDA novel drug approvals annually},
  author = {Friends of Cancer Research},
  year = {2023},
  journal = {Friends of Cancer Research},
  url = {https://www.focr.org/},
  urldate = {2025-01-20},
  note = {Friends of Cancer Research, 2023 FDA Drug Approvals},
}

@article{ftc-act-15-usc-45,
  title = {Federal Trade Commission Act (15 U.S.C. § 45)},
  author = {United States Code},
  year = {2023},
  journal = {15 U.S.C. § 45},
  url = {https://www.law.cornell.edu/uscode/text/15/45},
  urldate = {2025-01-20},
  note = {15 U.S.C. § 45 | Federal Register: Civil Penalty Adjustments 2023},
}

@article{furniture-accidents-vs-terrorism-deaths,
  title = {Deaths from furniture accidents compared to terrorism},
  author = {Washington Post},
  year = {2015},
  journal = {Washington Post: More Likely Crushed by Furniture},
  url = {https://www.washingtonpost.com/news/monkey-cage/wp/2015/11/23/youre-more-likely-to-be-fatally-crushed-by-furniture-than-killed-by-a-terrorist/},
  urldate = {2025-01-20},
  note = {Washington Post: More Likely Crushed by Furniture | CPSC: Tip-Over Report 2023 | Our World in Data: Terrorism vs Other Causes},
}

@article{gao-clinical-research-figure,
  title = {GAO: NIH Clinical Research Spending ($5.6B/year)},
  author = {GAO},
  year = {},
  journal = {GAO-23-105656},
  url = {https://www.gao.gov/products/gao-23-105656},
  urldate = {2025-01-20},
  note = {GAO-23-105656},
}

@article{gao-healthcare-gov-costs,
  title = {HealthCare.gov initial build costs},
  author = {GAO Reports and Public Reporting},
  year = {},
  journal = {GAO Reports and Public Reporting},
  url = {https://www.gao.gov/assets/gao-07-49.pdf},
  urldate = {2025-01-20},
  note = {GAO Reports and Public Reporting, GAO Healthcare IT},
}

@article{gates-foundation-endowment-size,
  title = {Gates Foundation Endowment Size},
  author = {Gates Foundation},
  year = {2024},
  journal = {Gates Foundation: Fact Sheet},
  url = {https://www.gatesfoundation.org/about/foundation-fact-sheet},
  urldate = {2025-01-20},
  note = {Gates Foundation: Fact Sheet | Fortune: Spend Down to Zero},
}

@article{gates-wellcome-novo-partnership-2024,
  title = {Gates Foundation, Wellcome, and Novo Nordisk partnership 2024},
  author = {Wellcome},
  year = {},
  journal = {Wellcome},
  url = {https://wellcome.org/news/novo-nordisk-foundation-wellcome-and-gates-foundation-join-forces-accelerate-global-health},
  urldate = {2025-01-20},
  note = {Wellcome, Global Health Equity Partnership},
}

@article{gates-wellcome-tb-vaccine-550m,
  title = {Gates and Wellcome TB vaccine funding},
  author = {Philanthropy News Digest},
  year = {},
  journal = {Philanthropy News Digest},
  url = {https://philanthropynewsdigest.org/news/wellcome-gates-foundation-award-550-million-for-tuberculosis-vaccine},
  urldate = {2025-01-20},
  note = {Philanthropy News Digest, TB Vaccine Funding},
}

@article{gdp-of-china,
  title = {GDP of China},
  author = {China Briefing},
  year = {2024},
  journal = {China Briefing: China's Economy 2024},
  url = {https://www.china-briefing.com/news/chinas-economy-in-2024-gdp-trade-fdi/},
  urldate = {2025-01-20},
  note = {China Briefing: China's Economy 2024 | Wikipedia: Economy of China | Visual Capitalist: China's $18.6T Economy},
}

@article{gdp-of-greenland,
  title = {Gross Domestic Product (GDP) of Greenland},
  author = {Trading Economics},
  year = {},
  journal = {Trading Economics: Greenland GDP},
  url = {https://tradingeconomics.com/greenland/gdp},
  urldate = {2025-01-20},
  note = {Trading Economics: Greenland GDP | Wikipedia: Economy of Greenland | World Bank: Greenland Data},
}

@article{gdpr-biometric-data,
  title = {GDPR Biometric Data requirements},
  author = {GDPR Article 9(1)},
  year = {},
  journal = {GDPR Article 9(1)},
  url = {https://gdpr-info.eu/art-9-gdpr/},
  urldate = {2025-01-20},
  note = {GDPR Article 9(1), EU General Data Protection Regulation},
}

@article{gdufa-user-fees,
  title = {Generic Drug User Fee Act (GDUFA)},
  author = {FDA},
  year = {2025},
  journal = {FDA: GDUFA},
  url = {https://www.fda.gov/industry/fda-user-fee-programs/generic-drug-user-fee-amendments},
  urldate = {2025-01-20},
  note = {FDA: GDUFA | CRS: Generic Drug User Fee Amendments | Federal Register: GDUFA Rates FY2026},
}

@article{general-dynamics-annual-revenue-39b,
  title = {General Dynamics annual revenue},
  author = {General Dynamics},
  year = {2025},
  journal = {General Dynamics: Q4 \& FY2024 Results},
  url = {https://www.gd.com/Articles/2025/01/29/general-dynamics-reports-fourth-quarter-and-full-year-2024-financial-results},
  urldate = {2025-01-20},
  note = {General Dynamics: Q4 \& FY2024 Results | Statista: General Dynamics Revenue},
}

@article{generic-drug-substitution-savings,
  title = {Generic Drug Substitution Savings},
  author = {FDA},
  year = {},
  journal = {FDA},
  url = {https://www.fda.gov/drugs/generic-drugs/generic-drug-facts},
  urldate = {2025-01-20},
  note = {FDA, Link},
}

@article{geographic-literacy-survey,
  title = {Survey on Americans' geographic literacy},
  author = {National Geographic},
  year = {2006},
  journal = {National Geographic: Survey Reveals Geographic Illiteracy},
  url = {https://www.nationalgeographic.com/science/article/geography-survey-illiteracy},
  urldate = {2025-01-20},
  note = {National Geographic: Survey Reveals Geographic Illiteracy | National Geographic-Roper 2006 Report | ETIAS: EU Country Survey},
}

@article{germany-medical-research-spending-6b,
  title = {Germany medical research spending: ~$6 billion/year},
  author = {Research in Germany},
  year = {},
  journal = {Research in Germany: Government Funding},
  url = {https://www.research-in-germany.org/en/research-landscape/why-germany/research-funding-system/government-funding.html},
  urldate = {2025-01-20},
  note = {Research in Germany: Government Funding | Lancet: Public Investment in Biomedical Research Europe00326-8/fulltext) | Science: German Research Budget Increases},
}

@article{gilens2014,
  title = {Testing Theories of American Politics: Elites, Interest Groups, and Average Citizens},
  author = {Gilens, Martin and Page, Benjamin I.},
  year = {2014},
  journal = {Perspectives on Politics},
  volume = {12},
  number = {3},
  pages = {564-581},
  doi = {10.1017/S1537592714001595},
  url = {https://scholar.princeton.edu/sites/default/files/mgilens/files/gilens_and_page_2014_-testing_theories_of_american_politics.doc.pdf},
  urldate = {2025-01-20},
}

@article{gitcoin-passport,
  title = {Gitcoin Passport for digital identity scoring},
  author = {Gitcoin},
  year = {},
  journal = {Gitcoin: Intro to Passport},
  url = {https://www.gitcoin.co/blog/intro-to-passport},
  urldate = {2025-01-20},
  note = {Gitcoin: Intro to Passport | Human Passport | Gitcoin: Building Sybil Resistance},
}

@article{givewell-cost-per-life-saved,
  title = {GiveWell Cost per Life Saved for Top Charities (2024)},
  author = {GiveWell},
  year = {},
  journal = {GiveWell: Top Charities},
  url = {https://www.givewell.org/charities/top-charities},
  urldate = {2025-01-20},
  note = {GiveWell: Top Charities | GiveWell: Helen Keller Vitamin A | Our World in Data: Cost-Effectiveness},
}

@article{givewell-impact-multipliers,
  title = {GiveWell Impact Multipliers},
  author = {GiveWell},
  year = {2023},
  journal = {GiveWell},
  url = {https://www.givewell.org/how-we-work/our-criteria/cost-effectiveness/cost-effectiveness-models},
  urldate = {2025-01-20},
  note = {GiveWell, 2023, Cost-Effectiveness},
}

@article{global-aging-research-spending-500m,
  title = {Global aging research spending: ~$500 million},
  author = {PMC},
  year = {2022},
  journal = {PMC: Funding Channels of Geroscience},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC9808549/},
  urldate = {2025-01-20},
  note = {PMC: Funding Channels of Geroscience | NIA: FY2022 Budget | Spannr: Lack of Government Funding},
}

@article{global-armed-forces-size-and-salary,
  title = {Global armed forces size and average salary},
  author = {Our World in Data},
  year = {2024},
  journal = {Our World in Data: Military Personnel \& Spending},
  url = {https://ourworldindata.org/military-personnel-spending},
  urldate = {2025-01-20},
  note = {Our World in Data: Military Personnel \& Spending | World Bank: Armed Forces Personnel | SIPRI: Military Spending 2024},
}

@article{global-burden-disease-chronic-conditions-2013,
  title = {Global Burden of Disease Study 2013: 2.4 billion people with chronic diseases},
  author = {ScienceDaily},
  year = {2013},
  journal = {ScienceDaily: GBD 2013 Study},
  url = {https://www.sciencedaily.com/releases/2015/06/150608081753.htm},
  urldate = {2025-01-20},
  note = {ScienceDaily: GBD 2013 Study | UN News: Chronic Diseases Taking Toll | WHO: Noncommunicable Diseases Fact Sheet | PMC: The Burden of Chronic Disease},
}

@article{global-cancer-research-spending,
  title = {Global cancer research spending (~\$51.4B, 2016-2023)},
  author = {The Conversation},
  year = {2023},
  journal = {The Conversation},
  url = {https://theconversation.com/billions-spent-on-cancer-research-globally-but-is-it-money-well-spent-201407},
  urldate = {2025-01-20},
  note = {The Conversation, 2023, Billions spent on cancer research globally | The Lancet Oncology, 2023, Global funding for cancer research between 2016 and 202000182-1/fulltext) | NCI, 2024, Budget and App...},
}

@article{global-cancer-research-spending-20b,
  title = {Global cancer research spending},
  author = {Lancet Oncology},
  year = {2016},
  journal = {Lancet Oncology: Global Funding 2016-202000182-1/fulltext)},
  url = {https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23},
  urldate = {2025-01-20},
  note = {Lancet Oncology: Global Funding 2016-202000182-1/fulltext) | NCI: Budget Fact Book | The Conversation: Billions Spent on Cancer Research},
}

@article{global-cancer-spending-25b,
  title = {Global cancer research spending: ~$25 billion},
  author = {Lancet Oncology},
  year = {2016},
  journal = {Lancet Oncology: Global Funding 2016-202000182-1/fulltext)},
  url = {https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23},
  urldate = {2025-01-20},
  note = {Lancet Oncology: Global Funding 2016-202000182-1/fulltext) | The Conversation: Billions Spent Globally},
}

@article{global-clinical-trials-market-2024,
  title = {Global clinical trials market 2024},
  author = {Research and Markets},
  year = {2024},
  journal = {Research and Markets},
  url = {https://www.globenewswire.com/news-release/2024/04/19/2866012/0/en/Global-Clinical-Trials-Market-Research-Report-2024-An-83-16-Billion-Market-by-2030-AI-Machine-Learning-and-Blockchain-will-Transform-the-Clinical-Trials-Landscape.html},
  urldate = {2025-01-20},
  note = {Research and Markets, Global Clinical Trials Market Report 2024 | Precedence Research, Clinical Trials Market Size},
}

@article{global-cosmetics-market-90b,
  title = {Global cosmetics market size: $90 billion},
  author = {Fortune},
  year = {},
  journal = {Fortune: Cosmetics Market},
  url = {https://www.fortunebusinessinsights.com/cosmetics-market-102614},
  urldate = {2025-01-20},
  note = {Fortune: Cosmetics Market | Precedence Research: Cosmetics Market | Oberlo: Global Cosmetics Market Size},
}

@article{global-dementia-research-spending,
  title = {Global dementia research spending (~\$5-6B annually, 2024)},
  author = {Alzheimer's Association},
  year = {2024},
  journal = {Alzheimer's Association},
  url = {https://www.alz.org/news/2024/congress-bipartisan-funding-alzheimers-research},
  urldate = {2025-01-20},
  note = {Alzheimer's Association, 2024, Congress Reaches Bipartisan Agreement on Alzheimer's Research Funding | National Institute on Aging, Nations gather to coordinate global dementia research},
}

@article{global-disease-burden-savings-9-76t-annually,
  title = {Global disease burden savings of ~\$9.76 trillion annually},
  author = {WEF},
  year = {},
  journal = {WEF: Global Economic Burden NCDs},
  url = {https://www3.weforum.org/docs/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf},
  urldate = {2025-01-20},
  note = {WEF: Global Economic Burden NCDs | PMC: Health Benefits Accelerated Research},
}

@article{global-education-market-size,
  title = {Global annual spending on education},
  author = {Morgan Stanley},
  year = {},
  journal = {Morgan Stanley: Global Education $8T Reboot},
  url = {<https://www.morganstanley.com/ideas/education-system-technology-reboot>},
  urldate = {2025-01-20},
  note = {Morgan Stanley: Global Education $8T Reboot | UNESCO: Finance GEM Report | HolonIQ: Global Education Market},
}

@article{global-food-market-size,
  title = {Global annual spending on food},
  author = {Statista},
  year = {},
  journal = {Statista: Food Market Revenue Worldwide},
  url = {https://www.statista.com/forecasts/1243605/revenue-food-market-worldwide},
  urldate = {2025-01-20},
  note = {Statista: Food Market Revenue Worldwide | Statista: Food Worldwide Outlook | World Metrics: Global Food Industry Statistics},
}

@article{global-fund,
  title = {The Global Fund},
  author = {The Global Fund},
  year = {},
  journal = {The Global Fund},
  url = {https://www.theglobalfund.org/en/about-the-global-fund/},
  urldate = {2025-01-20},
  note = {The Global Fund, Overview},
}

@article{global-fund-50-million-lives-saved,
  title = {Lives saved by The Global Fund},
  author = {Global Fund},
  year = {2025},
  journal = {Global Fund: Results Report 2025},
  url = {https://www.theglobalfund.org/en/results/},
  urldate = {2025-01-20},
  note = {Global Fund: Results Report 2025 | Global Fund: 50M Lives Saved Press Release 2022},
}

@article{global-gdp,
  title = {Global GDP (\$101T, 2022)},
  author = {Statista},
  year = {2023},
  journal = {Statista},
  url = {https://www.statista.com/statistics/268750/global-gross-domestic-product-gdp/},
  urldate = {2025-01-20},
  note = {Statista, 2023, Global GDP},
}

@article{global-gdp-2023,
  title = {Global GDP in 2023 (\$89.5 trillion)},
  author = {World Bank},
  year = {2023},
  journal = {World Bank},
  url = {https://data.worldbank.org/indicator/NY.GDP.MKTP.CD},
  urldate = {2025-01-20},
  note = {World Bank, World GDP | Note: 2023 global GDP was $106.2T; 2024 was $111.3T according to World Bank data},
}

@article{global-gdp-per-capita,
  title = {Global GDP per capita (\$12,263, 2022)},
  author = {World Bank},
  year = {2023},
  journal = {World Bank},
  url = {https://data.worldbank.org/indicator/NY.GDP.PCAP.CD},
  urldate = {2025-01-20},
  note = {World Bank, GDP per capita data | Statista: Global GDP per capita 2023},
}

@article{global-gov-med-research-spending,
  title = {Global government medical research spending (\$67.5B, 2023–2024)},
  author = {See component country budgets:},
  year = {},
  journal = {See component country budgets: NIH Budget},
  url = {#nih-budget-fy2025},
  urldate = {2025-01-20},
  note = {See component country budgets: NIH Budget, China R\&D, EU Horizon Health},
}

@article{global-government-clinical-trial-spending-estimate,
  title = {Global government spending on interventional clinical trials: ~$3-6 billion/year},
  author = {Applied Clinical Trials},
  year = {},
  journal = {Applied Clinical Trials},
  url = {https://www.appliedclinicaltrialsonline.com/view/sizing-clinical-research-market},
  urldate = {2025-01-20},
  note = {Applied Clinical Trials | Lancet Global Health30357-0/fulltext)},
}

@article{global-health-spending-gdp,
  title = {Global health spending as a share of GDP (9.8\%, 2020)},
  author = {World Health Organization},
  year = {2022},
  journal = {World Health Organization},
  url = {https://www.who.int/publications/i/item/9789240064929},
  urldate = {2025-01-20},
  note = {World Health Organization, Global Health Expenditure Report 2022},
}

@article{global-heart-disease-spending-8b,
  title = {Global heart disease research spending: ~$8 billion},
  author = {AHA},
  year = {1996},
  journal = {AHA: Scientific Research},
  url = {https://www.heart.org/en/about-us/scientific-research},
  urldate = {2025-01-20},
  note = {AHA: Scientific Research | PMC: Spending on CVD in US 1996-2016 | ScienceDaily: CVD Costs $1T by 2035},
}

@article{global-infectious-disease-spending-12b,
  title = {Global infectious diseases research spending: ~$12 billion},
  author = {Global Fund},
  year = {},
  journal = {Global Fund: Overview},
  url = {https://www.theglobalfund.org/en/about-the-global-fund/},
  urldate = {2025-01-20},
  note = {Global Fund: Overview},
}

@article{global-infrastructure-market-size,
  title = {Global annual spending on infrastructure (roads \& internet)},
  author = {MHI Spectra},
  year = {2019},
  journal = {MHI Spectra: Infrastructure Investment Doubling},
  url = {https://spectra.mhi.com/heres-why-investment-in-global-infrastructure-will-double-over-the-next-decade},
  urldate = {2025-01-20},
  note = {MHI Spectra: Infrastructure Investment Doubling | Global Infrastructure Outlook | World Bank: $4.2T Saved by Resilient Infrastructure},
}

@article{global-major-military-facilities,
  title = {Number of major global military facilities (4,435)},
  author = {Wikipedia},
  year = {},
  journal = {Wikipedia: List of American Military Installations},
  url = {https://en.wikipedia.org/wiki/List_of_American_military_installations},
  urldate = {2025-01-20},
  note = {Wikipedia: List of American Military Installations | Visual Capitalist: US Military Bases Overseas | World Beyond War: Military Empires},
}

@article{global-mental-health-research-spending-1-5b,
  title = {Global mental health research spending},
  author = {Lancet Global Health},
  year = {2023},
  journal = {Lancet Global Health: Mental Health Matters30432-0/fulltext)},
  url = {https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20},
  urldate = {2025-01-20},
  note = {Lancet Global Health: Mental Health Matters30432-0/fulltext) | United GMH: Financing Mental Health | ScienceDirect: Accounting for Mental Health Research Funding},
}

@article{global-mental-health-spending-3b,
  title = {Global mental health research spending: ~$3 billion},
  author = {Lancet Global Health},
  year = {},
  journal = {Lancet Global Health: Mental Health Matters30432-0/fulltext)},
  url = {https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20},
  urldate = {2025-01-20},
  note = {Lancet Global Health: Mental Health Matters30432-0/fulltext)},
}

@article{global-military-spending,
  title = {Global military spending (\$2.72T, 2024)},
  author = {SIPRI},
  year = {2025},
  journal = {SIPRI},
  url = {https://www.sipri.org/publications/2025/sipri-fact-sheets/trends-world-military-expenditure-2024},
  urldate = {2025-01-20},
  note = {SIPRI, 2025, Trends in World Military Expenditure 2024},
}

@article{global-military-spending-2-44t,
  title = {Global military spending of $2.44 trillion annually},
  author = {SIPRI},
  year = {2025},
  journal = {SIPRI},
  url = {https://www.sipri.org/publications/2025/sipri-fact-sheets/trends-world-military-expenditure-2024},
  urldate = {2025-01-20},
  note = {SIPRI, 2025, Trends in World Military Expenditure, 2024 | Note: 2024 spending reached $2.718 trillion, up 9.4\% from 2023 | SIPRI Military Expenditure Database, Database},
}

@article{global-new-drug-approvals-50-annually,
  title = {Annual number of new drugs approved globally: ~50},
  author = {C\&EN},
  year = {2025},
  journal = {C\&EN},
  url = {https://cen.acs.org/pharmaceuticals/50-new-drugs-received-FDA/103/i2},
  urldate = {2025-01-20},
  note = {C\&EN, 2025, 50 new drugs received FDA approval in 2024 | FDA, Novel Drug Approvals | Note: Average ~50 per year 2018-2024; 32 small molecules + 18 biologics in 2024},
}

@article{global-nuclear-weapon-maintenance-100b,
  title = {Global nuclear weapon maintenance cost: $100 billion/year},
  author = {ICAN},
  year = {2024},
  journal = {ICAN: Global Spending $100B 2024},
  url = {<https://www.icanw.org/global_spending_on_nuclear_weapons_topped_100_billion_in_2024>},
  urldate = {2025-01-20},
  note = {ICAN: Global Spending $100B 2024 | ICAN: The Cost of Nuclear Weapons},
}

@article{global-population-8-billion,
  title = {Global population reaches 8 billion},
  author = {UN},
  year = {2022},
  journal = {UN: World Population 8 Billion Nov 15 2022},
  url = {https://www.un.org/en/desa/world-population-reach-8-billion-15-november-2022},
  urldate = {2025-01-20},
  note = {UN: World Population 8 Billion Nov 15 2022 | UN: Day of 8 Billion | Wikipedia: Day of Eight Billion},
}

@article{global-rare-disease-research-spending-6b,
  title = {Global rare disease research spending},
  author = {Statista},
  year = {},
  journal = {Statista: Rare Diseases Funding NIH},
  url = {https://www.statista.com/statistics/713320/rare-diseases-funding-by-the-national-institutes-for-health/},
  urldate = {2025-01-20},
  note = {Statista: Rare Diseases Funding NIH | NIH: Funding Bolsters Rare Diseases Research},
}

@article{global-rare-disease-spending-2b,
  title = {Global rare diseases research spending: ~$2 billion},
  author = {Statista},
  year = {},
  journal = {Statista: Rare Diseases Funding NIH},
  url = {https://www.statista.com/statistics/713320/rare-diseases-funding-by-the-national-institutes-for-health/},
  urldate = {2025-01-20},
  note = {Statista: Rare Diseases Funding NIH},
}

@article{global-real-estate-market-size,
  title = {Global annual spending on housing},
  author = {Statista},
  year = {},
  journal = {Statista: Real Estate Worldwide},
  url = {https://www.statista.com/outlook/fmo/real-estate/worldwide},
  urldate = {2025-01-20},
  note = {Statista: Real Estate Worldwide | Straits Research: Real Estate Market | Grand View Research: Real Estate Market},
}

@article{global-transportation-market-size,
  title = {Global annual spending on transportation (cars \& planes)},
  author = {Business Research Company},
  year = {2025},
  journal = {Business Research Company: Transport Market 2025},
  url = {https://www.thebusinessresearchcompany.com/report/transport-global-market-report},
  urldate = {2025-01-20},
  note = {Business Research Company: Transport Market 2025 | Precedence Research: Transportation Services | Cervicorn: Transportation Market $17.23T by 2034},
}

@article{global-trial-participant-capacity,
  title = {Global trial capacity},
  author = {IQVIA Report},
  year = {},
  journal = {IQVIA Report: Clinical Trial Subjects Number Drops Due to Decline in COVID-19 Enrollment},
  url = {https://gmdpacademy.org/news/iqvia-report-clinical-trial-subjects-number-drops-due-to-decline-in-covid-19-enrollment/},
  urldate = {2025-01-20},
  note = {IQVIA Report: Clinical Trial Subjects Number Drops Due to Decline in COVID-19 Enrollment},
}

@article{global-university-student-population-20m,
  title = {Global university student population of 20 million},
  author = {UNESCO},
  year = {2025},
  journal = {UNESCO: Record 264M Students 2025},
  url = {https://www.unesco.org/en/articles/record-number-higher-education-students-highlights-global-need-recognition-qualifications},
  urldate = {2025-01-20},
  note = {UNESCO: Record 264M Students 2025 | ICEF: Growth Through 2040},
}

@article{global-video-game-market-85b,
  title = {Global video games market size: $85 billion},
  author = {Grand View Research},
  year = {2024},
  journal = {Grand View Research: Video Game Market},
  url = {https://www.grandviewresearch.com/industry-analysis/video-game-market},
  urldate = {2025-01-20},
  note = {Grand View Research: Video Game Market | Statista: Games Worldwide | Visual Capitalist: Video Game Revenue 2024},
}

@article{global-violence-costs,
  title = {Global Cost of Violence},
  author = {Institute for Economics \& Peace},
  year = {2022},
  journal = {Institute for Economics \& Peace},
  url = {https://www.visionofhumanity.org/maps/global-peace-index/},
  urldate = {2025-01-20},
  note = {Institute for Economics \& Peace, 2022, Global Peace Index},
}

@article{gm-ev-subsidy-lobbying,
  title = {General Motors lobbying for electric vehicle subsidies},
  author = {TT News},
  year = {2022},
  journal = {TT News: GM Ford Lobby to Save EV Tax Incentives},
  url = {https://www.ttnews.com/articles/gm-ford-ev-tax-incentives},
  urldate = {2025-01-20},
  note = {TT News: GM Ford Lobby to Save EV Tax Incentives | CBS: GM Lobbying Blitz | Bloomberg: Ford GM Toyota Lobby},
}

@article{goodhart1984,
  title = {Problems of Monetary Management: The UK Experience},
  author = {Goodhart, Charles A. E.},
  year = {1984},
  journal = {Monetary Theory and Practice},
  pages = {91-121},
}

@article{grant-writing-time-50pct,
  title = {Grant writing time for top researchers (50\%)},
  author = {Acquisition Talk},
  year = {2021},
  journal = {Acquisition Talk},
  url = {https://acquisitiontalk.com/2021/12/top-researchers-spend-50-of-their-time-writing-grants-how-to-fix-it-and-what-it-means-for-dod/},
  urldate = {2025-01-20},
  note = {Acquisition Talk, 2021, Top researchers spend 50\% of their time writing grants},
}

@article{great-leap-forward-deaths,
  title = {Death toll of China's Great Leap Forward (1958-62)},
  author = {Wikipedia},
  year = {},
  journal = {Wikipedia: Great Leap Forward},
  url = {https://en.wikipedia.org/wiki/Great_Leap_Forward},
  urldate = {2025-01-20},
  note = {Wikipedia: Great Leap Forward | Wikipedia: Great Chinese Famine | History in Charts: Death Toll | SCMP: 45 Million Died},
}

@article{green-revolution-impact,
  title = {Economic value and lives saved by the Green Revolution},
  author = {Wikipedia},
  year = {},
  journal = {Wikipedia: Norman Borlaug},
  url = {https://en.wikipedia.org/wiki/Norman_Borlaug},
  urldate = {2025-01-20},
  note = {Wikipedia: Norman Borlaug | World Food Prize: About Borlaug | All That's Interesting: Saved A Billion Lives | University of Minnesota: Saved A Billion Lives},
}

@article{gtd-terror-attack-deaths,
  title = {Terror attack deaths (8,300 annually)},
  author = {Our World in Data},
  year = {2024},
  journal = {Our World in Data: Terrorism},
  url = {https://ourworldindata.org/terrorism},
  urldate = {2025-01-20},
  note = {Our World in Data: Terrorism | Global Terrorism Index 2024 | START Global Terrorism Database | Our World in Data: Terrorism Deaths},
}

@report{gustafsson2017,
  title = {Measuring the Success of Impact Bonds},
  institution = {Gustafsson-Wright, Emily and Gardiner, Sophie and Putcha, Vidya},
  year = {2017},
  url = {https://www.brookings.edu/articles/measuring-the-success-of-impact-bonds/},
  urldate = {2025-01-20},
}

@article{hallmarks-of-aging,
  title = {The Nine Hallmarks of Aging},
  author = {PubMed},
  year = {},
  journal = {PubMed: The Hallmarks of Aging},
  url = {https://pubmed.ncbi.nlm.nih.gov/23746838/},
  urldate = {2025-01-20},
  note = {PubMed: The Hallmarks of Aging | Cell: The Hallmarks of Aging00645-4) | PMC: The Hallmarks of Aging | Cell: Telomeres \& Hallmarks31750-5)},
}

@report{hartung2023,
  title = {March of the Four-Stars: The Role of Retired Generals and Admirals in the Arms Industry},
  institution = {Hartung, William D. and Fisher, Dillon},
  year = {2023},
  url = {https://quincyinst.org/research/march-of-the-four-stars-the-role-of-retired-generals-and-admirals-in-the-arms-industry/},
  urldate = {2025-01-20},
  note = {Found over 80\% of four-star officers who retired after June 2018 went to work for the arms industry},
}

@article{hayek-nobel-prize,
  title = {Hayek's Nobel Prize for Economic Science},
  author = {Nobel Prize},
  year = {1974},
  journal = {Nobel Prize: 1974 Economic Sciences},
  url = {https://www.nobelprize.org/prizes/economic-sciences/1974/hayek/facts/},
  urldate = {2025-01-20},
  note = {Nobel Prize: 1974 Economic Sciences | Wikipedia: Friedrich Hayek | Britannica: F.A. Hayek | Econlib: Friedrich August Hayek},
}

@article{healthcare-cost-savings-4-5t-us-annually,
  title = {$4.5 trillion annual healthcare cost savings (US)},
  author = {CDC},
  year = {2022},
  journal = {CDC: Health Expenditures},
  url = {https://www.cdc.gov/nchs/fastats/health-expenditures.htm},
  urldate = {2025-01-20},
  note = {CDC: Health Expenditures | Medical Economics: $4.5T in 2022 | PMC: Improving Healthcare Prognosis | NCBI: Missed Prevention Opportunities},
}

@article{healthcare-investment-economic-multiplier,
  title = {Healthcare investment economic multiplier (1.8)},
  author = {PMC},
  year = {2022},
  journal = {PMC: California Universal Health Care},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC5954824/},
  urldate = {2025-01-20},
  note = {PMC: California Universal Health Care | CEPR: Government Investment | PMC: Health Sector Investment \& Growth | ODI: Fiscal Multipliers Review},
}

@article{healthcare-workers-60m-globally,
  title = {60 million healthcare workers globally},
  author = {PubMed},
  year = {2020},
  journal = {PubMed: Global Health Workforce 2020-2030},
  url = {https://pubmed.ncbi.nlm.nih.gov/35760437/},
  urldate = {2025-01-20},
  note = {PubMed: Global Health Workforce 2020-2030 | WHO: Global Health Workforce Statistics | PMC: Health Workforce Distribution | WHO Global Health Learning: Workforce Shortage},
}

@article{heckman2010,
  title = {The rate of return to the HighScope Perry Preschool Program},
  author = {Heckman, James J. and Moon, Seong Hyeok and Pinto, Rodrigo and Savelyev, Peter A. and Yavitz, Adam},
  year = {2010},
  journal = {Journal of Public Economics},
  volume = {94},
  number = {1-2},
  pages = {114-128},
  doi = {10.1016/j.jpubeco.2009.11.001},
}

@article{helios-voting,
  title = {Helios (end-to-end verifiable voting)},
  author = {Adida et al., Helios},
  year = {},
  journal = {Adida et al.},
  url = {https://heliosvoting.org/},
  urldate = {2025-01-20},
  note = {Adida et al., Helios, heliosvoting.org},
}

@article{hevenstone2023,
  title = {The Impact of Social Impact Bond Financing},
  author = {Hevenstone, Debra},
  year = {2023},
  journal = {Public Administration Review},
  volume = {83},
  number = {4},
  pages = {821-836},
  doi = {10.1111/puar.13631},
}

@article{hhs2023,
  title = {The Revolving Door In Health Care Regulation},
  author = {Sood, Neeraj and Ribero, Rachel and Ryan, Megan and Van Nuys, Karen},
  year = {2023},
  journal = {Health Affairs},
  volume = {42},
  number = {9},
  pages = {1284-1291},
  doi = {10.1377/hlthaff.2023.00418},
  url = {https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2023.00418},
  urldate = {2025-01-20},
  note = {Found 32\% of HHS appointees exited to industry employment},
}

@article{historical-healthcare-inflation-rate,
  title = {Historical healthcare inflation rate (6.2\%)},
  author = {US Inflation Calculator},
  year = {1948},
  journal = {US Inflation Calculator: Health Care 1948-2025},
  url = {https://www.usinflationcalculator.com/inflation/health-care-inflation-in-the-united-states/},
  urldate = {2025-01-20},
  note = {US Inflation Calculator: Health Care 1948-2025 | In2013Dollars: Medical Care Inflation 1935-2025 | PMC: Adjusting Health Expenditures | YCharts: Health Care Inflation},
}

@article{historical-life-expectancy-30-years,
  title = {Historical life expectancy around 30 years},
  author = {Our World in Data},
  year = {2022},
  journal = {Our World in Data: Life Expectancy},
  url = {https://ourworldindata.org/life-expectancy},
  urldate = {2025-01-20},
  note = {Our World in Data: Life Expectancy | PMC: Changing Life Expectancy | USC: Old Age Not Modern Phenomenon | Discover: Life Expectancy Ancient Humans},
}

@article{horizon-europe-budget,
  title = {Horizon Europe total budget},
  author = {European Commission},
  year = {},
  journal = {European Commission},
  url = {https://ecrin.org/funding-multinational-clinical-trials},
  urldate = {2025-01-20},
  note = {European Commission, Horizon Europe Overview},
}

@article{hospital-room-costs,
  title = {Hospital room costs},
  author = {NCH Stats},
  year = {2025},
  journal = {Average Hospital Stay Costs 2025},
  url = {https://nchstats.com/average-cost-of-hospital-stays-in-us/},
  urldate = {2025-01-20},
  note = {Average Hospital Stay Costs 2025},
}

@article{howey-test-securities,
  title = {Howey Test Securities Definition},
  author = {Supreme Court},
  year = {},
  journal = {Supreme Court},
  url = {https://supreme.justia.com/cases/federal/us/328/293/},
  urldate = {2025-01-20},
  note = {Supreme Court, Case Link},
}

@article{human-genome-and-genetic-editing,
  title = {Human Genome Project and CRISPR Discovery},
  author = {NHGRI},
  year = {2003},
  journal = {NHGRI},
  url = {https://www.genome.gov/11006929/2003-release-international-consortium-completes-hgp},
  urldate = {2025-01-20},
  note = {NHGRI, International Consortium Completes Human Genome Project | Nobel Prize, The Nobel Prize in Chemistry 2020 | Note: HGP cost ~$2.7B; CRISPR discovered by Doudna \& Charpentier in 2012},
}

@article{human-metabolic-activity,
  title = {Estimated Chemical Reactions in the Human Body},
  author = {Step One Foods},
  year = {},
  journal = {Step One Foods: 37 Billion Billion},
  url = {https://www.steponefoods.com/blogs/news/37-billion-billion-and-why-it-matters},
  urldate = {2025-01-20},
  note = {Step One Foods: 37 Billion Billion | Biology Insights: Chemical Reactions | ECHEMI: Chemical Reactions in Body},
}

@article{hunter-gatherer-violence,
  title = {Violence in Hunter-Gatherer Societies},
  author = {Pinker, Steven},
  year = {2011},
  journal = {Pinker},
  url = {https://stevenpinker.com/publications/better-angels-our-nature},
  urldate = {2025-01-20},
  note = {Pinker, Steven, 2011, The Better Angels of Our Nature},
}

@article{hurwicz1972,
  title = {On Informationally Decentralized Systems},
  author = {Hurwicz, Leonid},
  year = {1972},
  journal = {Decision and Organization},
  pages = {297-336},
}

@article{hypertension-screening-treatment-qaly,
  title = {Hypertension Screening \& Treatment Cost per QALY},
  author = {PMC521},
  year = {7841},
  journal = {PMC5217841},
  url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217841/},
  urldate = {2025-01-20},
  note = {PMC5217841, Link},
}

@article{ican-nuclear-ban-treaty,
  title = {International Campaign to Abolish Nuclear Weapons (ICAN) - Treaty on the Prohibition of Nuclear Weapons (2017)},
  author = {ICAN},
  year = {2017},
  journal = {ICAN},
  url = {https://www.icanw.org/ican_history},
  urldate = {2025-01-20},
  note = {ICAN, History | Wikipedia, International Campaign to Abolish Nuclear Weapons | Nobel Prize, 2017 Peace Prize | ICAN, The Treaty},
}

@article{icbl-ottawa-treaty,
  title = {International Campaign to Ban Landmines (ICBL) - Ottawa Treaty (1997)},
  author = {ICRC},
  year = {1997},
  journal = {ICRC},
  url = {https://www.icrc.org/en/doc/resources/documents/article/other/57jpjn.htm},
  urldate = {2025-01-20},
  note = {ICRC, Ottawa Treaty History | Wikipedia, International Campaign to Ban Landmines | Nobel Prize, 1997 Peace Prize | UN Press, ICBL Press Conference 1999 | Landmine Monitor, Mine Action Funding},
}

@article{icd-10-code-count,
  title = {ICD-10 Code Count (~14,000)},
  author = {WHO},
  year = {2019},
  journal = {WHO},
  url = {https://icd.who.int/browse10/2019/en},
  urldate = {2025-01-20},
  note = {WHO, ICD-10 Browser},
}

@article{icer-qaly-methodology,
  title = {ICER QALY methodology and standards},
  author = {ICER},
  year = {2024},
  journal = {ICER},
  url = {https://icer.org/our-approach/methods-process/cost-effectiveness-the-qaly-and-the-evlyg/},
  urldate = {2025-01-20},
  note = {ICER, Cost-Effectiveness, the QALY, and the evLYG | ICER, Reference Case 4.0},
}

@article{id-me-verification,
  title = {ID.me digital identity verification service},
  author = {ID.me},
  year = {},
  journal = {ID.me: Government Services},
  url = {https://www.id.me/individuals/government},
  urldate = {2025-01-20},
  note = {ID.me: Government Services | Wikipedia: ID.me | ID.me: About | ID.me: Public Sector},
}

@article{iea-net-zero-roadmap-cost,
  title = {IEA Net Zero Roadmap cost for energy transition},
  author = {IEA},
  year = {2050},
  journal = {IEA: Net Zero by 2050},
  url = {https://www.iea.org/reports/net-zero-by-2050},
  urldate = {2025-01-20},
  note = {IEA: Net Zero by 2050 | IEA PDF: Net Zero Roadmap | WRI: 5 Things About IEA Roadmap},
}

@article{ihi-horizon-europe,
  title = {Innovative Health Initiative (IHI) Horizon Europe},
  author = {European Commission},
  year = {},
  journal = {European Commission},
  url = {https://ecrin.org/funding-multinational-clinical-trials},
  urldate = {2025-01-20},
  note = {European Commission, Horizon Europe Health Funding},
}

@article{ihme-gbd-2019,
  title = {IHME Global Burden of Disease (2.55B DALYs, 2019)},
  author = {Institute for Health Metrics and Evaluation (IHME)},
  year = {2020},
  journal = {Institute for Health Metrics and Evaluation (IHME)},
  url = {https://vizhub.healthdata.org/gbd-compare/},
  urldate = {2025-01-20},
  note = {Institute for Health Metrics and Evaluation (IHME), GBD Compare Viz Hub | IHME, Global Burden of Disease Study | The Lancet, 2020, Global burden of 369 diseases and injuries in 204 countries and te...},
}

@article{illinois-bipa,
  title = {Illinois Biometric Information Privacy Act (BIPA)},
  author = {ACLU Illinois},
  year = {},
  journal = {ACLU Illinois: BIPA},
  url = {https://www.aclu-il.org/en/campaigns/biometric-information-privacy-act-bipa},
  urldate = {2025-01-20},
  note = {ACLU Illinois: BIPA | Wikipedia: BIPA | Securiti: Illinois BIPA Overview | Winston \& Strawn: What Is BIPA},
}

@report{imf2023,
  title = {IMF Fossil Fuel Subsidies Data: 2023 Update},
  institution = {Black, Simon and Parry, Ian and Vernon, Nate},
  year = {2023},
  url = {https://www.imf.org/en/Topics/climate-change/energy-subsidies},
  urldate = {2025-01-20},
}

@article{immunotherapy-pioneers-nih-rejection,
  title = {NIH rejection of early immunotherapy research},
  author = {Cancer Research Institute},
  year = {2015},
  journal = {Cancer Research Institute: Coley's Toxins},
  url = {https://www.cancerresearch.org/blog/april-2015/what-ever-happened-to-coleys-toxins},
  urldate = {2025-01-20},
  note = {Cancer Research Institute: Coley's Toxins | Wikipedia: Coley's toxins | PMC: Talkin' Toxins | Wikipedia: William Coley | NIH: Rosenberg Immunotherapy Pioneer},
}

@article{impact-investing-regulatory-reform,
  title = {Impact investing regulatory reform},
  author = {Norton Rose Fulbright},
  year = {},
  journal = {Norton Rose Fulbright},
  url = {https://www.nortonrosefulbright.com/en/knowledge/publications/dae2d556/regulatory-initiatives-applicable-to-impact-investing},
  urldate = {2025-01-20},
  note = {Norton Rose Fulbright, Regulatory Initiatives Applicable to Impact Investing},
}

@article{india-medical-research-spending-1-2b,
  title = {India medical research spending: $1.2 billion},
  author = {ACS},
  year = {2021},
  journal = {ACS: India Budget Biotech Health},
  url = {https://cen.acs.org/policy/research-funding/India-prioritizes-new-research-foundation-biotech-and-health-in-new-budget/99/web/2021/03},
  urldate = {2025-01-20},
  note = {ACS: India Budget Biotech Health | National Medical Journal of India: Health Research Funding | Dept of Health Research: Budget Reports},
}

@article{india-population-1-4b,
  title = {India population: 1.4 billion},
  author = {Worldometer},
  year = {2025},
  journal = {Worldometer: India Population 2025},
  url = {https://www.worldometers.info/world-population/india-population/},
  urldate = {2025-01-20},
  note = {Worldometer: India Population 2025 | Statistics Times: India Population 2025 | UNFPA: India Dashboard | Wikipedia: Demographics of India},
}

@article{indian-aadhaar-system,
  title = {Indian Aadhaar national identity system},
  author = {PMC},
  year = {},
  journal = {PMC: Aadhaar Failure to Do No Harm},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC5741784/},
  urldate = {2025-01-20},
  note = {PMC: Aadhaar Failure to Do No Harm | TIME: India Supreme Court Upholds | Privacy International: Aadhaar Analysis | Yale Insights: Billion Identities Digitized},
}

@misc{industry-clinical-trial-spending-estimate,
  title = {Private industry clinical trial spending},
  author = {Derived from global market size and public/private funding ratios},
  year = {},
  note = {Derived from global market size and public/private funding ratios},
}

@article{industry-phase-1-per-approved-drug,
  title = {Industry Phase 1 spending per approved drug},
  author = {CBO},
  year = {},
  journal = {CBO},
  url = {https://www.cbo.gov/publication/57126},
  urldate = {2025-01-20},
  note = {CBO, R\&D Cost Analysis},
}

@article{industry-phase-2-per-approved-drug,
  title = {Industry Phase 2 spending per approved drug},
  author = {CBO},
  year = {},
  journal = {CBO},
  url = {https://www.cbo.gov/publication/57126},
  urldate = {2025-01-20},
  note = {CBO, Clinical Trial Economics},
}

@article{industry-phase-3-per-approved-drug,
  title = {Industry Phase 3 spending per approved drug},
  author = {CBO},
  year = {},
  journal = {CBO},
  url = {https://www.cbo.gov/publication/57126},
  urldate = {2025-01-20},
  note = {CBO, Drug Development Costs},
}

@article{industry-rd-growth-2012-2022,
  title = {Industry R\&D spending growth 2012-2022},
  author = {CBO},
  year = {},
  journal = {CBO},
  url = {https://www.cbo.gov/publication/57126},
  urldate = {2025-01-20},
  note = {CBO, Research and Development in the Pharmaceutical Industry},
}

@article{industry-vs-government-trial-spending-split,
  title = {Industry vs. Government Clinical Trial Spending Split (90/10)},
  author = {Applied Clinical Trials},
  year = {},
  journal = {Applied Clinical Trials},
  url = {https://www.appliedclinicaltrialsonline.com/view/sizing-clinical-research-market},
  urldate = {2025-01-20},
  note = {Applied Clinical Trials | TCTMD},
}

@article{infrastructure-investment-economic-multiplier,
  title = {Infrastructure investment economic multiplier (1.6)},
  author = {World Bank},
  year = {2022},
  journal = {World Bank: Infrastructure Investment as Stimulus},
  url = {https://blogs.worldbank.org/en/ppps/effectiveness-infrastructure-investment-fiscal-stimulus-what-weve-learned},
  urldate = {2025-01-20},
  note = {World Bank: Infrastructure Investment as Stimulus | Global Infrastructure Hub: Fiscal Multiplier | CEPR: Government Investment | Richmond Fed: Infrastructure Spending},
}

@article{injuries-largely-preventable,
  title = {Injuries are largely preventable events},
  author = {WHO},
  year = {},
  journal = {WHO: Injuries and Violence Fact Sheet},
  url = {https://www.who.int/news-room/fact-sheets/detail/injuries-and-violence},
  urldate = {2025-01-20},
  note = {WHO: Injuries and Violence Fact Sheet | PMC: Global Burden of Unintentional Injuries | WHO: Injury Chart Book},
}

@article{insulin-history-and-pricing,
  title = {History of insulin patent and modern price disparities},
  author = {Snopes},
  year = {2019},
  journal = {Snopes: Insulin Patent Dollar},
  url = {https://www.snopes.com/fact-check/insulin-patent-dollar/},
  urldate = {2025-01-20},
  note = {Snopes: Insulin Patent Dollar | T1International: 100 Years Gift to Greed | PNHP: Why Insulin is Overpriced | NPR: Skyrocketing Price of Insulin},
}

@article{intelligence-spending-military-budgets,
  title = {Intelligence spending as percentage of military budgets},
  author = {US Government Info},
  year = {},
  journal = {US Government Info: Cost of Intelligence},
  url = {https://www.govinfo.gov/content/pkg/GPO-INTELLIGENCE/html/int017.html},
  urldate = {2025-01-20},
  note = {US Government Info: Cost of Intelligence | FAS: Intelligence Community Spending Trends | Wikipedia: US Intelligence Budget},
}

@article{interleukin-2-drug-lag-deaths,
  title = {Estimated deaths due to FDA delay in approving Interleukin-2},
  author = {C\&EN},
  year = {},
  journal = {C\&EN: IL-2 FDA Market Clearance},
  url = {https://pubs.acs.org/doi/10.1021/cen-v070n019.p005},
  urldate = {2025-01-20},
  note = {C\&EN: IL-2 FDA Market Clearance | PMC: IL-2 for Renal Cancer | PMC: Contemporary IL-2 Experience},
}

@article{internet-darpa-investment-roi,
  title = {Economic value created by the internet from DARPA investment},
  author = {NBER},
  year = {2025},
  journal = {NBER: Pre-commercial Internet under DARPA},
  url = {https://www.nber.org/system/files/chapters/c11755/revisions/c11755.rev0.pdf},
  urldate = {2025-01-20},
  note = {NBER: Pre-commercial Internet under DARPA | DARPA: ARPANET Vignette | DARPA: ARPANET Timeline | NSF: Birth of Commercial Internet},
}

@article{internet-users-5-billion,
  title = {Number of global internet users},
  author = {Statista},
  year = {2024},
  journal = {Statista: Internet Users Worldwide 2024},
  url = {https://www.statista.com/statistics/273018/number-of-internet-users-worldwide/},
  urldate = {2025-01-20},
  note = {Statista: Internet Users Worldwide 2024 | Digital Information World: 5.56B in 2025 | DataReportal: Global Digital Overview | SG Analytics: Global Internet Usage 2025},
}

@article{investment-community-50m,
  title = {Over 50 million people in the investment community},
  author = {CFA Institute},
  year = {},
  journal = {CFA Institute: About},
  url = {https://www.cfainstitute.org/},
  urldate = {2025-01-20},
  note = {CFA Institute: About | Wikipedia: Investment Company Institute},
}

@article{investment-return-comparison,
  title = {Investment Return Comparison},
  author = {Yahoo Finance},
  year = {},
  journal = {iShares U.S. Aerospace \& Defense ETF Performance},
  url = {https://finance.yahoo.com/quote/ITA/performance/},
  urldate = {2025-01-20},
  note = {iShares U.S. Aerospace \& Defense ETF Performance | XLV Performance Analysis},
}

@misc{irs501c3,
  title = {Exemption Requirements - 501(c)(3) Organizations},
  author = {Internal Revenue Service},
  year = {},
  url = {https://www.irs.gov/charities-non-profits/charitable-organizations/exemption-requirements-501c3-organizations},
  urldate = {2025-01-20},
}

@article{jacobson1978,
  title = {The Effects of Campaign Spending in Congressional Elections},
  author = {Jacobson, Gary C.},
  year = {1978},
  journal = {American Political Science Review},
  volume = {72},
  number = {2},
  pages = {469-491},
  doi = {10.2307/1953105},
}

@article{jama-founded-1893,
  title = {Journal of the American Medical Association (JAMA) founded in 1883},
  author = {Wikipedia},
  year = {},
  journal = {Wikipedia: JAMA},
  url = {https://en.wikipedia.org/wiki/JAMA},
  urldate = {2025-01-20},
  note = {Wikipedia: JAMA | JAMA Network: History of AMA | Penn: JAMA Archives},
}

@article{jama-hypertension-pharmacist-led,
  title = {Pharmacist-led hypertension management cost-effectiveness},
  author = {JAMA Network Open},
  year = {2023},
  journal = {JAMA Network Open},
  url = {https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2811317},
  urldate = {2025-01-20},
  note = {JAMA Network Open, 2023, Cost-Effectiveness of Pharmacist-Led Hypertension Management},
}

@article{james-buchanan-nobel-prize-1986,
  title = {James Buchanan Nobel Prize in Economics, 1986},
  author = {Nobel Prize},
  year = {1986},
  journal = {Nobel Prize: 1986 Economic Sciences},
  url = {https://www.nobelprize.org/prizes/economic-sciences/1986/press-release/},
  urldate = {2025-01-20},
  note = {Nobel Prize: 1986 Economic Sciences | Wikipedia: James M. Buchanan | Britannica: James M. Buchanan | Econlib: James M. Buchanan},
}

@article{japan-medical-research-spending-5b,
  title = {Japan medical research spending: ~$5 billion/year},
  author = {PMC},
  year = {},
  journal = {PMC: Limited Alignment Disease Funding Japan},
  url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010241/},
  urldate = {2025-01-20},
  note = {PMC: Limited Alignment Disease Funding Japan | Nature: Promoting Better Medical Research Japan | PMC: Effectiveness Japanese Public Funding | Statista: Japan Pharma R\&D},
}

@article{japan-oldest-population,
  title = {Japan has the oldest population on Earth},
  author = {WEF},
  year = {2023},
  journal = {WEF: Japan's Ageing Population},
  url = {https://www.weforum.org/stories/2023/09/elderly-oldest-population-world-japan/},
  urldate = {2025-01-20},
  note = {WEF: Japan's Ageing Population | Wikipedia: Aging of Japan | Database.earth: Japan Median Age | Statista: Japan Median Age 1950-2100 | National Geographic: Japan Nation of Old People},
}

@article{japans-regenerative-medicine-act,
  title = {Japan's Regenerative Medicine Act and conditional approval pathway},
  author = {FDLI},
  year = {2019},
  journal = {FDLI: Japan's Regen Med Pathways},
  url = {https://www.fdli.org/2019/02/global-focus-japans-regenerative-medicine-regulatory-pathways-encouraging-innovation-and-patient-access/},
  urldate = {2025-01-20},
  note = {FDLI: Japan's Regen Med Pathways | Cell \& Gene Therapy Insights: SAKIGAKE | PMC: Flexible Regulatory Review Japan},
}

@article{jnj-2023-financials,
  title = {Johnson \& Johnson 2023 Financials},
  author = {Johnson \& Johnson},
  year = {2024},
  journal = {Johnson \& Johnson},
  url = {https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/revenue},
  urldate = {2025-01-20},
  note = {Johnson \& Johnson, 2024, Investor Relations},
}

@article{kefauver-harris-amendment-1962,
  title = {Kefauver Harris Amendment of 1962},
  author = {GovTrack},
  year = {1962},
  journal = {GovTrack},
  url = {https://www.govtrack.us/congress/bills/87/s1552},
  urldate = {2025-01-20},
  note = {GovTrack, S.1552 (87th Congress, 1962) | FDA, Promoting Safe \& Effective Drugs for 100 Years | NEJM, Reform, Regulation, and Pharmaceuticals — The Kefauver–Harris Amendments at 50},
}

@article{khmer-rouge-deaths,
  title = {Death toll of the Khmer Rouge regime (1975-79)},
  author = {Wikipedia},
  year = {1975},
  journal = {Wikipedia: Cambodian Genocide},
  url = {https://en.wikipedia.org/wiki/Cambodian_genocide},
  urldate = {2025-01-20},
  note = {Wikipedia: Cambodian Genocide | Britannica: Khmer Rouge | UCLA: Cambodia Death Toll Estimate | USHMM: Cambodia 1975-1979},
}

@article{kidney-disease-deaths-1-4m-annually,
  title = {Annual deaths from kidney disease},
  author = {National Kidney Foundation},
  year = {2022},
  journal = {National Kidney Foundation: Global Facts},
  url = {https://www.kidney.org/global-facts-about-kidney-disease},
  urldate = {2025-01-20},
  note = {National Kidney Foundation: Global Facts | PMC: Epidemiology CKD 2022 | Lancet: Global Burden CKD 201730045-3/fulltext) | IHME: CKD Global Killer},
}

@report{kpmg2018,
  title = {Economic Impact of Medical Research in Australia},
  institution = {KPMG},
  year = {2018},
  note = {Finds return of $3.90 for every $1 invested in medical research},
}

@article{kyc-biometric-verification-costs-2024,
  title = {KYC and biometric identity verification costs (2024)},
  author = {ComplyCube},
  year = {},
  journal = {ComplyCube},
  url = {https://www.complycube.com/en/how-much-does-kyc-cost/},
  urldate = {2025-01-20},
  note = {ComplyCube, How Much Does KYC Really Cost? | Alice Biometrics, Cost of Identity Verification | Ondato, Identity Verification Pricing},
}

@book{laffont1993,
  title = {A Theory of Incentives in Procurement and Regulation},
  author = {Laffont, Jean-Jacques and Tirole, Jean},
  year = {1993},
  publisher = {MIT Press},
}

@article{landmark-gene-therapies,
  title = {Approval of Landmark Gene Therapies (Luxturna, Zolgensma, CAR-T)},
  author = {BioPharma Dive},
  year = {2017},
  journal = {BioPharma Dive: Luxturna},
  url = {https://www.biopharmadive.com/news/luxturna-gene-therapy-eye-leber-lca/609832/},
  urldate = {2025-01-20},
  note = {BioPharma Dive: Luxturna | C\&EN: First Gene Therapy Genetic Disease | NPR: First Gene Therapy Inherited Disease | PMC: Recombinant AAV Gene Therapy},
}

@article{landray-recovery-trial-quote,
  title = {Landray, Sir Martin, on the RECOVERY Trial},
  author = {Sir Martin Landray},
  year = {},
  journal = {Sir Martin Landray},
  url = {https://www.ox.ac.uk/news/features/recovery-trial-two-years},
  urldate = {2025-01-20},
  note = {Sir Martin Landray, Oxford University News},
}

@article{lasik-cosmetic-surgery-price-drops,
  title = {Price drops in cash-based medical markets},
  author = {Healthcare Economist},
  year = {2006},
  journal = {Healthcare Economist: LASIK Markets at Work},
  url = {https://www.healthcare-economist.com/2006/04/25/markets-at-work-lasik/},
  urldate = {2025-01-20},
  note = {Healthcare Economist: LASIK Markets at Work | All About Vision: LASIK Cost 2024 | CRSToday: Retail Pricing Refractive Surgery},
}

@misc{lcv2024,
  title = {About the Scorecard},
  author = {League of Conservation Voters},
  year = {2024},
  url = {https://scorecard.lcv.org/methodology},
  urldate = {2025-01-20},
  note = {Accessed 2024},
}

@article{leading-causes-of-death-by-age-group,
  title = {Leading causes of death by age group},
  author = {NCBI},
  year = {2021},
  journal = {NCBI: Leading Causes by Age},
  url = {https://www.ncbi.nlm.nih.gov/books/NBK600454/table/ch2.tab4/},
  urldate = {2025-01-20},
  note = {NCBI: Leading Causes by Age | CDC NVSS: Leading Causes | USAFacts: Causes Death by Age | CDC WISQARS: Leading Causes by Age 2021},
}

@article{liebman2011,
  title = {Social Impact Bonds: A Guide for State and Local Governments},
  author = {Liebman, Jeffrey B.},
  year = {2011},
  journal = {Harvard Kennedy School Social Impact Bond Technical Assistance Lab},
  url = {https://www.hks.harvard.edu/centers/mrcbg/publications/awp},
  urldate = {2025-01-20},
}

@article{life-expectancy-gains-medical-advances,
  title = {Life expectancy gains from antibiotics and vaccines},
  author = {Slate},
  year = {2013},
  journal = {Slate},
  url = {https://slate.com/technology/2013/09/life-expectancy-history-public-health-and-medical-advances-that-lead-to-long-lives.html},
  urldate = {2025-01-20},
  note = {Slate, Life Expectancy History | PMC, Antibiotics Impact | Our World in Data, Life Expectancy | Concierge MDLA, Life Expectancy Evolution},
}

@article{life-expectancy-gains-smoking-reduction,
  title = {Contribution of smoking reduction to life expectancy gains},
  author = {PMC},
  year = {2012},
  journal = {PMC: Benefits Smoking Cessation Longevity},
  url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1447499/},
  urldate = {2025-01-20},
  note = {PMC: Benefits Smoking Cessation Longevity | CDC: Estimating Benefits Smoking Reductions | AJPM: Benefits Quitting Different Ages00217-4/fulltext) | NEJM: 21st-Century Hazards \& Benefits},
}

@article{life-expectancy-increase-pre-1962,
  title = {Claim of linear 4-year life expectancy increase from 1890-1960},
  author = {Our World in Data},
  year = {},
  journal = {Our World in Data: Life Expectancy},
  url = {https://ourworldindata.org/life-expectancy},
  urldate = {2025-01-20},
  note = {Our World in Data: Life Expectancy | WHO: Global Health Estimates},
}

@article{life-sciences-venture-capital-2024,
  title = {Life sciences venture capital funding},
  author = {AAMC},
  year = {},
  journal = {AAMC},
  url = {https://www.aamc.org/news/whats-stake-when-clinical-trials-research-gets-cut},
  urldate = {2025-01-20},
  note = {AAMC, Clinical Trials Research Funding},
}

@article{lobbying-100m,
  title = {Defense industry lobbying spending},
  author = {Watson Institute, Brown University},
  year = {2022},
  journal = {Watson Institute},
  url = {https://watson.brown.edu/costsofwar/news/2022/defense-sector-spent-101-million-lobbying-during-first-three-quarters-2022},
  urldate = {2025-01-20},
  note = {Watson Institute, Brown University, 2022, Defense Sector Lobbying | OpenSecrets, 2024, Defense industry lobbying totals},
}

@article{lobbying-breast-cancer-funding,
  title = {Lobbying impact on breast cancer funding},
  author = {The New York Times},
  year = {1992},
  journal = {The New York Times},
  url = {https://www.nytimes.com/1992/10/19/us/effective-lobbying-increases-us-funds-for-breast-cancer-research.html},
  urldate = {2025-01-20},
  note = {The New York Times, 1992, Effective Lobbying Increases U.S. Funds for Breast Cancer Research},
}

@article{lobbying-impact-nih-funding,
  title = {Lobbying impact on NIH funding},
  author = {BMJ via PMC},
  year = {1999},
  journal = {BMJ via PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC1116068/},
  urldate = {2025-01-20},
  note = {BMJ via PMC, 1999, Role of advocacy in allocation of NIH funds},
}

@article{lobbying-roi-calc,
  title = {Lobbying ROI Calculation (\$1,813 per \$1)},
  author = {Responsible Statecraft},
  year = {2021},
  journal = {Responsible Statecraft},
  url = {https://responsiblestatecraft.org/2021/09/02/top-defense-firms-see-2t-return-on-1b-investment-in-afghan-war/},
  urldate = {2025-01-20},
  note = {Responsible Statecraft, 2021, Top 5 Defense Firms See $2T Return on $1B Investment in Afghan War},
}

@article{lobbying-roi-feasibility,
  title = {Lobbying ROI Feasibility},
  author = {Watson Institute, Brown University},
  year = {2021},
  journal = {Watson Institute},
  url = {https://costsofwar.watson.brown.edu/paper/profits-war-corporate-beneficiaries-post-911-pentagon-spending-surge},
  urldate = {2025-01-20},
  note = {Watson Institute, Brown University, 2021, Profits of War},
}

@article{lobbying-roi-nih-funding,
  title = {Lobbying ROI for NIH funding},
  author = {Nature},
  year = {2014},
  journal = {Nature},
  url = {https://www.nature.com/articles/515019a},
  urldate = {2025-01-20},
  note = {Nature, 2014, Lobbying for research funding reaps rewards},
}

@article{lobbying-spend-defense,
  title = {Lobbying Spend (Defense)},
  author = {OpenSecrets},
  year = {2024},
  journal = {OpenSecrets},
  url = {https://www.opensecrets.org/federal-lobbying/industries/summary?cycle=2024\&id=D},
  urldate = {2025-01-20},
  note = {OpenSecrets, 2024, Defense Lobbying},
}

@article{lobbyist-statistics-dc,
  title = {Lobbyist statistics for Washington D.C.},
  author = {OpenSecrets},
  year = {},
  journal = {OpenSecrets: Lobbying in US},
  url = {https://en.wikipedia.org/wiki/Lobbying_in_the_United_States},
  urldate = {2025-01-20},
  note = {OpenSecrets: Lobbying in US | OpenSecrets: Revolving Door | Citizen.org: Revolving Congress | ProPublica: 281 Lobbyists Trump Admin},
}

@article{lockheed-2023-revenue,
  title = {Lockheed Martin 2023 Revenue},
  author = {Wikipedia},
  year = {2024},
  journal = {Wikipedia},
  url = {https://en.wikipedia.org/wiki/Top_100_Contractors_of_the_U.S._federal_government},
  urldate = {2025-01-20},
  note = {Wikipedia, 2024, Top 100 Contractors of the U.S. federal government},
}

@article{lockheed-health-it-division,
  title = {Lockheed Martin's diversification into health IT},
  author = {Lockheed Martin},
  year = {2015},
  journal = {Lockheed Martin: Healthcare Alliance Launch},
  url = {https://news.lockheedmartin.com/2015-07-29-Lockheed-Martin-Launches-Healthcare-Technology-Alliance},
  urldate = {2025-01-20},
  note = {Lockheed Martin: Healthcare Alliance Launch | PR Newswire: Healthcare Alliance | Healthcare Dive: Big New Alliance | Washington Post: Tackles Health Care},
}

@article{lockheed-martin-political-influence-2022,
  title = {Lockheed Martin's political donations, contracts, and state operations in 2022},
  author = {OpenSecrets},
  year = {2022},
  journal = {OpenSecrets: Lockheed Martin Summary},
  url = {https://www.opensecrets.org/orgs/lockheed-martin/summary?id=d000000104},
  urldate = {2025-01-20},
  note = {OpenSecrets: Lockheed Martin Summary | OpenSecrets: Lockheed PAC 2022 | Taxpayer.net: Military Industry Political Footprint},
}

@article{lohmann1998,
  title = {An Information Rationale for the Power of Special Interests},
  author = {Lohmann, Susanne},
  year = {1998},
  journal = {American Political Science Review},
  volume = {92},
  number = {4},
  pages = {809-827},
  url = {https://www.cambridge.org/core/journals/american-political-science-review/article/abs/an-information-rationale-for-the-power-of-special-interests/2321FE7C64F1799F58A69BB5A1FE594D},
  urldate = {2025-01-20},
  note = {Reports U.S. sugar quotas generated 2,261 jobs at cost of $1.162 billion in welfare reduction (citing Hufbauer and Elliott 1994)},
}

@article{long-term-capital-management-collapse,
  title = {The Collapse of Long-Term Capital Management (LTCM) in 1998},
  author = {Wikipedia},
  year = {2013},
  journal = {Wikipedia: LTCM},
  url = {https://en.wikipedia.org/wiki/Long-Term_Capital_Management},
  urldate = {2025-01-20},
  note = {Wikipedia: LTCM | Federal Reserve History: LTCM Near Failure | Wall Street Mojo: LTCM Collapse | CFA Institute: How Financial World Almost Ended},
}

@article{longevity-escape-velocity,
  title = {Longevity Escape Velocity (LEV) - Maximum Human Life Extension Potential},
  author = {Wikipedia},
  year = {},
  journal = {Wikipedia: Longevity Escape Velocity},
  url = {https://en.wikipedia.org/wiki/Longevity_escape_velocity},
  urldate = {2025-01-20},
  note = {Wikipedia: Longevity Escape Velocity | PMC: Escape Velocity - Why Life Extension Matters Now | Popular Mechanics: Can Science Cure Death? | Diamandis: Longevity Escape Velocity},
}

@article{lost-human-capital-war-cost,
  title = {Lost human capital due to war (\$270B annually)},
  author = {Think by Numbers},
  year = {2021},
  journal = {Think by Numbers: War Costs $74},
  url = {<https://thinkbynumbers.org/military/war/the-economic-case-for-peace-a-comprehensive-financial-analysis/>},
  urldate = {2025-01-20},
  note = {Think by Numbers: War Costs $74,259/Lifetime | WEF: War Violence Costs $5/Day | PubMed: Economic Value DALYs Violence},
}

@article{makerdao-scale,
  title = {MakerDAO scale},
  author = {MakerDAO},
  year = {2024},
  journal = {MakerDAO},
  url = {https://defillama.com/protocol/maker},
  urldate = {2025-01-20},
  note = {MakerDAO, 2024, Official Site.},
}

@article{malaria-deaths-600k-annually,
  title = {Annual deaths from malaria},
  author = {WHO},
  year = {2024},
  journal = {WHO},
  url = {https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2024},
  urldate = {2025-01-20},
  note = {WHO, 2024, World Malaria Report 2024 | Note: 597,000 deaths in 2023; 73.7\% were children under 5},
}

@article{manhattan-project-cost-30b,
  title = {Manhattan Project cost in modern dollars},
  author = {Brookings},
  year = {},
  journal = {Brookings: Costs of the Manhattan Project},
  url = {https://www.brookings.edu/the-costs-of-the-manhattan-project/},
  urldate = {2025-01-20},
  note = {Brookings: Costs of the Manhattan Project | MoneyZine: Manhattan Project Cost},
}

@article{maskin1999,
  title = {Nash Equilibrium and Welfare Optimality},
  author = {Maskin, Eric},
  year = {1999},
  journal = {Review of Economic Studies},
  volume = {66},
  number = {1},
  pages = {23-38},
}

@misc{mccutcheon2014,
  title = {McCutcheon v. Federal Election Commission},
  author = {Supreme Court of the United States},
  year = {2014},
  note = {572 U.S. 185},
}

@misc{mcdonnell2016,
  title = {McDonnell v. United States},
  author = {Supreme Court of the United States},
  year = {2016},
  note = {579 U.S. 550},
}

@article{me-too-drug-market-40b,
  title = {Pharmaceutical spending on me-too drugs: $40 billion/year},
  author = {Stanford Medicine},
  year = {},
  journal = {Stanford Medicine: Me-too Drugs},
  url = {https://sm.stanford.edu/archive/stanmed/2005summer/drugs-metoo.html},
  urldate = {2025-01-20},
  note = {Stanford Medicine: Me-too Drugs | Wikipedia: Me-too Drug | PMC: Me-Too Innovation Pharmaceutical Markets | PMC: Me-too Products History},
}

@article{measles-vaccination-roi,
  title = {Measles Vaccination ROI},
  author = {MDPI Vaccines},
  year = {2024},
  journal = {MDPI Vaccines},
  url = {https://www.mdpi.com/2076-393X/12/11/1210},
  urldate = {2025-01-20},
  note = {MDPI Vaccines, 2024, Health and Economic Benefits of US Measles and Rubella Control | Taylor \& Francis, 2024, Economic Evaluation of Second MCV Dose},
}

@article{medical-research-funding-vs-gdp,
  title = {Medical research funding trends as a percentage of GDP},
  author = {American Progress},
  year = {2019},
  journal = {American Progress: NIH Funding Erosion},
  url = {https://www.americanprogress.org/article/erosion-of-funding-for-the-national-institutes-of-health-threatens-u-s-leadership-in-biomedical-research/},
  urldate = {2025-01-20},
  note = {American Progress: NIH Funding Erosion | ITIF: Healthy Funding | US News: US Medical Research Spending Drops},
}

@article{medical-research-lives-saved-annually,
  title = {Medical research lives saved annually (4.2 million)},
  author = {ScienceDaily},
  year = {2020},
  journal = {ScienceDaily: Physical Activity Prevents 4M Deaths},
  url = {https://www.sciencedaily.com/releases/2020/06/200617194510.htm},
  urldate = {2025-01-20},
  note = {ScienceDaily: Physical Activity Prevents 4M Deaths | PMC: Lives Saved by COVID Vaccines | Circulation: Three Interventions Save 94M Lives | PMC: Saving Millions Pandemic Research},
}

@article{medicare-clinical-trial-coverage-provisions,
  title = {Medicare Clinical Trial Coverage Provisions (Social Security Act Amendments)},
  author = {NCBI},
  year = {},
  journal = {NCBI: Paying for Patient Care Clinical Trials},
  url = {https://www.ncbi.nlm.nih.gov/books/NBK225267/},
  urldate = {2025-01-20},
  note = {NCBI: Paying for Patient Care Clinical Trials | CMS: Medicare Coverage Clinical Trials NCD | NCBI: Recommendations Medicare Clinical Trial Reimbursement},
}

@article{medicare-medicaid-clinical-trial-reimbursement,
  title = {Medicare and Medicaid reimbursement for clinical trial costs},
  author = {CMS},
  year = {},
  journal = {CMS: Medicare Clinical Trial Policies},
  url = {https://www.cms.gov/medicare/coverage/approved-facilities-trials-registries/clinical-policies},
  urldate = {2025-01-20},
  note = {CMS: Medicare Clinical Trial Policies | SCDHHS: Medicaid Coverage Clinical Trials | NCBI: Paying for Patient Care},
}

@article{medicare-modernization-act-pharma-lobbying,
  title = {Pharmaceutical lobby influence on Medicare Modernization Act of 2003},
  author = {Wikipedia},
  year = {},
  journal = {Wikipedia: Medicare Modernization Act},
  url = {https://en.wikipedia.org/wiki/Medicare_Prescription_Drug,_Improvement,_and_Modernization_Act},
  urldate = {2025-01-20},
  note = {Wikipedia: Medicare Modernization Act | Health Affairs: Politics Medicare Drug-Price Negotiation | CRS: Medicare Drug Price Negotiation},
}

@article{mental-health-burden,
  title = {Mental health global burden},
  author = {World Health Organization},
  year = {2022},
  journal = {World Health Organization},
  url = {https://www.who.int/news/item/28-09-2001-the-world-health-report-2001-mental-disorders-affect-one-in-four-people},
  urldate = {2025-01-20},
  note = {World Health Organization, 2022, Mental Health Fact Sheet},
}

@article{mental-health-nonprofit-grants,
  title = {Total annual grant funding for mental health nonprofits},
  author = {Instrumentl},
  year = {},
  journal = {Instrumentl: Mental Health Grants},
  url = {https://www.instrumentl.com/browse-grants/mental-health-grants},
  urldate = {2025-01-20},
  note = {Instrumentl: Mental Health Grants | Inside Philanthropy: Mental Health Grants | SAMHSA: Grants | Bloomerang: Mental Health Funding Resources},
}

@article{meta-rd-spending-38b,
  title = {Meta R\&D spending: $38 billion},
  author = {MacroTrends},
  year = {},
  journal = {MacroTrends: Meta R\&D},
  url = {https://www.macrotrends.net/stocks/charts/META/meta-platforms/research-development-expenses},
  urldate = {2025-01-20},
  note = {MacroTrends: Meta R\&D | Statista: R\&D Costs of Online Companies},
}

@book{milgrom2004,
  title = {Putting Auction Theory to Work},
  author = {Milgrom, Paul},
  year = {2004},
  publisher = {Cambridge University Press},
}

@article{military-lobbying-returns,
  title = {Military Lobbying Returns},
  author = {Watson Institute, Brown University},
  year = {2021},
  journal = {Watson Institute},
  url = {https://costsofwar.watson.brown.edu/paper/profits-war-corporate-beneficiaries-post-911-pentagon-spending-surge},
  urldate = {2025-01-20},
  note = {Watson Institute, Brown University, 2021, Profits of War},
}

@article{military-spending-economic-multiplier,
  title = {Military spending economic multiplier (0.6)},
  author = {Mercatus},
  year = {},
  journal = {Mercatus: Defense Spending and Economy},
  url = {https://www.mercatus.org/research/research-papers/defense-spending-and-economy},
  urldate = {2025-01-20},
  note = {Mercatus: Defense Spending and Economy | CEPR: WWII Spending Multipliers | RAND: Defense Spending Economic Growth},
}

@article{milken-high-yield-bonds,
  title = {Michael Milken and the Development of the High-Yield Bond Market},
  author = {Wikipedia},
  year = {},
  journal = {Wikipedia: Michael Milken},
  url = {https://en.wikipedia.org/wiki/Michael_Milken},
  urldate = {2025-01-20},
  note = {Wikipedia: Michael Milken | HBS: Junk Bond King Case | Britannica: Michael Milken | SEC Historical: Milken Scandal},
}

@article{mrna-vaccine-development-history,
  title = {Role of industry vs. NIH in mRNA vaccine development},
  author = {NIAID},
  year = {2021},
  journal = {NIAID},
  url = {https://www.niaid.nih.gov/diseases-conditions/decades-making-mrna-covid-19-vaccines},
  urldate = {2025-01-20},
  note = {NIAID, Decades in the Making: mRNA COVID-19 Vaccines | Johns Hopkins, The Long History of mRNA Vaccines | Note: 50+ years of public/private research; COVID vaccines developed in <12 months vs. typi...},
}

@article{murphy2006,
  title = {The Value of Health and Longevity},
  author = {Murphy, Kevin M. and Topel, Robert H.},
  year = {2006},
  journal = {Journal of Political Economy},
  volume = {114},
  number = {5},
  pages = {871-904},
  doi = {10.1086/508033},
  note = {Estimates economic value of health gains 1970-2000 at $3.2 trillion annually},
}

@article{myerson1979,
  title = {Incentive Compatibility and the Bargaining Problem},
  author = {Myerson, Roger B.},
  year = {1979},
  journal = {Econometrica},
  volume = {47},
  number = {1},
  pages = {61-73},
}

@article{nasa-annual-budget,
  title = {NASA's annual budget},
  author = {NASA},
  year = {2024},
  journal = {NASA},
  url = {https://www.nasa.gov/budgets-plans-and-reports/},
  urldate = {2025-01-20},
  note = {NASA, FY 2024 Budget | The Planetary Society, NASA's FY 2024 Budget | Note: $24.875B in FY2024 (0.37\% of federal budget)},
}

@article{nato-om-ratios-global-spending,
  title = {NATO O\&M ratios for global spending},
  author = {USAFacts},
  year = {2024},
  journal = {USAFacts: US Military Spending},
  url = {https://usafacts.org/articles/how-much-does-the-us-spend-on-the-military/},
  urldate = {2025-01-20},
  note = {USAFacts: US Military Spending | CBO: DoD O\&M Trends | NATO: Defence Expenditures | Statista: NATO Combined Defense Expenditures 2024},
}

@article{nature2014,
  title = {Lobbying sways NIH grants},
  author = {Reardon, Sara},
  year = {2014},
  journal = {Nature},
  volume = {515},
  pages = {19},
  url = {https://www.nature.com/articles/515019a},
  urldate = {2025-01-20},
  note = {Reports on Best (2012) finding: each $1,000 in lobbying correlated with $25,000 increase in NIH funding},
}

@article{net-neutrality-comments,
  title = {Net Neutrality Comments (nearly 4M, 2014-2015)},
  author = {TechCrunch},
  year = {2014},
  journal = {TechCrunch},
  url = {https://techcrunch.com/2014/12/23/fcc-confirms-that-nearly-4m-net-neutrality-comments-were-submitted-by-the-public/},
  urldate = {2025-01-20},
  note = {TechCrunch, 2014, FCC Confirms That Nearly 4M Net Neutrality Comments Were Submitted By The Public},
}

@article{neurodegenerative-stem-cell-potential,
  title = {Stem cell therapy shows promise for neurodegenerative diseases},
  author = {PMC},
  year = {2023},
  journal = {PMC: Regenerative Stem Cell Therapy for Neurodegenerative Diseases},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC7926761/},
  urldate = {2025-01-20},
  note = {PMC: Regenerative Stem Cell Therapy for Neurodegenerative Diseases | Stanford Medicine: Stem Cell Alzheimer's Study | Stem Cell Research \& Therapy: Cell-based Strategies},
}

@article{neuromodulation-trd-response-rates,
  title = {Closed-loop neuromodulation and accelerated TMS for treatment-resistant depression},
  author = {Stanford Medicine},
  year = {2020},
  journal = {Stanford SAINT Study (2020)},
  url = {https://psychiatryonline.org/doi/10.1176/appi.ajp.2019.19070720},
  urldate = {2025-01-20},
  note = {Stanford SAINT Study (2020) | Stanford SNT RCT (2021) | UCSF Closed-Loop Nature Medicine (2021) | Stanford News},
}

@article{nia-budget-4-41b,
  title = {National Institute on Aging Budget: $4.41 billion},
  author = {NIA},
  year = {2024},
  journal = {NIA: FY2024 Budget},
  url = {https://www.nia.nih.gov/about/budget/fiscal-year-2024-budget},
  urldate = {2025-01-20},
  note = {NIA: FY2024 Budget | NIA: FY2025 Budget},
}

@article{nih-admin-to-scientist-ratio,
  title = {NIH administrator to scientist employment ratio},
  author = {NIH OIR},
  year = {},
  journal = {NIH OIR: Staff Scientist},
  url = {https://oir.nih.gov/sourcebook/personnel/ipds-appointment-mechanisms/staff-scientist},
  urldate = {2025-01-20},
  note = {NIH OIR: Staff Scientist | NIH: Scientist Administrators},
}

@article{nih-administrative-costs-31pct,
  title = {NIH administrative costs percentage (31\%)},
  author = {American Action Forum},
  year = {},
  journal = {American Action Forum: NIH 15% Cap},
  url = {https://www.americanactionforum.org/weekly-checkup/nihs-15-percent-cap-leaner-budgets-stronger-science/},
  urldate = {2025-01-20},
  note = {American Action Forum: NIH 15\% Cap | Feldesman: NIH Indirect Costs},
}

@article{nih-all-of-us-inefficiency,
  title = {NIH All of Us Research Program outcomes and spending},
  author = {All of Us},
  year = {2026},
  journal = {All of Us: Program Overview},
  url = {https://allofus.nih.gov/article/program-overview},
  urldate = {2025-01-20},
  note = {All of Us: Program Overview | NEJM: All of Us Research Program | GenomeWeb: All of Us Plans},
}

@article{nih-all-of-us-program,
  title = {NIH All of Us Research Program},
  author = {All of Us},
  year = {},
  journal = {All of Us: Official Site},
  url = {https://allofus.nih.gov/},
  urldate = {2025-01-20},
  note = {All of Us: Official Site | Wikipedia: All of Us)},
}

@article{nih-annual-papers-published,
  title = {Annual number of papers published from NIH-funded research},
  author = {NSF},
  year = {},
  journal = {NSF: Publications Output},
  url = {https://ncses.nsf.gov/pubs/nsb20206},
  urldate = {2025-01-20},
  note = {NSF: Publications Output | Our World in Data: Scientific Publications | PMC: NIH Funding Productivity},
}

@article{nih-budget-allocation-breakdown,
  title = {NIH budget allocation for basic vs. clinical research},
  author = {PMC},
  year = {2021},
  journal = {PMC: NIH Clinical Development Spending},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC10349341/},
  urldate = {2025-01-20},
  note = {PMC: NIH Clinical Development Spending | HHS Budget Brief | NIH Triennial Report FY2019-2021 | Science: NIH Basics},
}

@article{nih-budget-fy2025,
  title = {NIH Budget (FY 2025)},
  author = {NIH},
  year = {2024},
  journal = {NIH},
  url = {https://www.nih.gov/about-nih/organization/budget},
  urldate = {2025-01-20},
  note = {NIH, 2024, Budget Overview | NIH, Office of Budget | Note: FY2024 budget was $47.1B},
}

@article{nih-clinical-research-funding-2023,
  title = {NIH clinical research funding 2023},
  author = {Statista},
  year = {},
  journal = {Statista},
  url = {https://www.statista.com/statistics/716602/total-clinical-research-funding-by-the-national-institutes-for-health/},
  urldate = {2025-01-20},
  note = {Statista, NIH Clinical Research Funding},
}

@article{nih-clinical-trials-small-fraction,
  title = {NIH Actual Interventional Trial Spending: Only 3.3\% of Budget},
  author = {JAMA Health Forum},
  year = {2023},
  journal = {JAMA Health Forum: NIH Clinical Development Spending (2023)},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC10349341/},
  urldate = {2025-01-20},
  note = {JAMA Health Forum: NIH Clinical Development Spending (2023) | Harvard Catalyst: NIH vs Industry Spending},
}

@article{nih-clinical-trials-spending-pct-3-3,
  title = {NIH spending on clinical trials: ~3.3\%},
  author = {Bentley et al.},
  year = {2023},
  journal = {Bentley et al.},
  url = {https://www.fiercebiotech.com/biotech/nih-spending-clinical-trials-reached-81b-over-decade},
  urldate = {2025-01-20},
  note = {Bentley et al., 2023 | Fierce Biotech: NIH Spending},
}

@article{nih-common-fund-overview,
  title = {NIH Common Fund overview},
  author = {NIH},
  year = {},
  journal = {NIH},
  url = {https://commonfund.nih.gov/about},
  urldate = {2025-01-20},
  note = {NIH, Common Fund Overview},
}

@article{nih-ctsa-program-funding,
  title = {NIH Clinical and Translational Science Awards (CTSA) Program},
  author = {NCBI},
  year = {},
  journal = {NCBI: CTSA Program Summary},
  url = {https://www.ncbi.nlm.nih.gov/books/NBK169198/},
  urldate = {2025-01-20},
  note = {NCBI: CTSA Program Summary | Wikipedia: CTSA | NCATS: CTSA Program},
}

@article{nih-decision-makers-200-people,
  title = {NIH centralized decision-making structure},
  author = {NIH},
  year = {},
  journal = {NIH Almanac},
  url = {https://www.nih.gov/about-nih/what-we-do/nih-almanac},
  urldate = {2025-01-20},
  note = {NIH Almanac | NIH Organization},
}

@article{nih-eradicated-zero-diseases,
  title = {Number of diseases eradicated by the NIH},
  author = {PMC},
  year = {},
  journal = {PMC: Six Challenges in Eradication},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC7612385/},
  urldate = {2025-01-20},
  note = {PMC: Six Challenges in Eradication | PMC: Contribution of Vaccination | NCBI: Major Efforts for Disease Eradication},
}

@article{nih-favors-experienced-writers,
  title = {NIH grant system favors experienced writers},
  author = {The New York Times},
  year = {2018},
  journal = {The New York Times},
  url = {https://www.nytimes.com/2018/06/18/upshot/why-the-medical-research-grant-system-could-be-costing-us-great-ideas.html},
  urldate = {2025-01-20},
  note = {The New York Times, 2018, Why the Medical Research Grant System Could Be Costing Us Great Ideas},
}

@article{nih-first-r01-age-45,
  title = {NIH first R01 grant average age (>45)},
  author = {PNAS},
  year = {2015},
  journal = {PNAS},
  url = {https://www.pnas.org/doi/10.1073/pnas.1418761112},
  urldate = {2025-01-20},
  note = {PNAS, 2015, The growing age disadvantage in NIH funding of physician-scientists},
}

@article{nih-funded-approved-drugs,
  title = {FY2016 Budget in Brief - NIH},
  author = {HHS},
  year = {2020},
  journal = {HHS},
  url = {https://www.hhs.gov/about/budget/budget-in-brief/nih/index.html},
  urldate = {2025-01-20},
  note = {HHS, FY2016 Budget in Brief - NIH},
}

@article{nih-funding-bias,
  title = {NIH funding bias towards established researchers},
  author = {Science},
  year = {2017},
  journal = {Science},
  url = {https://www.science.org/doi/10.1126/science.aan6504},
  urldate = {2025-01-20},
  note = {Science, 2017, NIH grant cap plan is dead},
}

@article{nih-funding-cuts-brain-drain,
  title = {NIH funding cuts and brain drain},
  author = {Silicon Valley Business Journal},
  year = {2025},
  journal = {Silicon Valley Business Journal},
  url = {https://www.bizjournals.com/sanjose/news/2025/08/15/nih-funding-cuts-science-brain-drain-berkeley.html},
  urldate = {2025-01-20},
  note = {Silicon Valley Business Journal, 2025, NIH funding cuts could create a science 'brain drain'},
}

@article{nih-funding-deaths-comparison,
  title = {Comparison of NIH funding and death rates for breast cancer vs. heart disease},
  author = {PMC},
  year = {},
  journal = {PMC: Allocation of Research Funding},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC5836059/},
  urldate = {2025-01-20},
  note = {PMC: Allocation of Research Funding | PMC: Cancer Burden vs Research Spending | PubMed: Preventing Cancer, CVD, Diabetes},
}

@article{nih-funding-hot-topics,
  title = {NIH funding follows "hot topics"},
  author = {PMC},
  year = {1999},
  journal = {PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC1116068/},
  urldate = {2025-01-20},
  note = {PMC, 1999, Role of advocacy in allocation of NIH funds},
}

@article{nih-funding-vs-disease-burden-correlation,
  title = {Correlation between NIH funding priorities and disease burden},
  author = {ScienceDirect},
  year = {},
  journal = {ScienceDirect: Persistence of Very Low Correlations},
  url = {https://www.sciencedirect.com/science/article/pii/S2666535224001174},
  urldate = {2025-01-20},
  note = {ScienceDirect: Persistence of Very Low Correlations | NEJM: NIH Funding vs Burden of Disease | PMC: NIH Disease Funding Levels},
}

@article{nih-grant-success-rate-19pct,
  title = {NIH grant success rate (~19\%)},
  author = {NIH Data Book},
  year = {2024},
  journal = {NIH Data Book},
  url = {https://report.nih.gov/nihdatabook/category/10},
  urldate = {2025-01-20},
  note = {NIH Data Book, 2024, Success Rates},
}

@article{nih-institute-budgets-fy24,
  title = {NIH Institute and Center Budgets, FY2024},
  author = {AIP},
  year = {2024},
  journal = {AIP: FY2024 NIH Budget},
  url = {https://www.aip.org/fyi/fy2024-national-institutes-of-health},
  urldate = {2025-01-20},
  note = {AIP: FY2024 NIH Budget | CRS: NIH Funding FY1996-FY2025 | NCI: FY2024 Appropriation},
}

@article{nih-misaligned-outcomes,
  title = {NIH research misalignment with public health outcomes},
  author = {Nature},
  year = {2011},
  journal = {Nature},
  url = {https://www.nature.com/articles/471569a},
  urldate = {2025-01-20},
  note = {Nature, 2011, US health reform: The NIH's weak report card},
}

@article{nih-od-budget,
  title = {NIH Office of the Director budget info},
  author = {NIH},
  year = {},
  journal = {NIH},
  url = {https://officeofbudget.od.nih.gov/br.html},
  urldate = {2025-01-20},
  note = {NIH, OD Budget},
}

@article{nih-organizational-complexity,
  title = {NIH organizational complexity},
  author = {National Academies Press},
  year = {2003},
  journal = {National Academies Press},
  url = {https://www.ncbi.nlm.nih.gov/books/NBK43482/},
  urldate = {2025-01-20},
  note = {National Academies Press, 2003, Enhancing the Vitality of the National Institutes of Health},
}

@article{nih-organizational-stats,
  title = {NIH organizational statistics},
  author = {NIH CSR},
  year = {},
  journal = {NIH CSR: Study Sections},
  url = {https://public.csr.nih.gov/StudySections},
  urldate = {2025-01-20},
  note = {NIH CSR: Study Sections | NIH CSR: Regular Standing Study Sections},
}

@article{nih-patient-treatments-tested,
  title = {Number of patient-treatments tested by NIH for its budget},
  author = {ClinicalTrials.gov},
  year = {2000},
  journal = {ClinicalTrials.gov},
  url = {https://clinicaltrials.gov/},
  urldate = {2025-01-20},
  note = {ClinicalTrials.gov | PMC: Clinical Trial Landscape 2000-2020},
}

@article{nih-peer-review-risk-penalty,
  title = {NIH peer review penalizes risk},
  author = {Federation of American Scientists},
  year = {},
  journal = {Federation of American Scientists},
  url = {https://fas.org/publication/supercharging-biomedical-science-at-the-national-institutes-of-health/},
  urldate = {2025-01-20},
  note = {Federation of American Scientists, Supercharging Biomedical Science at the NIH},
}

@article{nih-phase-1-coverage,
  title = {NIH Phase 1 cost coverage},
  author = {PMC},
  year = {},
  journal = {PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC10349341/},
  urldate = {2025-01-20},
  note = {PMC, NIH Coverage Analysis},
}

@article{nih-phase-1-industry-percentage,
  title = {NIH Phase 1 as percentage of industry costs},
  author = {PMC},
  year = {},
  journal = {PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC10349341/},
  urldate = {2025-01-20},
  note = {PMC, NIH Industry Cost Comparison},
}

@article{nih-phase-1-percentage,
  title = {NIH Phase 1 trial percentage},
  author = {PMC},
  year = {},
  journal = {PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC5802548/},
  urldate = {2025-01-20},
  note = {PMC, NIH Clinical Trial Characteristics},
}

@article{nih-phase-1-spending-per-drug,
  title = {NIH Phase 1 spending per drug},
  author = {PMC},
  year = {},
  journal = {PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC10349341/},
  urldate = {2025-01-20},
  note = {PMC, NIH Clinical Development Spending},
}

@article{nih-phase-2-coverage,
  title = {NIH Phase 2 cost coverage},
  author = {PMC},
  year = {},
  journal = {PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC10349341/},
  urldate = {2025-01-20},
  note = {PMC, NIH Phase Funding},
}

@article{nih-phase-2-industry-percentage,
  title = {NIH Phase 2 as percentage of industry costs},
  author = {PMC},
  year = {},
  journal = {PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC10349341/},
  urldate = {2025-01-20},
  note = {PMC, NIH Phase Cost Analysis},
}

@article{nih-phase-2-percentage,
  title = {NIH Phase 2 trial percentage},
  author = {PMC},
  year = {},
  journal = {PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC5802548/},
  urldate = {2025-01-20},
  note = {PMC, NIH Trial Distribution},
}

@article{nih-phase-2-spending-per-drug,
  title = {NIH Phase 2 spending per drug},
  author = {PMC},
  year = {},
  journal = {PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC10349341/},
  urldate = {2025-01-20},
  note = {PMC, NIH Clinical Trial Expenditures},
}

@article{nih-phase-3-coverage,
  title = {NIH Phase 3 cost coverage},
  author = {PMC},
  year = {},
  journal = {PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC10349341/},
  urldate = {2025-01-20},
  note = {PMC, NIH Late-Stage Funding},
}

@article{nih-phase-3-industry-percentage,
  title = {NIH Phase 3 as percentage of industry costs},
  author = {PMC},
  year = {},
  journal = {PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC10349341/},
  urldate = {2025-01-20},
  note = {PMC, NIH Industry Funding Comparison},
}

@article{nih-phase-3-minimal-coverage,
  title = {NIH Phase 3 Underfunding: Only 3.7-4.3\% of Industry Spending},
  author = {JAMA Health Forum},
  year = {2023},
  journal = {JAMA Health Forum: NIH Phase Distribution (2023)},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC10349341/},
  urldate = {2025-01-20},
  note = {JAMA Health Forum: NIH Phase Distribution (2023)},
}

@article{nih-phase-3-percentage,
  title = {NIH Phase 3 trial percentage},
  author = {PMC},
  year = {},
  journal = {PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC5802548/},
  urldate = {2025-01-20},
  note = {PMC, NIH Clinical Trial Portfolio},
}

@article{nih-phase-3-spending-per-drug,
  title = {NIH Phase 3 spending per drug},
  author = {PMC},
  year = {},
  journal = {PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC10349341/},
  urldate = {2025-01-20},
  note = {PMC, NIH Clinical Development Analysis},
}

@article{nih-phase-4-percentage,
  title = {NIH Phase 4 trial percentage},
  author = {PMC},
  year = {},
  journal = {PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC5802548/},
  urldate = {2025-01-20},
  note = {PMC, NIH Clinical Trial Portfolio},
}

@article{nih-phase-other-percentage,
  title = {NIH trials with unspecified phase},
  author = {PMC},
  year = {},
  journal = {PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC5802548/},
  urldate = {2025-01-20},
  note = {PMC, NIH Trial Characteristics},
}

@article{nih-phased-trial-spending-2010-2019,
  title = {NIH phased trial spending for approved drugs 2010-2019},
  author = {PMC},
  year = {},
  journal = {PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC10349341/},
  urldate = {2025-01-20},
  note = {PMC, NIH vs Industry Clinical Trial Spending},
}

@article{nih-recover-inefficiency,
  title = {NIH RECOVER Initiative inefficiency},
  author = {RECOVER Initiative \& News Reports},
  year = {2025},
  journal = {RECOVER Initiative \& News Reports},
  url = {https://recovercovid.org/about},
  urldate = {2025-01-20},
  note = {RECOVER Initiative \& News Reports, 2025, Official Site},
}

@article{nih-research-percentage,
  title = {NIH research funding percentage},
  author = {AAMC},
  year = {},
  journal = {AAMC},
  url = {https://www.aamc.org/news/whats-stake-when-clinical-trials-research-gets-cut},
  urldate = {2025-01-20},
  note = {AAMC, NIH Research Funding},
}

@article{nih-sbir-grant-success-rate,
  title = {NIH SBIR grant success rate (9.9\%)},
  author = {LinkedIn, Kirk Macolini},
  year = {2024},
  journal = {LinkedIn},
  url = {https://www.linkedin.com/posts/kirk-macolini-25148b12_nih-sbir-sttr-activity-7328164071042686976-fsG7},
  urldate = {2025-01-20},
  note = {LinkedIn, Kirk Macolini, 2024, NIH SBIR STTR activity},
}

@article{nih-spending-per-drug-bentley,
  title = {NIH spending per FDA-approved drug (adjusted)},
  author = {Bentley University},
  year = {2022},
  journal = {Bentley University},
  url = {https://www.bentley.edu/news/new-study-shows-nih-investment-new-drug-approvals-comparable-investment-pharmaceutical},
  urldate = {2025-01-20},
  note = {Bentley University, 2022, New Study Shows NIH Investment in New Drug Approvals},
}

@article{nih-vs-industry-spending-ratio,
  title = {NIH vs industry spending ratio},
  author = {Harvard Catalyst},
  year = {2010},
  journal = {Harvard Catalyst},
  url = {https://catalyst.harvard.edu/news/article/nih-spent-8-1b-for-phased-clinical-trials-of-drugs-approved-2010-19-10-of-reported-industry-spending/},
  urldate = {2025-01-20},
  note = {Harvard Catalyst, NIH Industry Spending Comparison},
}

@misc{nobelprize2007,
  title = {The Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel 2007},
  author = {Nobel Prize Committee},
  year = {2007},
  url = {https://www.nobelprize.org/prizes/economic-sciences/2007/summary/},
  urldate = {2025-01-20},
  note = {Awarded to Leonid Hurwicz, Eric S. Maskin and Roger B. Myerson},
}

@legislation{nonprofit-clinical-trial-spending-estimate,
  title = {Nonprofit clinical trial funding estimate},
  institution = {Estimated from major foundation budgets and activities},
  year = {},
  note = {Estimated from major foundation budgets and activities},
}

@article{north-korea-famine-deaths,
  title = {Death toll from famine in North Korea},
  author = {Wikipedia},
  year = {1999},
  journal = {Wikipedia: 1990s North Korean Famine},
  url = {https://en.wikipedia.org/wiki/1990s_North_Korean_famine},
  urldate = {2025-01-20},
  note = {Wikipedia: 1990s North Korean Famine | National Interest: 3.5 Million Dead | USIP: Politics of Famine},
}

@article{northrop-grumman-annual-revenue-36b,
  title = {Northrop Grumman annual revenue},
  author = {Wikipedia},
  year = {2024},
  journal = {Wikipedia: Northrop Grumman},
  url = {https://en.wikipedia.org/wiki/Northrop_Grumman},
  urldate = {2025-01-20},
  note = {Wikipedia: Northrop Grumman | Statista: Northrop Grumman Revenue 2024 | Northrop Grumman Investor Relations},
}

@article{npr-nsf-freezes,
  title = {NSF grant freezes (news report)},
  author = {NPR},
  year = {2025},
  journal = {NPR},
  url = {https://www.npr.org/2025/01/31/nx-s1-5282162/scientists-grants-frozen-trump-executive-actions-dei-deia},
  urldate = {2025-01-20},
  note = {NPR, 2025, NSF freezes payments},
}

@article{nuclear-disarmament-movement-freeze,
  title = {The Nuclear Disarmament "Freeze" Movement of the 1980s},
  author = {Wikipedia},
  year = {2010},
  journal = {Wikipedia: Nuclear Freeze Campaign},
  url = {https://en.wikipedia.org/wiki/Nuclear_Freeze_campaign},
  urldate = {2025-01-20},
  note = {Wikipedia: Nuclear Freeze Campaign | Arms Control: Nuclear Freeze and Its Impact | Pace: Nuclear Freeze Campaign 1970s-1980s},
}

@misc{nuclear-extinction,
  title = {Nuclear Extinction Events (Estimated 10-100 winter scenarios)},
  author = {Based on FAS arsenal data and climate models},
  year = {},
  note = {Based on FAS arsenal data and climate models},
}

@article{nuke-winter-150tg,
  title = {Nuclear Winter Famine},
  author = {Xia et al., Nature Food},
  year = {2022},
  journal = {Xia et al.},
  url = {https://www.nature.com/articles/s43016-022-00573-0},
  urldate = {2025-01-20},
  note = {Xia et al., Nature Food, 2022, Global food insecurity and famine from nuclear war soot injection},
}

@article{number-of-drugs-tested-thoroughly,
  title = {Number of drug compounds thoroughly tested},
  author = {PMC},
  year = {},
  journal = {PMC: Estimation of Clinical Trial Success Rates},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC6409418/},
  urldate = {2025-01-20},
  note = {PMC: Estimation of Clinical Trial Success Rates | Statista: Registered Clinical Studies Worldwide | PLOS Medicine: Number of Patients Studied Prior to Approval},
}

@article{number-of-known-diseases,
  title = {Estimated number of known human diseases},
  author = {WHO},
  year = {},
  journal = {WHO: Rare Diseases FAQ},
  url = {https://www.who.int/standards/classifications/frequently-asked-questions/rare-diseases},
  urldate = {2025-01-20},
  note = {WHO: Rare Diseases FAQ | Orphanet: Rare Diseases in ICD11 | PMC: Rendering of Human Phenotype in ICD-11},
}

@article{obesity-epidemic-stats,
  title = {Obesity Epidemic Statistics},
  author = {CDC},
  year = {2020},
  journal = {CDC},
  url = {https://www.cdc.gov/nchs/products/databriefs/db360.htm},
  urldate = {2025-01-20},
  note = {CDC, 2020, Link},
}

@article{occupy-wall-street,
  title = {Occupy Wall Street Movement (2011)},
  author = {Wikipedia},
  year = {},
  journal = {Wikipedia: Occupy Wall Street},
  url = {https://en.wikipedia.org/wiki/Occupy_Wall_Street},
  urldate = {2025-01-20},
  note = {Wikipedia: Occupy Wall Street | Britannica: Occupy Wall Street | History: Occupy Wall Street Begins},
}

@article{odds-of-decisive-vote,
  title = {Odds of a single vote being decisive in a U.S. presidential election},
  author = {Columbia/NBER},
  year = {2012},
  journal = {Columbia/NBER: What Is the Probability Your Vote Will Make a Difference?},
  url = {https://sites.stat.columbia.edu/gelman/research/published/probdecisive2.pdf},
  urldate = {2025-01-20},
  note = {Columbia/NBER: What Is the Probability Your Vote Will Make a Difference? | Economic Inquiry 2012},
}

@book{olson1965,
  title = {The Logic of Collective Action: Public Goods and the Theory of Groups},
  author = {Olson, Mancur},
  year = {1965},
  publisher = {Harvard University Press},
  address = {Cambridge, MA},
}

@misc{omar2024,
  title = {Sanders, Omar Introduce Legislation to End Corporate Welfare for the Fossil Fuel Industry},
  author = {Office of Senator Bernie Sanders},
  year = {2024},
  url = {https://www.sanders.senate.gov/press-releases/news-sanders-omar-introduce-legislation-to-end-corporate-welfare-for-the-fossil-fuel-industry-and-save-american-taxpayers-billions-of-dollars/},
  urldate = {2025-01-20},
  note = {Cites $137M lobbying vs. $17B in annual subsidies},
}

@article{onc-healthit,
  title = {Office of the National Coordinator for Health Information Technology (ONC)},
  author = {Wikipedia},
  year = {},
  journal = {Wikipedia: ONC},
  url = {https://en.wikipedia.org/wiki/Office_of_the_National_Coordinator_for_Health_Information_Technology},
  urldate = {2025-01-20},
  note = {Wikipedia: ONC | HHS: ASTP/ONC | HealthIT.gov},
}

@article{oncologist-median-salary-200k,
  title = {Median oncologist salary},
  author = {Weatherby},
  year = {2024},
  journal = {Weatherby: Medical Oncologist Salary 2024},
  url = {https://weatherbyhealthcare.com/blog/medical-oncologist-salary},
  urldate = {2025-01-20},
  note = {Weatherby: Medical Oncologist Salary 2024 | Sermo: Oncologist Salaries 2025 | AMN Healthcare: Oncologist Salary 2025},
}

@article{open-source-platform-multi-trillion-dollar-reality,
  title = {Open-source and platform-as-a-service multi-trillion dollar market},
  author = {Grand View Research},
  year = {},
  journal = {Grand View Research: Open Source Services Market},
  url = {https://www.grandviewresearch.com/industry-analysis/open-source-services-market-report},
  urldate = {2025-01-20},
  note = {Grand View Research: Open Source Services Market | Precedence Research: Open Source Services Market},
}

@report{opensecrets2020,
  title = {More Money, Less Transparency: A Decade Under Citizens United},
  institution = {OpenSecrets},
  year = {2020},
  url = {https://www.opensecrets.org/news/reports/a-decade-under-citizens-united},
  urldate = {2025-01-20},
  note = {Documents growth in independent expenditures from $52M in 2006 to over $1B by 2012},
}

@report{opensecrets2025,
  title = {Federal Lobbying Set New Record in 2024},
  institution = {OpenSecrets},
  year = {2025},
  url = {https://www.opensecrets.org/news/2025/02/federal-lobbying-set-new-record-in-2024/},
  urldate = {2025-01-20},
  note = {Oil and gas industry spent $151.1 million; pharmaceuticals spent over $293 million},
}

@article{opentrials-database,
  title = {OpenTrials Database Initiative},
  author = {OpenTrials},
  year = {2016},
  journal = {OpenTrials: Official Site},
  url = {https://opentrials.net/},
  urldate = {2025-01-20},
  note = {OpenTrials: Official Site | Trials: OpenTrials Article | Open Knowledge Blog},
}

@article{ostrom-game-theory-cooperation,
  title = {Elinor Ostrom's work on cooperation vs. punishment},
  author = {ResearchGate},
  year = {2025},
  journal = {ResearchGate: Ostrom's Contributions to Experimental Study of Social Dilemmas},
  url = {https://www.researchgate.net/publication/225351948_Elinor_Ostrom's_contributions_to_the_experimental_study_of_social_dilemmas},
  urldate = {2025-01-20},
  note = {ResearchGate: Ostrom's Contributions to Experimental Study of Social Dilemmas | Jacobin: The Economist Who Solved the Free-Rider Problem},
}

@article{pandemics-vs-wars,
  title = {Pandemic vs. war deaths comparison},
  author = {Our World in Data},
  year = {2024},
  journal = {Our World in Data},
  url = {https://ourworldindata.org/covid-deaths},
  urldate = {2025-01-20},
  note = {Our World in Data, 2024, COVID-19 Deaths},
}

@article{parents-of-sick-children-50m,
  title = {Over 50 million parents of sick children},
  author = {UCLA Health},
  year = {},
  journal = {UCLA Health: Pediatric Chronic Disease Prevalence},
  url = {https://www.uclahealth.org/news/release/pediatric-chronic-disease-prevalence-has-risen-nearly-30},
  urldate = {2025-01-20},
  note = {UCLA Health: Pediatric Chronic Disease Prevalence | PMC: Health Outcomes of Parents | Documenting Hope: Statistics},
}

@article{patient-access-clinical-trials,
  title = {Patient enrollment rates in clinical trials},
  author = {Applied Clinical Trials},
  year = {},
  journal = {Applied Clinical Trials: Rebooting the 5% Statistic},
  url = {https://www.appliedclinicaltrialsonline.com/view/rebooting-the-statistic-that-5-of-eligible-patients-participate-in-clinical-trials},
  urldate = {2025-01-20},
  note = {Applied Clinical Trials: Rebooting the 5\% Statistic | JNCI: When Offered to Participate | JCO: National Estimates},
}

@article{patient-willingness-clinical-trials,
  title = {Patient willingness to participate in clinical trials},
  author = {Trials},
  year = {},
  journal = {Trials: Patients' Willingness Survey},
  url = {https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-015-1105-3},
  urldate = {2025-01-20},
  note = {Trials: Patients' Willingness Survey | Applied Clinical Trials: Patient Participation | PMC: Study Design Factors},
}

@article{patientslikeme-advocacy,
  title = {PatientsLikeMe Patient Advocacy Group},
  author = {Wikipedia},
  year = {},
  journal = {Wikipedia: PatientsLikeMe},
  url = {https://en.wikipedia.org/wiki/PatientsLikeMe},
  urldate = {2025-01-20},
  note = {Wikipedia: PatientsLikeMe | PMC: Scaling PatientsLikeMe | PatientsLikeMe},
}

@article{patrick-soon-shiong-cancer-research-focus,
  title = {Patrick Soon-Shiong's focus on cancer research},
  author = {Wikipedia},
  year = {2017},
  journal = {Wikipedia: Patrick Soon-Shiong},
  url = {https://en.wikipedia.org/wiki/Patrick_Soon-Shiong},
  urldate = {2025-01-20},
  note = {Wikipedia: Patrick Soon-Shiong | STAT: Soon-Shiong Cancer Therapy | BioSpace: Cancer Moonshot Progress},
}

@article{patriot-act-passage,
  title = {Passage of the USA PATRIOT Act},
  author = {Wikipedia},
  year = {2001},
  journal = {Wikipedia: Patriot Act},
  url = {https://en.wikipedia.org/wiki/Patriot_Act},
  urldate = {2025-01-20},
  note = {Wikipedia: Patriot Act | Britannica: USA PATRIOT Act | ALA: Chronology of USA PATRIOT Act},
}

@article{paypal-dropbox-referral-case-studies,
  title = {PayPal and Dropbox referral program case studies (viral growth economics)},
  author = {Wikipedia},
  year = {2019},
  journal = {PayPal Wars Book},
  url = {https://en.wikipedia.org/wiki/The_PayPal_Wars},
  urldate = {2025-01-20},
  note = {PayPal Wars Book | Dropbox Growth Case Study | Harvard Business Review: Hard Truth About Innovative Cultures | Rogers (2003): Diffusion of Innovations Theory},
}

@article{pdufa-user-fees,
  title = {Prescription Drug User Fee Act (PDUFA)},
  author = {Wikipedia},
  year = {},
  journal = {Wikipedia: PDUFA},
  url = {https://en.wikipedia.org/wiki/Prescription_Drug_User_Fee_Act},
  urldate = {2025-01-20},
  note = {Wikipedia: PDUFA | FDA: PDUFA | PMC: PDUFA More Than User Fees},
}

@article{pe-military-returns,
  title = {Private Equity Military Sector Returns},
  author = {PitchBook \& Industry Analysis},
  year = {2024},
  journal = {PitchBook \& Industry Analysis},
  url = {https://www.nber.org/system/files/working_papers/w17874/w17874.pdf},
  urldate = {2025-01-20},
  note = {PitchBook \& Industry Analysis, 2024, Link},
}

@article{peirce-token-safe-harbor,
  title = {Token Safe Harbor concept (Peirce 2.0)},
  author = {Hester M. Peirce, SEC Commissioner},
  year = {2021},
  journal = {Hester M. Peirce},
  url = {https://www.sec.gov/news/public-statement/peirce-statement-token-safe-harbor-proposal-2.0},
  urldate = {2025-01-20},
  note = {Hester M. Peirce, SEC Commissioner, 2021, Token Safe Harbor 2.0},
}

@article{pension-fund-fiduciary-duty,
  title = {Fiduciary Duty of Pension Funds to Maximize Returns},
  author = {Harvard Corp Gov},
  year = {2023},
  journal = {Harvard Corp Gov: Fiduciary Duties},
  url = {https://corpgov.law.harvard.edu/2023/03/01/fiduciary-duties-of-public-pension-systems-and-registered-investment-advisors/},
  urldate = {2025-01-20},
  note = {Harvard Corp Gov: Fiduciary Duties | DOL: Meeting Fiduciary Responsibilities | IRS: Retirement Plan Fiduciary Responsibilities},
}

@article{pentagon-unaccounted-2-5t,
  title = {Pentagon audit failures (\$2.46T unaccounted)},
  author = {The Commune},
  year = {2024},
  journal = {The Commune},
  url = {https://thecommunemag.com/the-pentagon-misplaced-2-46-trillion-an-in-depth-look-at-the-financial-audit-failures},
  urldate = {2025-01-20},
  note = {The Commune, 2024, Pentagon Misplaced \$2.46 Trillion | Accounting Magazine, 2016, Audit: Pentagon Cannot Account for \$6.5 Trillion Dollars},
}

@misc{per-capita-lifetime,
  title = {Per Capita Lifetime Cost of Violence (Estimated ~\$170,000)},
  author = {Based on IEP Global Peace Index},
  year = {},
  note = {Based on IEP Global Peace Index},
}

@article{per-person-impact-74259-lifetime-savings,
  title = {$74,259 per person lifetime savings from conflict reduction},
  author = {Think by Numbers},
  year = {2021},
  journal = {Think by Numbers: War Costs $74},
  url = {<https://thinkbynumbers.org/military/war/the-economic-case-for-peace-a-comprehensive-financial-analysis/>},
  urldate = {2025-01-20},
  note = {Think by Numbers: War Costs $74,259/Lifetime | WEF: War Violence Costs $5/Day},
}

@article{pharma-drug-revenue-average,
  title = {Average lifetime revenue per successful drug},
  author = {Value in Health},
  year = {},
  journal = {Value in Health: Sales Revenues for New Therapeutic Agents02754-2/fulltext)},
  url = {https://www.valueinhealthjournal.com/article/S1098-3015(24},
  urldate = {2025-01-20},
  note = {Value in Health: Sales Revenues for New Therapeutic Agents02754-2/fulltext) | ScienceDirect: Sales Revenues FDA Drugs},
}

@article{pharma-lobbying-stats,
  title = {Pharmaceutical industry lobbying statistics},
  author = {OpenSecrets},
  year = {},
  journal = {OpenSecrets: Pharmaceuticals/Health Products},
  url = {https://www.opensecrets.org/industries/indus?ind=H04},
  urldate = {2025-01-20},
  note = {OpenSecrets: Pharmaceuticals/Health Products},
}

@article{pharma-marketing-spending-60b,
  title = {Pharmaceutical spending on marketing research: $60 billion/year},
  author = {Statista},
  year = {2023},
  journal = {Statista: Pharma Marketing Spend},
  url = {https://www.statista.com/statistics/1411882/pharma-marketing-spend-worldwide/},
  urldate = {2025-01-20},
  note = {Statista: Pharma Marketing Spend | JHU: Consumer Advertising Spending | TechTarget: Big Pharma DTC Ad Spend},
}

@article{pharma-novel-cure-rd-spending-20b,
  title = {Pharmaceutical spending on actual novel cures: ~$20 billion},
  author = {Statista},
  year = {2023},
  journal = {Statista: Worldwide Pharma R\&D},
  url = {https://www.statista.com/statistics/309466/global-r-and-d-expenditure-for-pharmaceuticals/},
  urldate = {2025-01-20},
  note = {Statista: Worldwide Pharma R\&D | CBO: R\&D in Pharmaceutical Industry | IQVIA: Global Trends in R\&D 2023},
}

@article{pharma-profit-from-treatment,
  title = {Annual profits for pharmaceutical industry from treatment vs. cures},
  author = {Statista},
  year = {2001},
  journal = {Statista: Pharmaceutical Market Worldwide Revenue},
  url = {https://www.statista.com/statistics/263102/pharmaceutical-market-worldwide-revenue-since-2001/},
  urldate = {2025-01-20},
  note = {Statista: Pharmaceutical Market Worldwide Revenue | PMC: Profitability of Large Pharma | Acumen: Pharmaceutical Market Size},
}

@article{pharma-profits-500b,
  title = {Pharmaceutical industry annual profits},
  author = {PMC},
  year = {},
  journal = {PMC: Profitability of Large Pharmaceutical Companies},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC7054843/},
  urldate = {2025-01-20},
  note = {PMC: Profitability of Large Pharmaceutical Companies | Bentley: Pharma More Profitable Than S\&P 500 | GAO: Drug Industry Profits},
}

@article{pharma-roi-current,
  title = {Pharmaceutical R\&D return on investment (ROI)},
  author = {Deloitte},
  year = {2025},
  journal = {Deloitte: Measuring Pharmaceutical Innovation 2025},
  url = {https://www.deloitte.com/ch/en/Industries/life-sciences-health-care/research/measuring-return-from-pharmaceutical-innovation.html},
  urldate = {2025-01-20},
  note = {Deloitte: Measuring Pharmaceutical Innovation 2025 | Deloitte 2023: Pharma R\&D ROI Falls | HIT Consultant: 13-Year Low},
}

@article{pharmaceutical-innovation-acceleration-economics,
  title = {Pharmaceutical innovation acceleration through cost reduction},
  author = {Nature},
  year = {},
  journal = {Nature},
  url = {https://www.nature.com/articles/d41586-023-03172-6},
  urldate = {2025-01-20},
  note = {Nature, AI's potential to accelerate drug discovery | McKinsey, The pursuit of excellence in new-drug development | Health Economics Review, Adaptive clinical trials and productivity},
}

@article{pharmaceutical-innovation-dynamic-efficiency,
  title = {Optimal value share for pharmaceutical innovation (dynamic efficiency framework)},
  author = {Health Economics, Woods et al.},
  year = {2024},
  journal = {Health Economics},
  url = {https://onlinelibrary.wiley.com/doi/full/10.1002/hec.4795},
  urldate = {2025-01-20},
  note = {Health Economics, Woods et al. 2024, Achieving dynamic efficiency in pharmaceutical innovation},
}

@article{pharmaceutical-rd-cost-barriers-timeline-impact,
  title = {Impact of R\&D cost barriers on drug development timelines},
  author = {ASPE},
  year = {2000},
  journal = {ASPE},
  url = {https://aspe.hhs.gov/reports/examination-clinical-trial-costs-barriers-drug-development-0},
  urldate = {2025-01-20},
  note = {ASPE, Examination of Clinical Trial Costs and Barriers for Drug Development | JAMA Network Open, Costs of Drug Development 2000-2018 | Tandfonline, Public sector replacement of privately funded pha...},
}

@article{phase-1-cost-per-patient-137k,
  title = {Phase 1 cost per patient},
  author = {JAMA Internal Medicine},
  year = {},
  journal = {JAMA Internal Medicine},
  url = {https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2702287},
  urldate = {2025-01-20},
  note = {JAMA Internal Medicine, Clinical Trial Cost Breakdown},
}

@article{phase-1-cost-per-trial-range,
  title = {Phase 1 cost per trial range},
  author = {SofproMed},
  year = {2021},
  journal = {SofproMed},
  url = {https://www.sofpromed.com/how-much-does-a-clinical-trial-cost},
  urldate = {2025-01-20},
  note = {SofproMed, Clinical Trial Cost Analysis | CBO, 2021},
}

@article{phase-1-cost-typical,
  title = {Typical Phase 1 trial cost},
  author = {GreenField Chemical},
  year = {2023},
  journal = {GreenField Chemical},
  url = {https://greenfieldchemical.com/2023/08/10/the-staggering-cost-of-drug-development-a-look-at-the-numbers/},
  urldate = {2025-01-20},
  note = {GreenField Chemical, Cost of Drug Development},
}

@article{phase-1-duration-average,
  title = {Average Phase 1 trial duration},
  author = {ASPE},
  year = {},
  journal = {ASPE},
  url = {https://aspe.hhs.gov/reports/examination-clinical-trial-costs-barriers-drug-development-0},
  urldate = {2025-01-20},
  note = {ASPE, Clinical Trial Timeline Analysis},
}

@misc{phase-1-global-spending-estimate,
  title = {Phase 1 global spending estimate},
  author = {Derived from market analysis and phase distribution data},
  year = {},
  note = {Derived from market analysis and phase distribution data},
}

@article{phase-1-participant-numbers,
  title = {Phase 1 trial participant numbers},
  author = {ASPE},
  year = {},
  journal = {ASPE},
  url = {https://aspe.hhs.gov/reports/examination-clinical-trial-costs-barriers-drug-development-0},
  urldate = {2025-01-20},
  note = {ASPE, Clinical Trial Characteristics},
}

@article{phase-1-rd-percentage,
  title = {Phase 1 as percentage of total R\&D},
  author = {Knowledge Portal},
  year = {},
  journal = {Knowledge Portal},
  url = {https://www.knowledgeportalia.org/costs-r-d},
  urldate = {2025-01-20},
  note = {Knowledge Portal, R\&D Costs Distribution},
}

@article{phase-1-to-approval-success-rate,
  title = {Clinical trial success rate Phase 1 to approval},
  author = {CBO},
  year = {},
  journal = {CBO},
  url = {https://www.cbo.gov/publication/57126},
  urldate = {2025-01-20},
  note = {CBO, Pharmaceutical R\&D Success Rates},
}

@misc{phase-2-3-spending-percentage,
  title = {Phase 2-3 spending as percentage of total},
  author = {Derived from phase cost distribution data},
  year = {},
  note = {Derived from phase cost distribution data},
}

@article{phase-2-cost-per-patient-130k,
  title = {Phase 2 cost per patient},
  author = {JAMA Internal Medicine},
  year = {},
  journal = {JAMA Internal Medicine},
  url = {https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2702287},
  urldate = {2025-01-20},
  note = {JAMA Internal Medicine, Clinical Trial Cost Analysis},
}

@article{phase-2-cost-per-trial-range,
  title = {Phase 2 cost per trial range},
  author = {SofproMed},
  year = {2021},
  journal = {SofproMed},
  url = {https://www.sofpromed.com/how-much-does-a-clinical-trial-cost},
  urldate = {2025-01-20},
  note = {SofproMed, Clinical Trial Costs | CBO, 2021},
}

@misc{phase-2-duration-average,
  title = {Average Phase 2 trial duration},
  author = {ClinicalTrials.gov resources and industry estimates},
  year = {},
  note = {ClinicalTrials.gov resources and industry estimates},
}

@misc{phase-2-global-spending-estimate,
  title = {Phase 2 global spending estimate},
  author = {Derived from market analysis and phase distribution data},
  year = {},
  note = {Derived from market analysis and phase distribution data},
}

@article{phase-2-participant-numbers,
  title = {Phase 2 trial participant numbers},
  author = {FDA},
  year = {},
  journal = {FDA},
  url = {https://www.fda.gov/patients/drug-development-process/step-3-clinical-research},
  urldate = {2025-01-20},
  note = {FDA, Clinical Research Phases},
}

@article{phase-2-rd-percentage,
  title = {Phase 2 as percentage of total R\&D},
  author = {Knowledge Portal},
  year = {},
  journal = {Knowledge Portal},
  url = {https://www.knowledgeportalia.org/costs-r-d},
  urldate = {2025-01-20},
  note = {Knowledge Portal, R\&D Cost Distribution},
}

@article{phase-2-therapeutic-area-costs,
  title = {Phase 2 costs by therapeutic area},
  author = {ASPE},
  year = {},
  journal = {ASPE},
  url = {https://aspe.hhs.gov/reports/examination-clinical-trial-costs-barriers-drug-development-0},
  urldate = {2025-01-20},
  note = {ASPE, Clinical Trial Cost Examination},
}

@article{phase-3-cost-per-patient-113k,
  title = {Phase 3 cost per patient},
  author = {JAMA Internal Medicine},
  year = {},
  journal = {JAMA Internal Medicine},
  url = {https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2702287},
  urldate = {2025-01-20},
  note = {JAMA Internal Medicine, Clinical Trial Cost Breakdown},
}

@article{phase-3-cost-per-trial-range,
  title = {Phase 3 cost per trial range},
  author = {SofproMed},
  year = {},
  journal = {SofproMed},
  url = {https://www.sofpromed.com/how-much-does-a-clinical-trial-cost},
  urldate = {2025-01-20},
  note = {SofproMed, How Much Does a Clinical Trial Cost | CBO, Research and Development in the Pharmaceutical Industry},
}

@article{phase-3-duration-average,
  title = {Average Phase 3 trial duration},
  author = {ASPE},
  year = {},
  journal = {ASPE},
  url = {https://aspe.hhs.gov/reports/examination-clinical-trial-costs-barriers-drug-development-0},
  urldate = {2025-01-20},
  note = {ASPE, Examination of Clinical Trial Costs and Barriers},
}

@article{phase-3-market-share-2024,
  title = {Phase 3 clinical trials market share},
  author = {Towards Healthcare},
  year = {2024},
  journal = {Towards Healthcare},
  url = {https://www.towardshealthcare.com/insights/innovation-in-drug-development-calls-for-clinical-trials},
  urldate = {2025-01-20},
  note = {Towards Healthcare, Clinical Trials Market Phase Analysis | Global Market Insights, 2024},
}

@article{phase-3-median-cost,
  title = {Phase 3 median trial cost},
  author = {JAMA Internal Medicine},
  year = {},
  journal = {JAMA Internal Medicine},
  url = {https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2702287},
  urldate = {2025-01-20},
  note = {JAMA Internal Medicine, Clinical Trial Costs Study},
}

@article{phase-3-participant-numbers,
  title = {Phase 3 trial participant numbers},
  author = {FDA},
  year = {},
  journal = {FDA},
  url = {https://www.fda.gov/patients/drug-development-process/step-3-clinical-research},
  urldate = {2025-01-20},
  note = {FDA, Step 3: Clinical Research | ClinicalTrials.gov resources},
}

@article{phase-3-rd-percentage,
  title = {Phase 3 as percentage of total R\&D},
  author = {Knowledge Portal},
  year = {},
  journal = {Knowledge Portal},
  url = {https://www.knowledgeportalia.org/costs-r-d},
  urldate = {2025-01-20},
  note = {Knowledge Portal, R\&D Costs},
}

@article{phase-3-therapeutic-area-costs,
  title = {Phase 3 costs by therapeutic area},
  author = {ASPE},
  year = {},
  journal = {ASPE},
  url = {https://aspe.hhs.gov/reports/examination-clinical-trial-costs-barriers-drug-development-0},
  urldate = {2025-01-20},
  note = {ASPE, Clinical Trial Cost Drivers},
}

@article{phase-4-budget-percentage,
  title = {Phase 4 as percentage of pharma R\&D budgets},
  author = {PhRMA data cited in PMC},
  year = {},
  journal = {PhRMA data cited in PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC2651713/},
  urldate = {2025-01-20},
  note = {PhRMA data cited in PMC, Phase 4 Research Analysis},
}

@misc{phase-4-growth-rate,
  title = {Phase 4 trial growth rate},
  author = {Thomson CenterWatch data},
  year = {2009},
  note = {Thomson CenterWatch data, PMC 2009},
}

@article{phase-4-spending-2007,
  title = {Phase 4 clinical trial spending 2007},
  author = {PMC},
  year = {},
  journal = {PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC2651713/},
  urldate = {2025-01-20},
  note = {PMC, Phase 4 Research Growth},
}

@techreport{phase-4-spending-2024-estimate,
  title = {Phase 4 spending 2024 estimate},
  institution = {Estimated from 2007 data with market growth projections},
  year = {2007},
  publisher = {Estimated from 2007 data with market growth projections},
  note = {Estimated from 2007 data with market growth projections},
}

@article{polio-vaccination-roi,
  title = {Polio Vaccination ROI},
  author = {WHO},
  year = {2019},
  journal = {WHO},
  url = {https://www.who.int/news-room/feature-stories/detail/sustaining-polio-investments-offers-a-high-return},
  urldate = {2025-01-20},
  note = {WHO, 2019, Sustaining Polio Investments Offers a High Return},
}

@article{polypill-prevention-qaly,
  title = {Polypill for Primary Prevention Cost per QALY},
  author = {PLOS One},
  year = {},
  journal = {PLOS One},
  url = {https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0182625},
  urldate = {2025-01-20},
  note = {PLOS One, Link},
}

@article{pos-energy-efficiency,
  title = {Proof-of-Stake Energy Efficiency},
  author = {Ethereum Foundation},
  year = {2021},
  journal = {Ethereum Foundation: ETH Will Use 99.95% Less Energy},
  url = {https://blog.ethereum.org/2021/05/18/country-power-no-more},
  urldate = {2025-01-20},
  note = {Ethereum Foundation: ETH Will Use 99.95\% Less Energy | Ethereum.org: Energy Consumption | Decrypt: Energy Down 99.99\% After Merge},
}

@article{post-1962-drug-approval-drop,
  title = {Post-1962 drop in new drug approvals},
  author = {Think by Numbers},
  year = {},
  journal = {Think by Numbers: How Many Lives Does FDA Save?},
  url = {https://thinkbynumbers.org/health/how-many-net-lives-does-the-fda-save/},
  urldate = {2025-01-20},
  note = {Think by Numbers: How Many Lives Does FDA Save? | Wikipedia: Kefauver-Harris Amendment | PMC: Lost Medicines},
}

@article{post-1962-drug-costs-explode,
  title = {Post-1962 explosion in drug development costs},
  author = {Tufts Center for Study of Drug Development},
  year = {2014},
  journal = {Tufts Center for Study of Drug Development},
  url = {https://csdd.tufts.edu/cost-study},
  urldate = {2025-01-20},
  note = {Tufts Center for Study of Drug Development | C\&EN: Cost of Drug Development},
}

@article{post-1962-life-expectancy-slowdown,
  title = {Post-1962 slowdown in life expectancy gains},
  author = {Think by Numbers},
  year = {},
  journal = {Think by Numbers: How Many Lives Does FDA Save?},
  url = {https://thinkbynumbers.org/health/how-many-net-lives-does-the-fda-save/},
  urldate = {2025-01-20},
  note = {Think by Numbers: How Many Lives Does FDA Save?},
}

@article{pragmatic-trials-cost-advantage,
  title = {NIH Pragmatic Trials: Minimal Funding Despite 30x Cost Advantage},
  author = {NIH Common Fund},
  year = {},
  journal = {NIH Common Fund: HCS Research Collaboratory},
  url = {https://commonfund.nih.gov/hcscollaboratory},
  urldate = {2025-01-20},
  note = {NIH Common Fund: HCS Research Collaboratory | PMC: Pragmatic Clinical Trials in Healthcare Systems | PMC: Pragmatic Trials and Real-World Evidence},
}

@article{pragmatic-trials-patsopoulos-2011,
  title = {Pragmatic vs. explanatory trials},
  author = {Patsopoulos, Nikolaos A.},
  year = {2011},
  journal = {Patsopoulos},
  url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181997/},
  urldate = {2025-01-20},
  note = {Patsopoulos, Nikolaos A., 2011, A pragmatic view on pragmatic trials, Dialogues in Clinical Neuroscience 13(2): 217-224},
}

@article{pre-1962-drug-costs-timeline,
  title = {Pre-1962 drug development costs and timeline},
  author = {Think by Numbers},
  year = {1962},
  journal = {Think by Numbers: How Many Lives Does FDA Save?},
  url = {https://thinkbynumbers.org/health/how-many-net-lives-does-the-fda-save/},
  urldate = {2025-01-20},
  note = {Think by Numbers: How Many Lives Does FDA Save? | Wikipedia: Cost of Drug Development | STAT: 1962 Law Slowed Development},
}

@article{pre-1962-physician-trials,
  title = {Pre-1962 physician-led clinical trials},
  author = {Think by Numbers},
  year = {1966},
  journal = {Think by Numbers: How Many Lives Does FDA Save?},
  url = {https://thinkbynumbers.org/health/how-many-net-lives-does-the-fda-save/},
  urldate = {2025-01-20},
  note = {Think by Numbers: How Many Lives Does FDA Save? | FDA: Drug Efficacy Study Implementation | NAS: Drug Efficacy Study 1966-1969},
}

@article{preferential-target-attachment,
  title = {Preferential target attachment in clinical trials},
  author = {arXiv},
  year = {2023},
  journal = {arXiv},
  url = {https://arxiv.org/abs/2301.10709},
  urldate = {2025-01-20},
  note = {arXiv, 2023, Preferential Attachment in Drug Development},
}

@article{prehistoric-violence-rates,
  title = {Prehistoric Violence Rates},
  author = {Bowles, Samuel},
  year = {2009},
  journal = {Bowles},
  url = {https://www.science.org/doi/10.1126/science.1168112},
  urldate = {2025-01-20},
  note = {Bowles, Samuel, 2009, Did Warfare Among Ancestral Hunter-Gatherers Affect the Evolution of Human Social Behaviors?},
}

@article{prevention-cost-savings-ratio,
  title = {Prevention cost-savings ratio},
  author = {Trust for America's Health},
  year = {2013},
  journal = {Trust for America's Health},
  url = {https://www.tfah.org/report-details/a-healthier-america-2013/},
  urldate = {2025-01-20},
  note = {Trust for America's Health, 2013, A Healthier America: Savings from Prevention},
}

@article{prevention-savings,
  title = {\$5.60 saved per \$1 prevention},
  author = {Trust for America's Health},
  year = {2008},
  journal = {Trust for America's Health},
  url = {https://www.tfah.org/wp-content/uploads/archive/reports/prevention08/Prevention08Exec.pdf},
  urldate = {2025-01-20},
  note = {Trust for America's Health, 2008},
}

@article{princeton-oligarchy-study,
  title = {Princeton study on policy outcomes and influence of elites vs. average citizens},
  author = {Princeton},
  year = {2014},
  journal = {Princeton: Testing Theories of American Politics (PDF)},
  url = {https://scholar.princeton.edu/sites/default/files/mgilens/files/gilens_and_page_2014_-testing_theories_of_american_politics.doc.pdf},
  urldate = {2025-01-20},
  note = {Princeton: Testing Theories of American Politics (PDF) | RepresentUs: US Oligarchy Research Explained | Internet Archive: Gilens and Page 2014},
}

@article{principal-agent-theory-cost-reduction,
  title = {Cost reduction in principal-agent theory through incentive alignment},
  author = {Wikipedia},
  year = {},
  journal = {Wikipedia: Principal-Agent Problem},
  url = {https://en.wikipedia.org/wiki/Principal–agent_problem},
  urldate = {2025-01-20},
  note = {Wikipedia: Principal-Agent Problem | Inspired Economist: Agency Theory | AEA: The Costs of Misaligned Incentives},
}

@article{prostate-vs-breast-cancer-deaths,
  title = {Prostate vs. Breast Cancer Deaths},
  author = {BMJ},
  year = {2018},
  journal = {BMJ},
  url = {https://blogs.bmj.com/bmjebmspotlight/2018/03/09/prostate-cancer-now-kills-more-people-than-breast-cancer-cause-for-alarm/},
  urldate = {2025-01-20},
  note = {BMJ, 2018, Prostate cancer now kills more people than breast cancer: cause for alarm?},
}

@article{psychological-impact-war-cost,
  title = {Psychological impact of war cost (\$100B annually)},
  author = {PubMed},
  year = {},
  journal = {PubMed: Economic Burden of PTSD},
  url = {https://pubmed.ncbi.nlm.nih.gov/35485933/},
  urldate = {2025-01-20},
  note = {PubMed: Economic Burden of PTSD | VA News: Study Economic Burden | PMC: Mental Health Costs Armed Conflicts},
}

@article{public-support-for-peace-funding-70-pct,
  title = {Public support for redirecting military spending to health},
  author = {The Nation},
  year = {2020},
  journal = {The Nation: Americans Want Jobs Not War},
  url = {https://www.thenation.com/article/archive/pentagon-military-spending/},
  urldate = {2025-01-20},
  note = {The Nation: Americans Want Jobs Not War | Data for Progress: Cut Pentagon Budget | Chicago Council: Americans Prioritize Domestic Spending},
}

@article{publication-bias-clinical-trials,
  title = {Publication rate of clinical trial results},
  author = {AllTrials},
  year = {2013},
  journal = {AllTrials: Half of Trials Unreported},
  url = {https://www.alltrials.net/news/half-of-all-trials-unreported/},
  urldate = {2025-01-20},
  note = {AllTrials: Half of Trials Unreported | Nature: Half of US Trials Go Unpublished | PMC: Publication Bias in Clinical Trials},
}

@article{qaly-definition,
  title = {QALY definition and use},
  author = {ICER},
  year = {},
  journal = {ICER},
  url = {https://icer.org/our-approach/methods-process/cost-effectiveness-the-qaly-and-the-evlyg/},
  urldate = {2025-01-20},
  note = {ICER},
}

@article{qaly-delayed-access-cost,
  title = {QALY cost of delayed access to treatment},
  author = {Pho et al.},
  year = {2015},
  journal = {Pho et al.},
  url = {https://europepmc.org/articles/pmc4515086?pdf=render},
  urldate = {2025-01-20},
  note = {Pho et al., 2015, Hepatitis C delayed access | Lee et al., 2022, Syphilis health losses | BMJ, Statin QALY gains},
}

@article{qaly-value,
  title = {Value per QALY (standard economic value)},
  author = {ICER},
  year = {2024},
  journal = {ICER},
  url = {https://icer.org/wp-content/uploads/2024/02/Reference-Case-4.3.25.pdf},
  urldate = {2025-01-20},
  note = {ICER, Reference Case},
}

@article{rare-disease-patients-300m-globally,
  title = {300 million people with rare diseases globally},
  author = {Rare Diseases International},
  year = {2019},
  journal = {Rare Diseases International: 300 Million Worldwide},
  url = {https://www.rarediseasesinternational.org/new-scientific-paper-confirms-300-million-people-living-with-a-rare-disease-worldwide/},
  urldate = {2025-01-20},
  note = {Rare Diseases International: 300 Million Worldwide | ScienceDaily: 300 Million Affected | PMC: Rare Disease Global Priority},
}

@article{rare-disease-prevalence-400m,
  title = {Global prevalence of rare diseases: 400 million},
  author = {Global Genes},
  year = {},
  journal = {Global Genes: 300M+ Worldwide},
  url = {https://globalgenes.org/raredaily/study-estimates-more-than-300-million-with-rare-disease-worldwide-but-number-likely-higher/},
  urldate = {2025-01-20},
  note = {Global Genes: 300M+ Worldwide | AJMC: Not So Rare},
}

@article{raytheon-annual-revenue-42b,
  title = {Raytheon annual revenue},
  author = {RTX},
  year = {2024},
  journal = {RTX: 2024 Results},
  url = {https://investors.rtx.com/static-files/ceebbf85-eb69-4563-a303-c62ad9918fba},
  urldate = {2025-01-20},
  note = {RTX: 2024 Results | Wikipedia: RTX Corporation | Statista: Raytheon Revenue 2008-2024},
}

@article{reconstruction-costs-active-conflicts,
  title = {Reconstruction costs from active conflicts},
  author = {IMF},
  year = {2017},
  journal = {IMF: Cost of Conflict},
  url = {https://www.imf.org/external/pubs/ft/fandd/2017/12/imus.htm},
  urldate = {2025-01-20},
  note = {IMF: Cost of Conflict | WEF: Conflict Costs $14T/Year | Fortune: Ukraine $1T Reconstruction},
}

@article{recover-budget-update-2-3b,
  title = {RECOVER Initiative budget update (>\$2.3B)},
  author = {RECOVER Initiative},
  year = {2024},
  journal = {RECOVER Initiative},
  url = {https://recovercovid.org/news/nih-adds-funds-long-covid-research-advances-work-new-clinical-trials},
  urldate = {2025-01-20},
  note = {RECOVER Initiative, 2024, NIH Adds Funds to Long COVID Research},
}

@article{recover-initiative-patient-enrollment,
  title = {NIH RECOVER Initiative patient enrollment numbers},
  author = {NIH},
  year = {},
  journal = {NIH: RECOVER Initiative Enrollment},
  url = {https://www.nih.gov/news-events/news-releases/nih-builds-large-nationwide-study-population-tens-thousands-support-research-long-term-effects-covid-19},
  urldate = {2025-01-20},
  note = {NIH: RECOVER Initiative Enrollment | RECOVER: Long COVID Clinical Trials},
}

@article{recover-trial-status-update,
  title = {RECOVER Initiative trial status update},
  author = {The Sick Times},
  year = {2025},
  journal = {The Sick Times},
  url = {https://thesicktimes.org/2025/09/09/live-blog-recover-tlc-workshop-on-new-long-covid-clinical-trials/},
  urldate = {2025-01-20},
  note = {The Sick Times, 2025, Live Blog: RECOVER-TLC Workshop},
}

@article{recovery-cost-500,
  title = {RECOVERY Trial Cost per Patient},
  author = {Oren Cass, Manhattan Institute},
  year = {2023},
  journal = {Oren Cass},
  url = {https://manhattan.institute/article/slow-costly-clinical-trials-drag-down-biomedical-breakthroughs},
  urldate = {2025-01-20},
  note = {Oren Cass, Manhattan Institute, 2023, Slow, Costly Clinical Trials Drag Down Biomedical Breakthroughs},
}

@article{recovery-trial-100-days-to-cure,
  title = {RECOVERY trial time to first cure},
  author = {University of Oxford},
  year = {2020},
  journal = {University of Oxford},
  url = {https://www.ox.ac.uk/news/2020-06-16-dexamethasone-reduces-death-hospitalised-patients-severe-respiratory-complications},
  urldate = {2025-01-20},
  note = {University of Oxford, 2020, Dexamethasone reduces death in hospitalised patients with severe respiratory complications of COVID-19 | RECOVERY Trial, Low-cost dexamethasone reduces death by up to on...},
}

@article{recovery-trial-1m-lives-saved,
  title = {RECOVERY trial global lives saved},
  author = {NHS England},
  year = {2021},
  journal = {NHS England: 1 Million Lives Saved},
  url = {https://www.england.nhs.uk/2021/03/covid-treatment-developed-in-the-nhs-saves-a-million-lives/},
  urldate = {2025-01-20},
  note = {NHS England: 1 Million Lives Saved | Pharmaceutical Journal: 1M Lives Saved | RECOVERY Trial: Dexamethasone Result},
}

@article{recovery-trial-82x-cost-reduction,
  title = {RECOVERY trial 82× cost reduction},
  author = {Manhattan Institute},
  year = {},
  journal = {Manhattan Institute: Slow Costly Trials},
  url = {https://manhattan.institute/article/slow-costly-clinical-trials-drag-down-biomedical-breakthroughs},
  urldate = {2025-01-20},
  note = {Manhattan Institute: Slow Costly Trials | PMC: Establishing RECOVERY at Scale},
}

@article{recovery-trial-cost-reduction,
  title = {RECOVERY trial cost reduction},
  author = {RECOVERY Trial},
  year = {},
  journal = {RECOVERY Trial},
  url = {https://www.recoverytrial.net/},
  urldate = {2025-01-20},
  note = {RECOVERY Trial, Official Website | Manhattan Institute \& NCBI citations},
}

@article{recovery-trial-dexamethasone-results,
  title = {RECOVERY Trial Dexamethasone Results},
  author = {RECOVERY Trial},
  year = {},
  journal = {RECOVERY Trial},
  url = {https://www.recoverytrial.net/news/low-cost-dexamethasone-reduces-death-by-up-to-one-third-in-hospitalised-patients-with-severe-respiratory-complications-of-covid-19},
  urldate = {2025-01-20},
  note = {RECOVERY Trial, Link},
}

@article{recovery-trial-efficiency,
  title = {RECOVERY Trial efficiency},
  author = {Professor Martin Landray (co-chief investigator), quoted in Oren Cass, Manhattan Institute},
  year = {2023},
  journal = {Professor Martin Landray (co-chief investigator)},
  url = {https://manhattan.institute/article/slow-costly-clinical-trials-drag-down-biomedical-breakthroughs},
  urldate = {2025-01-20},
  note = {Professor Martin Landray (co-chief investigator), quoted in Oren Cass, Manhattan Institute, 2023, Slow, Costly Clinical Trials Drag Down Biomedical Breakthroughs},
}

@article{recovery-trial-roi,
  title = {RECOVERY Trial Cost-Effectiveness (~$300/QALY)},
  author = {RECOVERY Collaborative Group},
  year = {},
  journal = {RECOVERY Trial Results},
  url = {https://www.recoverytrial.net/results},
  urldate = {2025-01-20},
  note = {RECOVERY Trial Results},
}

@article{recovery-trial-summary-quote,
  title = {RECOVERY Trial Summary Quote},
  author = {Oxford University News},
  year = {},
  journal = {Oxford University News},
  url = {https://www.ox.ac.uk/news/features/recovery-trial-two-years},
  urldate = {2025-01-20},
  note = {Oxford University News, Link},
}

@article{refugee-lost-earning-potential,
  title = {Refugee lost annual earning potential (\$23,400)},
  author = {ASPE},
  year = {},
  journal = {ASPE: Fiscal Impact of Refugees},
  url = {https://aspe.hhs.gov/reports/fiscal-impact-refugees-asylees},
  urldate = {2025-01-20},
  note = {ASPE: Fiscal Impact of Refugees | American Immigration Council: Economic Impact | NBER: Economic Outcomes of Refugees},
}

@article{regenerative-medicine-milestones,
  title = {Milestones in Regenerative Medicine and Tissue Engineering},
  author = {Wake Forest},
  year = {},
  journal = {Wake Forest: Record of Firsts},
  url = {https://school.wakehealth.edu/research/institutes-and-centers/wake-forest-institute-for-regenerative-medicine/research/a-record-of-firsts},
  urldate = {2025-01-20},
  note = {Wake Forest: Record of Firsts | Built In: 3D-Printed Organs | PMC: 3D Bioprinting for Organ Regeneration},
}

@article{regulator-revolving-door-salary-increase,
  title = {Salary increases for regulators after entering private industry},
  author = {Science},
  year = {2016},
  journal = {Science: FDA's Revolving Door},
  url = {https://www.science.org/content/article/fda-s-revolving-door-companies-often-hire-agency-staffers-who-managed-their-successful},
  urldate = {2025-01-20},
  note = {Science: FDA's Revolving Door | NPR: How Revolving Door Spins | RAPS: Revolving Door Continues},
}

@article{research-to-practice-gap,
  title = {Research to practice gap (17 years)},
  author = {JAMA},
  year = {2023},
  journal = {JAMA},
  url = {https://pubmed.ncbi.nlm.nih.gov/37018006/},
  urldate = {2025-01-20},
  note = {JAMA, 2023, Mind the 17-Year Gap},
}

@article{respiratory-disease-deaths-6-9m-annually,
  title = {Annual deaths from respiratory disease},
  author = {WHO},
  year = {2019},
  journal = {WHO: COPD Fact Sheet)},
  url = {https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd},
  urldate = {2025-01-20},
  note = {WHO: COPD Fact Sheet) | Global Burden of Disease: Respiratory Diseases 2019},
}

@article{responsiblestatecraft2021,
  title = {Top defense firms see $2T return on $1B investment in Afghan war},
  author = {Smithberger, Mandy and Hartung, William},
  year = {2021},
  journal = {Responsible Statecraft},
  url = {https://responsiblestatecraft.org/2021/09/02/top-defense-firms-see-2t-return-on-1b-investment-in-afghan-war/},
  urldate = {2025-01-20},
  note = {Analysis of lobbying spending vs. Pentagon contracts for top five defense contractors 2001-2021},
}

@article{reversal-of-aging-in-mice-sinclair,
  title = {Reversal of Aging in Mice at David Sinclair's Lab},
  author = {HMS},
  year = {},
  journal = {HMS: Loss of Epigenetic Information},
  url = {https://hms.harvard.edu/news/loss-epigenetic-information-can-drive-aging-restoration-can-reverse},
  urldate = {2025-01-20},
  note = {HMS: Loss of Epigenetic Information | Science: Two Teams Reverse Aging in Mice | Time: Key Milestone in Reversing Aging},
}

@article{reynolds2011,
  title = {Age 26 Cost-Benefit Analysis of the Child-Parent Center Early Education Program},
  author = {Reynolds, Arthur J. and Temple, Judy A. and White, Barry A. and Ou, Suh-Ruu and Robertson, Dylan L.},
  year = {2011},
  journal = {Child Development},
  volume = {82},
  number = {1},
  pages = {379-404},
  doi = {10.1111/j.1467-8624.2010.01563.x},
  note = {Finds $10.83 return for every $1 invested},
}

@article{right-to-try-act-2018,
  title = {Right to Try Act (2018)},
  author = {Congress.gov},
  year = {2018},
  journal = {Congress.gov},
  url = {https://www.congress.gov/bill/115th-congress/house-bill/2368},
  urldate = {2025-01-20},
  note = {Congress.gov, H.R.2368 - Right to Try Act | FDA, Understanding the Right to Try Act | Signed by President Trump on May 30, 2018},
}

@article{right-to-try-act-outcomes,
  title = {Number of patients helped by the U.S. Right to Try Act},
  author = {PMC},
  year = {2024},
  journal = {PMC: Understanding Right to Try},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC7416898/},
  urldate = {2025-01-20},
  note = {PMC: Understanding Right to Try | STAT: Right to Try Hasn't Helped | Healio: Well-Intentioned But Misguided},
}

@article{right-to-try-terminal-illness-requirement,
  title = {Right to Try Act Eligibility Requirements},
  author = {PMC},
  year = {},
  journal = {PMC: Understanding Right to Try},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC7416898/},
  urldate = {2025-01-20},
  note = {PMC: Understanding Right to Try | FDA: Right to Try Fact Sheet | Congress: Right to Try Act},
}

@article{roth2002,
  title = {The Economist as Engineer: Game Theory, Experimentation, and Computation as Tools for Design Economics},
  author = {Roth, Alvin E.},
  year = {2002},
  journal = {Econometrica},
  volume = {70},
  number = {4},
  pages = {1341-1378},
}

@article{russia-medical-research-spending-800m,
  title = {Russia medical research spending: $800 million},
  author = {Frontiers},
  year = {2022},
  journal = {Frontiers: Promoting Biomedical Communication in Russia},
  url = {https://www.frontiersin.org/journals/communication/articles/10.3389/fcomm.2022.848578/full},
  urldate = {2025-01-20},
  note = {Frontiers: Promoting Biomedical Communication in Russia | WHO: Health R\&D Funding by Country},
}

@article{russia-military-spending-share,
  title = {Russia's Share of Global Military Spending},
  author = {SIPRI},
  year = {2024},
  journal = {SIPRI: 2024 Military Expenditure},
  url = {https://www.sipri.org/media/press-release/2025/unprecedented-rise-global-military-expenditure-european-and-middle-east-spending-surges},
  urldate = {2025-01-20},
  note = {SIPRI: 2024 Military Expenditure | SIPRI Fact Sheet 2024},
}

@article{russia-nuclear-weapons-spending,
  title = {Russia annual nuclear weapons spending: $65 billion},
  author = {SIPRI},
  year = {2018},
  journal = {SIPRI: How Much Does Russia Spend on Nuclear Weapons?},
  url = {https://www.sipri.org/commentary/topical-backgrounder/2018/how-much-does-russia-spend-nuclear-weapons},
  urldate = {2025-01-20},
  note = {SIPRI: How Much Does Russia Spend on Nuclear Weapons? | Statista: Nuclear Weapons Spending | ICAN: Wasted 2022 Report},
}

@article{science-tech-community-100m,
  title = {Science \& Tech Community},
  author = {NSF},
  year = {2023},
  journal = {NSF: STEM Workforce 2023},
  url = {https://ncses.nsf.gov/pubs/nsb20245},
  urldate = {2025-01-20},
  note = {NSF: STEM Workforce 2023 | BLS: STEM Occupations},
}

@article{sec-accredited-investor-definition,
  title = {SEC Definition of an Accredited Investor},
  author = {SEC},
  year = {2020},
  journal = {SEC: Accredited Investor Definition},
  url = {https://www.sec.gov/education/capitalraising/building-blocks/accredited-investor},
  urldate = {2025-01-20},
  note = {SEC: Accredited Investor Definition | SEC: Updated Investor Definition 2020},
}

@article{sec-form-d-filing,
  title = {SEC Form D Filing Requirement},
  author = {SEC},
  year = {},
  journal = {SEC: Form D},
  url = {https://www.sec.gov/files/formd.pdf},
  urldate = {2025-01-20},
  note = {SEC: Form D | SEC: Form D Overview | Investopedia: SEC Form D},
}

@article{sec-innovation-guidance-2025,
  title = {SEC innovation-friendly guidance (2025)},
  author = {Sidley},
  year = {2025},
  journal = {Sidley: Project Crypto},
  url = {https://www.sidley.com/en/insights/newsupdates/2025/08/sec-announces-launch-of-project-crypto},
  urldate = {2025-01-20},
  note = {Sidley: Project Crypto | CoinDesk: Innovation Exemption | SEC: Crypto Task Force},
}

@article{sec-investor-limit-private-offering,
  title = {Investor Limits for Private Offerings},
  author = {SEC},
  year = {},
  journal = {SEC: Rule 506(b)},
  url = {https://www.sec.gov/resources-small-businesses/exempt-offerings/private-placements-rule-506b},
  urldate = {2025-01-20},
  note = {SEC: Rule 506(b) | Cornell Law: Rule 506 | Investor.gov: Rule 506},
}

@article{sec-reg-a,
  title = {SEC Regulation A (Reg A) overview and cap (\$75M/yr)},
  author = {U.S. SEC},
  year = {},
  journal = {U.S. SEC},
  url = {https://www.sec.gov/smallbusiness/exemptofferings/rega},
  urldate = {2025-01-20},
  note = {U.S. SEC, Regulation A Overview},
}

@article{sec-reg-cf,
  title = {SEC Regulation Crowdfunding (Reg CF)},
  author = {U.S. SEC},
  year = {},
  journal = {U.S. SEC},
  url = {https://www.sec.gov/resources-small-businesses/exempt-offerings/regulation-crowdfunding},
  urldate = {2025-01-20},
  note = {U.S. SEC, Regulation Crowdfunding},
}

@article{sec-reg-cf-raise-limit,
  title = {SEC Regulation Crowdfunding (Reg CF) Raise Limit},
  author = {SEC},
  year = {},
  journal = {SEC: Regulation Crowdfunding},
  url = {https://www.sec.gov/resources-small-businesses/exempt-offerings/regulation-crowdfunding},
  urldate = {2025-01-20},
  note = {SEC: Regulation Crowdfunding | Republic: SEC Raises Reg CF to $5M | Williams Mullen: SEC Finalizes New Limits},
}

@article{sec-reg-d,
  title = {SEC Regulation D for accredited investors},
  author = {SEC},
  year = {},
  journal = {SEC: Private Placements Rule 506(b)},
  url = {https://www.sec.gov/resources-small-businesses/exempt-offerings/private-placements-rule-506b},
  urldate = {2025-01-20},
  note = {SEC: Private Placements Rule 506(b) | Investor.gov: Rule 506 | Wikipedia: Regulation D)},
}

@article{sec-reg-s,
  title = {SEC Regulation S for non-U.S. investors},
  author = {Fourscore Law},
  year = {1933},
  journal = {Fourscore Law: Regulation S},
  url = {https://www.fourscorelaw.com/resources/regulation-s-exemption-for-foreign-offerings},
  urldate = {2025-01-20},
  note = {Fourscore Law: Regulation S | Brinen Law: Regulation S | Deloitte DART: Regulation S},
}

@article{selfish-gene-dawkins,
  title = {The Selfish Gene Quote},
  author = {Richard Dawkins},
  year = {1976},
  journal = {Richard Dawkins},
  url = {https://en.wikipedia.org/wiki/The_Selfish_Gene},
  urldate = {2025-01-20},
  note = {Richard Dawkins, 1976, The Selfish Gene},
}

@article{shepherd2019,
  title = {Exit Strategy: Career Concerns and Revolving Doors in Congress},
  author = {Shepherd, Michael E. and You, Hye Young},
  year = {2019},
  journal = {American Political Science Review},
  volume = {114},
  number = {1},
  pages = {270-284},
  doi = {10.1017/S000305541900067X},
}

@article{short-term-trial-outcomes,
  title = {Typical duration of outcome tracking in clinical trials},
  author = {PMC},
  year = {},
  journal = {PMC: Duration of Response Endpoint},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC11524686/},
  urldate = {2025-01-20},
  note = {PMC: Duration of Response Endpoint | Wikipedia: Clinical Endpoint | arXiv: Duration of Response in Oncology},
}

@misc{sipri-2024-spending,
  title = {sipri-2024-spending},
  note = {See https://warondisease.org/knowledge/references.html\#sipri-2024-spending},
  url = {https://warondisease.org/knowledge/references.html\#sipri-2024-spending},
}

@report{sipri2024,
  title = {Trends in World Military Expenditure, 2023},
  institution = {Stockholm International Peace Research Institute},
  year = {2024},
  url = {https://www.sipri.org/publications/2024/sipri-fact-sheets/trends-world-military-expenditure-2023},
  urldate = {2025-01-20},
}

@article{skorea-medical-research-spending-2-1b,
  title = {South Korea medical research spending},
  author = {Science},
  year = {},
  journal = {Science: South Korea Proposes Cutbacks},
  url = {https://www.science.org/content/article/south-korea-science-spending-champion-proposes-cutbacks},
  urldate = {2025-01-20},
  note = {Science: South Korea Proposes Cutbacks | Statista: South Korea R\&D Expenditure | Nature: South Korea R\&D Budget Cuts | University World News: R\&D Budget Cuts},
}

@article{smallpox-eradicated,
  title = {Smallpox Eradicated},
  author = {WHO},
  year = {},
  journal = {WHO},
  url = {https://www.who.int/health-topics/smallpox},
  urldate = {2025-01-20},
  note = {WHO, Smallpox Overview},
}

@article{smallpox-eradication-10-year-campaign,
  title = {Smallpox eradication timeline (10-year intensive campaign)},
  author = {WHO},
  year = {1966},
  journal = {WHO},
  url = {https://www.who.int/news-room/feature-stories/detail/the-smallpox-eradication-programme---sep-(1966-1980},
  urldate = {2025-01-20},
  note = {WHO, Smallpox Eradication Programme 1966-1980) | WHO, History of smallpox vaccination | Note: Declared eradicated May 8, 1980; cost $300 million for global campaign},
}

@article{smallpox-eradication-roi,
  title = {Smallpox Eradication ROI},
  author = {CSIS},
  year = {},
  journal = {CSIS},
  url = {https://www.csis.org/analysis/smallpox-eradication-model-global-cooperation},
  urldate = {2025-01-20},
  note = {CSIS, Smallpox Eradication Model: Global Cooperation | PMC3720047, Link},
}

@misc{software-pricing-market-rates,
  title = {Software pricing},
  author = {Market rate estimates},
  year = {},
  note = {Market rate estimates},
}

@article{soros-bet-against-the-pound,
  title = {George Soros's 1992 Bet Against the British Pound},
  author = {Yahoo Finance},
  year = {},
  journal = {Yahoo Finance: British Pounding},
  url = {https://finance.yahoo.com/news/british-pounding-george-soros-made-160033593.html},
  urldate = {2025-01-20},
  note = {Yahoo Finance: British Pounding | Wikipedia: Black Wednesday | The Balance: Black Wednesday},
}

@article{south-sea-bubble-1720,
  title = {The South Sea Bubble of 1720},
  author = {Historic UK},
  year = {},
  journal = {Historic UK: South Sea Bubble},
  url = {https://www.historic-uk.com/HistoryUK/HistoryofEngland/South-Sea-Bubble/},
  urldate = {2025-01-20},
  note = {Historic UK: South Sea Bubble | Wikipedia: South Sea Company | Britannica: South Sea Bubble},
}

@article{soviet-collectivization-deaths,
  title = {Death toll of Soviet Collectivization Famine (1930-33)},
  author = {Wikipedia},
  year = {1930},
  journal = {Wikipedia: Soviet Famine 1930-33},
  url = {https://en.wikipedia.org/wiki/Soviet_famine_of_1930–1933},
  urldate = {2025-01-20},
  note = {Wikipedia: Soviet Famine 1930-33 | Wikipedia: Holodomor | Britannica: Holodomor},
}

@article{soviet-computer-technology-lag,
  title = {Soviet computer technology lag behind the West},
  author = {Wikipedia},
  year = {2023},
  journal = {Wikipedia: Computing in USSR},
  url = {https://en.wikipedia.org/wiki/History_of_computing_in_the_Soviet_Union},
  urldate = {2025-01-20},
  note = {Wikipedia: Computing in USSR | The Waves: Soviet Computer Failure | CyberNews: Why Soviets Didn't Start PC Revolution},
}

@article{soviet-famine-deaths-30m,
  title = {Soviet famine death toll estimates},
  author = {Wikipedia},
  year = {1930},
  journal = {Wikipedia: Soviet Famine 1930-33},
  url = {https://en.wikipedia.org/wiki/Soviet_famine_of_1930–1933},
  urldate = {2025-01-20},
  note = {Wikipedia: Soviet Famine 1930-33 | Wikipedia: Excess Mortality Under Stalin},
}

@article{soviet-union-100-million-deaths,
  title = {Deaths under communist regimes},
  author = {Wikipedia},
  year = {2025},
  journal = {Wikipedia: Black Book of Communism},
  url = {https://en.wikipedia.org/wiki/The_Black_Book_of_Communism},
  urldate = {2025-01-20},
  note = {Wikipedia: Black Book of Communism | Wikipedia: Mass Killings Under Communism | Jacobin: Black Book Shoddy History},
}

@article{spenkuch2018,
  title = {Does Campaign Spending Affect Election Outcomes? New Evidence from Transaction-Level Disbursement Data},
  author = {Spenkuch, Jörg L. and Toniatti, David},
  year = {2018},
  journal = {The Journal of Politics},
  volume = {82},
  number = {4},
  pages = {1502-1515},
  doi = {10.1086/708646},
}

@article{standard-medical-research-roi,
  title = {Standard Medical Research ROI ($20k-$100k/QALY)},
  author = {PMC},
  year = {1990},
  journal = {PMC: Cost-effectiveness Thresholds Used by Study Authors},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC10114019/},
  urldate = {2025-01-20},
  note = {PMC: Cost-effectiveness Thresholds Used by Study Authors, 1990-2021 | ICER Cost-Effectiveness Methods},
}

@article{statins-qaly,
  title = {Statins for High-Risk Patients Cost per QALY},
  author = {The Lancet},
  year = {},
  journal = {The Lancet},
  url = {https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(24},
  urldate = {2025-01-20},
  note = {The Lancet, Link00053-X/fulltext)},
}

@article{statnews-nih-terminates,
  title = {NIH terminates research grants (news report)},
  author = {STAT News},
  year = {2025},
  journal = {STAT News},
  url = {https://www.statnews.com/2025/03/07/nih-terminates-dei-transgender-related-research-grants/},
  urldate = {2025-01-20},
  note = {STAT News, 2025, NIH terminates grants},
}

@article{stratmann2002,
  title = {Can Special Interests Buy Congressional Votes? Evidence from Financial Services Legislation},
  author = {Stratmann, Thomas},
  year = {2002},
  journal = {The Journal of Law and Economics},
  volume = {45},
  number = {2},
  pages = {345-373},
  doi = {10.1086/340091},
}

@article{sugar-subsidies-cost,
  title = {Annual cost of U.S. sugar subsidies},
  author = {GAO},
  year = {},
  journal = {GAO: Sugar Program},
  url = {https://www.gao.gov/products/gao-24-106144},
  urldate = {2025-01-20},
  note = {GAO: Sugar Program | Heritage: US Sugar Program | AEI: $4B Sugar Subsidies},
}

@article{suicide-deaths-vs-war-deaths,
  title = {Global suicide deaths vs. combat deaths},
  author = {WHO},
  year = {2021},
  journal = {WHO},
  url = {https://www.who.int/publications/i/item/9789240110069},
  urldate = {2025-01-20},
  note = {WHO, Suicide worldwide in 2021 | WHO, Suicide Fact Sheet},
}

@misc{sundiamond1999,
  title = {United States v. Sun-Diamond Growers of California},
  author = {Supreme Court of the United States},
  year = {1999},
  note = {526 U.S. 398},
}

@article{swiss-military-budget-0-7-pct-gdp,
  title = {Swiss military budget as percentage of GDP},
  author = {World Bank},
  year = {},
  journal = {World Bank: Military Expenditure % GDP Switzerland},
  url = {https://data.worldbank.org/indicator/MS.MIL.XPND.GD.ZS?locations=CH},
  urldate = {2025-01-20},
  note = {World Bank: Military Expenditure \% GDP Switzerland | Avenir Suisse: Defense Spending | Trading Economics: Switzerland Military Expenditure},
}

@article{swiss-vs-us-gdp-per-capita,
  title = {Switzerland vs. US GDP per capita comparison},
  author = {World Bank},
  year = {},
  journal = {World Bank: Switzerland GDP Per Capita},
  url = {https://data.worldbank.org/indicator/NY.GDP.PCAP.CD?locations=CH},
  urldate = {2025-01-20},
  note = {World Bank: Switzerland GDP Per Capita | Trading Economics: Switzerland GDP Per Capita PPP | TheGlobalEconomy: USA GDP Per Capita PPP},
}

@article{swiss-vs-us-life-expectancy,
  title = {Switzerland vs. US life expectancy comparison},
  author = {KFF Health System Tracker},
  year = {},
  journal = {KFF Health System Tracker: Life Expectancy Comparison},
  url = {https://www.healthsystemtracker.org/chart-collection/u-s-life-expectancy-compare-countries/},
  urldate = {2025-01-20},
  note = {KFF Health System Tracker: Life Expectancy Comparison},
}

@article{switzerland-last-war-death-1847,
  title = {Switzerland's last military conflict},
  author = {Wikipedia},
  year = {2019},
  journal = {Wikipedia: Sonderbund War},
  url = {https://en.wikipedia.org/wiki/Sonderbund_War},
  urldate = {2025-01-20},
  note = {Wikipedia: Sonderbund War | MilitaryHistoryNow: Switzerland's Polite War | Zeit-Fragen: Last Armed Conflict},
}

@article{tarp-bailout-700b,
  title = {Troubled Asset Relief Program (TARP) of 2008},
  author = {Treasury},
  year = {},
  journal = {Treasury: TARP About},
  url = {https://home.treasury.gov/data/troubled-assets-relief-program/about-tarp},
  urldate = {2025-01-20},
  note = {Treasury: TARP About | Wikipedia: TARP | ProPublica: TARP Tracker},
}

@article{tesla-software-complexity,
  title = {Software Complexity of a Tesla Vehicle},
  author = {LinkedIn},
  year = {2012},
  journal = {LinkedIn: Car Software 100M Lines},
  url = {https://www.linkedin.com/pulse/20140626152045-3625632-car-software-100m-lines-of-code-and-counting},
  urldate = {2025-01-20},
  note = {LinkedIn: Car Software 100M Lines | MIT Technology Review: 100 Million Lines | Sweetish Hill: Tesla Lines of Code},
}

@article{thalidomide-birth-defects,
  title = {Thalidomide caused thousands of birth defects},
  author = {FDA},
  year = {},
  journal = {FDA},
  url = {https://www.fda.gov/about-fda/fda-history-exhibits/frances-oldham-kelsey-medical-reviewer-famous-averting-public-health-tragedy},
  urldate = {2025-01-20},
  note = {FDA, Frances Oldham Kelsey: Medical reviewer famous for averting a public health tragedy | Smithsonian Magazine, The Woman Who Stood Between America and a Generation of 'Thalidomide Babies' | Estim...},
}

@article{thalidomide-no-us-birth-defects,
  title = {FDA Dr. Kelsey prevented widespread thalidomide birth defects in the US},
  author = {FDA},
  year = {},
  journal = {FDA: Frances Oldham Kelsey},
  url = {https://www.fda.gov/about-fda/fda-history-exhibits/frances-oldham-kelsey-medical-reviewer-famous-averting-public-health-tragedy},
  urldate = {2025-01-20},
  note = {FDA: Frances Oldham Kelsey | UChicago Medicine: Dr. Kelsey Saved US | Smithsonian: Woman Who Stood Between America},
}

@article{thalidomide-scandal,
  title = {Thalidomide scandal: worldwide cases and mortality},
  author = {Wikipedia},
  year = {},
  journal = {Wikipedia},
  url = {https://en.wikipedia.org/wiki/Thalidomide_scandal},
  urldate = {2025-01-20},
  note = {Wikipedia, Thalidomide scandal},
}

@article{thalidomide-survivors-health,
  title = {Health and quality of life of Thalidomide survivors as they age},
  author = {PLOS One},
  year = {2019},
  journal = {PLOS One},
  url = {https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0210222},
  urldate = {2025-01-20},
  note = {PLOS One, 2019, The health and quality of life of Thalidomide survivors as they age},
}

@article{tobacco-control-roi,
  title = {Tobacco Control ROI},
  author = {UNDP},
  year = {},
  journal = {UNDP},
  url = {https://www.undp.org/asia-pacific/blog/how-raising-tobacco-taxes-can-save-lives-and-cut-poverty-across-asia-pacific-0},
  urldate = {2025-01-20},
  note = {UNDP, Link},
}

@misc{tobacco-industry-pivot,
  title = {Tobacco Industry Pivot Precedent},
  author = {Harvard Business Review},
  year = {2022},
  note = {Harvard Business Review, 2022},
}

@article{top-contractor-revenue,
  title = {Top Defense Contractor Revenue (Lockheed Martin, \$68.59B, FY23)},
  author = {Forecast International},
  year = {2024},
  journal = {Forecast International},
  url = {https://dsm.forecastinternational.com/2024/03/01/top-100-defense-contractors-2023/},
  urldate = {2025-01-20},
  note = {Forecast International, 2024, Top 10 US Defense Contractors Based on FY23 DoD Prime Contracts},
}

@article{top-pe-hedge-funds,
  title = {Top Performing Private Equity \& Hedge Funds},
  author = {Alternatives Investor},
  year = {2021},
  journal = {Alternatives Investor},
  url = {https://alternativesinvestor.com/top-performing-private-equity-funds-2016-2019},
  urldate = {2025-01-20},
  note = {Alternatives Investor, 2021, Top Performing Private Equity Funds | Traders' Log, 2023, Top Hedge Funds},
}

@misc{total-military-and-war-costs-11-4t,
  title = {Total military and war costs: $11.4 trillion},
  author = {Cost breakdown calculated using SIPRI},
  year = {},
  note = {Cost breakdown calculated using SIPRI, ACLED, World Bank, academic sources},
}

@article{trial-cost-41k,
  title = {Traditional Trial Cost per Patient},
  author = {Moore, T. J., Zhang, H., Anderson, G., \& Alexander, G. C. (2020). Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2017. _JAMA Internal Medicine_.},
  year = {2020},
  journal = {Moore},
  url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295430/},
  urldate = {2025-01-20},
  note = {Moore, T. J., Zhang, H., Anderson, G., \& Alexander, G. C. (2020). Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2017. _JAMA I...},
}

@article{trial-costs-fda-study,
  title = {Trial Costs, FDA Study},
  author = {FDA Study via NCBI},
  year = {},
  journal = {FDA Study via NCBI},
  url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248200/},
  urldate = {2025-01-20},
  note = {FDA Study via NCBI, Link},
}

@article{tuberculosis-deaths-1-3m-annually,
  title = {Annual deaths from tuberculosis},
  author = {WHO},
  year = {2024},
  journal = {WHO},
  url = {https://www.who.int/news-room/fact-sheets/detail/tuberculosis},
  urldate = {2025-01-20},
  note = {WHO, 2024, Tuberculosis Fact Sheet | WHO, Global Tuberculosis Report 2024 | Note: 1.25 million deaths in 2023 (including 161,000 people with HIV)},
}

@misc{tufts-drug-development-cost-2021,
  title = {Tufts Center drug development cost estimate 2021},
  author = {Tufts Center for the Study of Drug Development},
  year = {2021},
  note = {Tufts Center for the Study of Drug Development, 2021},
}

@article{ucdp-state-violence-deaths,
  title = {State violence deaths annually},
  author = {UCDP},
  year = {},
  journal = {UCDP: Uppsala Conflict Data Program},
  url = {https://ucdp.uu.se/},
  urldate = {2025-01-20},
  note = {UCDP: Uppsala Conflict Data Program | Wikipedia: UCDP | Our World in Data: Armed Conflict Deaths},
}

@article{uk-electoral-registration-threshold-500k,
  title = {UK electoral registration threshold over $500K},
  author = {UK Electoral Commission},
  year = {2022},
  journal = {UK Electoral Commission},
  url = {https://www.electoralcommission.org.uk/non-party-campaigners-uk-parliamentary-general-elections/notifications-and-registration/reporting-thresholds},
  urldate = {2025-01-20},
  note = {UK Electoral Commission, Registration thresholds | UK Electoral Commission, Elections Act 2022: Reporting threshold},
}

@article{uk-electoral-spending-limits,
  title = {UK Electoral Commission Spending Limits},
  author = {UK Electoral Commission},
  year = {},
  journal = {UK Electoral Commission},
  url = {https://www.electoralcommission.org.uk/non-party-campaigners-uk-parliamentary-general-elections/spending-limits},
  urldate = {2025-01-20},
  note = {UK Electoral Commission, Non-party campaigners guidance},
}

@article{uk-medical-research-spending-3b,
  title = {UK medical research spending: ~$3 billion/year},
  author = {UKRI},
  year = {},
  journal = {UKRI},
  url = {https://www.ukri.org/news/largest-study-of-uk-health-research-funding-released-today/},
  urldate = {2025-01-20},
  note = {UKRI, Largest study of UK health research funding | HM Treasury, £5 billion R\&D package},
}

@report{umr2024,
  title = {NIH's Role in Sustaining the U.S. Economy: 2024 Update},
  institution = {United for Medical Research},
  year = {2024},
  url = {https://www.unitedformedicalresearch.org/annual-economic-report/},
  urldate = {2025-01-20},
  note = {Finds $2.46 in economic activity for every $1 of NIH funding},
}

@article{unesco-education-for-all-cost,
  title = {UNESCO cost for universal education coverage},
  author = {UNESCO},
  year = {2023},
  journal = {UNESCO},
  url = {https://news.un.org/en/story/2023/04/1135697},
  urldate = {2025-01-20},
  note = {UNESCO, New UNESCO report reveals $97 billion barrier | UNESCO, Financing education in Sub-Saharan Africa},
}

@article{unhcr-forcibly-displaced-2023,
  title = {UNHCR forcibly displaced people 2023},
  author = {UNHCR},
  year = {2023},
  journal = {UNHCR},
  url = {https://www.unhcr.org/global-trends-report-2023},
  urldate = {2025-01-20},
  note = {UNHCR, Global Trends Report 2023},
}

@article{unhcr-refugee-support-cost,
  title = {UNHCR average refugee support cost},
  author = {CGDev},
  year = {2024},
  journal = {CGDev},
  url = {https://www.cgdev.org/blog/costs-hosting-refugees-oecd-countries-and-why-uk-outlier},
  urldate = {2025-01-20},
  note = {CGDev, Costs of Hosting Refugees in OECD Countries | UNHCR/World Bank, Global Cost of Refugee Inclusion},
}

@article{uniswap-labs-treasury-size,
  title = {Uniswap Labs Treasury Size},
  author = {Cryptopolitan},
  year = {2025},
  journal = {Cryptopolitan},
  url = {https://www.cryptopolitan.com/uniswap-dao-governance-attacks-2025/},
  urldate = {2025-01-20},
  note = {Cryptopolitan, Uniswap becomes the leading DAO | Blockchain Reporter, Top 15 DAOs Ranked By Treasury Size},
}

@report{unitedformedicalresearch2025,
  title = {Annual NIH Economic Impact Report: 2025 Update},
  institution = {United for Medical Research},
  year = {2025},
  url = {https://www.unitedformedicalresearch.org/statements/umr-releases-annual-nih-economic-impact-report-2025-update/},
  urldate = {2025-01-20},
  note = {Reports $2.56 economic return for every $1 in NIH research funding; FY2024 analysis showing $36.94B supporting 407,782 jobs and $94.58B in economic activity},
}

@article{university-indirect-costs-40-60pct,
  title = {University indirect costs on research grants (40-60\%)},
  author = {AAU},
  year = {},
  journal = {AAU},
  url = {https://www.aau.edu/key-issues/frequently-asked-questions-about-facilities-and-administrative-fa-costs-federally},
  urldate = {2025-01-20},
  note = {AAU, FAQ about F\&A Costs | UC Davis, Understanding Indirect Costs},
}

@article{unpaid-caregiver-hours-economic-value,
  title = {Unpaid caregiver hours and economic value},
  author = {AARP},
  year = {2023},
  journal = {AARP 2023},
  url = {https://www.aarp.org/caregiving/financial-legal/info-2023/unpaid-caregivers-provide-billions-in-care.html},
  urldate = {2025-01-20},
  note = {AARP 2023, Unpaid Care Report | Bureau of Labor Statistics 2023-2024, Unpaid Eldercare | National Alliance for Caregiving, Caregiver Statistics},
}

@article{us-adult-literacy-level,
  title = {Average reading level of U.S. adults},
  author = {National Literacy Institute},
  year = {2024},
  journal = {National Literacy Institute},
  url = {https://www.thenationalliteracyinstitute.com/2024-2025-literacy-statistics},
  urldate = {2025-01-20},
  note = {National Literacy Institute, 2024-2025 Literacy Statistics},
}

@article{us-aid-israel,
  title = {US foreign aid example},
  author = {Council on Foreign Relations},
  year = {2023},
  journal = {Council on Foreign Relations},
  url = {https://www.cfr.org/article/us-aid-israel-four-charts},
  urldate = {2025-01-20},
  note = {Council on Foreign Relations, 2023, US Aid to Israel},
}

@article{us-aircraft-carrier-cost-13b,
  title = {Cost of a single US aircraft carrier: $13 billion},
  author = {Wikipedia},
  year = {},
  journal = {Wikipedia},
  url = {https://en.wikipedia.org/wiki/Gerald_R._Ford-class_aircraft_carrier},
  urldate = {2025-01-20},
  note = {Wikipedia, Gerald R. Ford-class aircraft carrier | National Interest, Ford-Class Cost Analysis},
}

@article{us-annual-healthcare-costs,
  title = {Annual U.S. healthcare expenditure},
  author = {CMS},
  year = {2023},
  journal = {CMS},
  url = {https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data/nhe-fact-sheet},
  urldate = {2025-01-20},
  note = {CMS, National Health Expenditure Data | Health Affairs, National Health Expenditures In 2023},
}

@article{us-census-world-population-1960,
  title = {Historical world population estimates},
  author = {US Census Bureau},
  year = {},
  journal = {US Census Bureau},
  url = {https://www.census.gov/data/tables/time-series/demo/international-programs/historical-est-worldpop.html},
  urldate = {2025-01-20},
  note = {US Census Bureau, Historical Estimates of World Population},
}

@article{us-chronic-disease-spending,
  title = {U.S. chronic disease healthcare spending},
  author = {CDC},
  year = {},
  journal = {CDC},
  url = {https://www.cdc.gov/chronic-disease/data-research/facts-stats/index.html},
  urldate = {2025-01-20},
  note = {CDC, Chronic Disease Data},
}

@article{us-clinical-trials-market-2024,
  title = {US clinical trials market size 2024},
  author = {Precedence Research},
  year = {},
  journal = {Precedence Research},
  url = {https://www.precedenceresearch.com/us-clinical-trials-market},
  urldate = {2025-01-20},
  note = {Precedence Research, US Clinical Trials Market},
}

@article{us-code-21-396-off-label-use,
  title = {U.S. Code on Dissemination of Information on Unapproved Uses (21 U.S.C. § 396)},
  author = {Cornell Law School},
  year = {},
  journal = {Cornell Law School},
  url = {https://www.law.cornell.edu/uscode/text/21/396},
  urldate = {2025-01-20},
  note = {Cornell Law School, 21 U.S. Code § 396 - Practice of medicine},
}

@article{us-currency-thickness,
  title = {Thickness of US currency},
  author = {Certified Financial Group},
  year = {2021},
  journal = {Certified Financial Group},
  url = {https://financialgroup.com/2021/10/21/what-does-one-trillion-dollars-look-like/},
  urldate = {2025-01-20},
  note = {Certified Financial Group, What does one TRILLION dollars look like? | Las Vegas Sun, Putting debt into physical perspective},
}

@article{us-drug-prices,
  title = {U.S. prescription drug prices 50–90\% higher than peer countries},
  author = {RAND Corporation},
  year = {2024},
  journal = {RAND Corporation: 2024 International Drug Price Comparison},
  url = {https://www.rand.org/news/press/2024/02/01.html},
  urldate = {2025-01-20},
  note = {RAND Corporation: 2024 International Drug Price Comparison | Commonwealth Fund, 2017},
}

@article{us-drug-prices-vs-peer-countries,
  title = {U.S. drug prices compared to peer countries},
  author = {Sarnak et al.},
  year = {2017},
  journal = {Sarnak et al.},
  url = {https://www.commonwealthfund.org/publications/issue-briefs/2017/oct/paying-prescription-drugs-around-world-why-us-outlier},
  urldate = {2025-01-20},
  note = {Sarnak et al., 2017, Paying for Prescription Drugs Around the World | Kesselheim et al., 2016, High cost of prescription drugs in US},
}

@article{us-drug-spend,
  title = {\$449.7B U.S. drug spend (2023)},
  author = {CMS},
  year = {2020},
  journal = {CMS National Health Expenditure Data},
  url = {https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/nationalhealthexpenddata/nhe-fact-sheet},
  urldate = {2025-01-20},
  note = {CMS National Health Expenditure Data | CMS Office of the Actuary, 2020},
}

@article{us-eu-military-spending-share,
  title = {US/EU Combined Share of Global Military Spending},
  author = {SIPRI},
  year = {2024},
  journal = {SIPRI},
  url = {https://www.sipri.org/publications/2025/sipri-fact-sheets/trends-world-military-expenditure-2024},
  urldate = {2025-01-20},
  note = {SIPRI, Trends in World Military Expenditure 2024},
}

@article{us-federal-arts-spending,
  title = {U.S. federal government spending on the arts},
  author = {NEA},
  year = {2024},
  journal = {NEA},
  url = {https://www.arts.gov/news/press-releases/2023/statement-national-endowment-arts-chair-maria-rosario-jackson-presidents-fiscal-year-2024-budget},
  urldate = {2025-01-20},
  note = {NEA, FY 2024 Budget Statement | USASpending.gov, NEA Spending Profile},
}

@article{us-federal-education-spending,
  title = {U.S. federal government spending on education},
  author = {USASpending.gov},
  year = {2024},
  journal = {USASpending.gov},
  url = {https://www.usaspending.gov/agency/department-of-education},
  urldate = {2025-01-20},
  note = {USASpending.gov, Department of Education Spending Profile | ED.gov, FY 2024 Budget Summary},
}

@article{us-federal-healthcare-spending,
  title = {U.S. federal government spending on healthcare},
  author = {CMS},
  year = {2024},
  journal = {CMS},
  url = {https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data/nhe-fact-sheet},
  urldate = {2025-01-20},
  note = {CMS, NHE Fact Sheet | Note: 2024 federal healthcare spending was $1.98 trillion (Medicare $1.03T + Medicaid $0.91T); total US healthcare spending projected at $5.3 trillion (18\% of GDP)},
}

@article{us-government-prize-and-bounty-programs,
  title = {U.S. Government use of prize and bounty programs},
  author = {NASA},
  year = {},
  journal = {NASA},
  url = {https://www.nasa.gov/news-release/nasa-and-x-prize-announce-winners-of-lunar-lander-challenge/},
  urldate = {2025-01-20},
  note = {NASA, NASA and X Prize Announce Winners | XPRIZE, Past Challenges | HeroX, Prize Challenges: Government's Secret Weapon},
}

@article{us-health-stats-1970,
  title = {U.S. health statistics in 1970},
  author = {CDC},
  year = {1970},
  journal = {CDC},
  url = {https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5414a6.htm},
  urldate = {2025-01-20},
  note = {CDC, QuickStats Life Expectancy 1970 | Wikipedia, Obesity in the United States | Circulation, Trends in Type 2 Diabetes 1970s-1990s},
}

@article{us-health-stats-2024,
  title = {U.S. health statistics in 2024},
  author = {CDC},
  year = {2023},
  journal = {CDC},
  url = {https://www.cdc.gov/obesity/adult-obesity-facts/index.html},
  urldate = {2025-01-20},
  note = {CDC, Obesity Facts | CDC, Diabetes Prevalence | CDC, Life Expectancy 2023},
}

@article{us-healthcare-spending-cms,
  title = {U.S. healthcare spending (CMS data)},
  author = {CMS},
  year = {},
  journal = {CMS},
  url = {https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/nationalhealthexpenddata/nhe-fact-sheet},
  urldate = {2025-01-20},
  note = {CMS, NHE Fact Sheet},
}

@article{us-house-representative-constituents,
  title = {Number of constituents per U.S. House Representative},
  author = {US Census Bureau},
  year = {},
  journal = {US Census Bureau},
  url = {https://www.census.gov/topics/public-sector/congressional-apportionment/about.html},
  urldate = {2025-01-20},
  note = {US Census Bureau, About Congressional Apportionment | Wikipedia, US Congressional Apportionment},
}

@article{us-median-salary-2024,
  title = {US median salary},
  author = {Census Bureau},
  year = {2024},
  journal = {Census Bureau},
  url = {https://www.census.gov/library/publications/2025/demo/p60-286.html},
  urldate = {2025-01-20},
  note = {Census Bureau, Income in the United States: 2024},
}

@article{us-mil-spending-share,
  title = {US military spending share},
  author = {SIPRI},
  year = {2024},
  journal = {SIPRI},
  url = {https://www.sipri.org/sites/default/files/2025-04/2504_fs_milex_2024.pdf},
  urldate = {2025-01-20},
  note = {SIPRI, 2024, Military Expenditure Database},
}

@article{us-military-bands-cost-500m,
  title = {US military marching bands cost: $500 million/year},
  author = {Washington Post (2010)},
  year = {2010},
  journal = {Washington Post (2010)},
  url = {http://www.washingtonpost.com/wp-dyn/content/article/2010/09/06/AR2010090603018.html},
  urldate = {2025-01-20},
  note = {Washington Post (2010), Defense Department spends $500 million to strike up the bands | Glendale Parade Store, Military Bands Analysis},
}

@article{us-military-budget-3-5-pct-gdp,
  title = {US military budget as percentage of GDP},
  author = {Statista},
  year = {2024},
  journal = {Statista},
  url = {https://www.statista.com/statistics/262742/countries-with-the-highest-military-spending/},
  urldate = {2025-01-20},
  note = {Statista, Military spending as percent of GDP | SIPRI, Trends in World Military Expenditure 2024},
}

@article{us-military-budget-800b,
  title = {U.S. military budget},
  author = {Department of Defense},
  year = {2024},
  journal = {Department of Defense},
  url = {https://www.defense.gov/Spotlights/FY2024-Defense-Budget/},
  urldate = {2025-01-20},
  note = {Department of Defense, FY 2024 Defense Budget | Congress.gov, FY2024 Defense Budget Request},
}

@article{us-mortality-rate-by-age,
  title = {Annual risk of death by age group},
  author = {SSA},
  year = {2024},
  journal = {SSA},
  url = {https://www.ssa.gov/oact/STATS/table4c6.html},
  urldate = {2025-01-20},
  note = {SSA, Actuarial Life Table | SSA, Period Life Tables 2024},
}

@article{us-national-debt,
  title = {U.S. national debt},
  author = {US Treasury},
  year = {},
  journal = {US Treasury},
  url = {https://fiscaldata.treasury.gov/americas-finance-guide/national-debt/},
  urldate = {2025-01-20},
  note = {US Treasury, Understanding the National Debt | CRFB, Gross National Debt Reaches $36 Trillion},
}

@article{us-per-capita-military-spending-3000,
  title = {Per capita US military spending: $3,000/year},
  author = {USAFacts},
  year = {2024},
  journal = {USAFacts},
  url = {https://usafacts.org/articles/how-much-does-the-us-spend-on-the-military/},
  urldate = {2025-01-20},
  note = {USAFacts, How much does the US spend on the military? | DoD Comptroller, FY 2024 Defense Budget | Note: FY2024 total defense spending $886B÷335M people≈$2,640/capita},
}

@article{us-post-wwii-gdp-growth-8-pct,
  title = {US GDP growth rate post-WWII},
  author = {Wikipedia},
  year = {},
  journal = {Wikipedia},
  url = {https://en.wikipedia.org/wiki/Post–World_War_II_economic_expansion},
  urldate = {2025-01-20},
  note = {Wikipedia, Post-World War II economic expansion | St. Louis Fed, House Prices and Homeownership Rise After WWII},
}

@article{us-post-wwii-home-ownership-doubled,
  title = {US home ownership rate increase post-WWII},
  author = {St. Louis Fed},
  year = {},
  journal = {St. Louis Fed},
  url = {https://www.stlouisfed.org/timely-topics/house-prices-homeownership-rise},
  urldate = {2025-01-20},
  note = {St. Louis Fed, House Prices and Homeownership Rise After WWII | US Census, Historical Census of Housing Tables},
}

@article{us-post-wwii-military-spending-cut,
  title = {US military spending reduction after WWII},
  author = {Wikipedia},
  year = {2020},
  journal = {Wikipedia},
  url = {https://en.wikipedia.org/wiki/Demobilization_of_United_States_Armed_Forces_after_World_War_II},
  urldate = {2025-01-20},
  note = {Wikipedia, Demobilization After WWII | American Progress, Historical Perspective on Defense Budgets | St. Louis Fed, Which War Saw the Highest Defense Spending? | US Government Spending, Defense Sp...},
}

@article{us-tax-code-length,
  title = {Length of the U.S. tax code},
  author = {Tax Foundation},
  year = {2024},
  journal = {Tax Foundation},
  url = {https://taxfoundation.org/blog/how-many-words-are-tax-code/},
  urldate = {2025-01-20},
  note = {Tax Foundation, How Many Words Are in the Tax Code? | NTU, Tax Complexity 2024},
}

@article{us-trial-enrollment-targets-2009,
  title = {US clinical trial enrollment targets (2009)},
  author = {Institute of Medicine (US)},
  year = {},
  journal = {Institute of Medicine (US)},
  url = {https://www.ncbi.nlm.nih.gov/books/NBK50886/},
  urldate = {2025-01-20},
  note = {Institute of Medicine (US), The State of Clinical Research in the United States: An Overview},
}

@article{us-voter-population,
  title = {Number of registered or eligible voters in the U.S.},
  author = {US Census Bureau},
  year = {2024},
  journal = {US Census Bureau},
  url = {https://www.census.gov/newsroom/press-releases/2025/2024-presidential-election-voting-registration-tables.html},
  urldate = {2025-01-20},
  note = {US Census Bureau, 2024 Voting and Registration | US EAC, 2024 Election Survey Report},
}

@misc{uscode201,
  title = {18 U.S. Code � 201 - Bribery of Public Officials and Witnesses},
  author = {United States Code},
  year = {},
  url = {https://www.law.cornell.edu/uscode/text/18/201},
  urldate = {2025-01-20},
}

@article{usds-18f-initiatives,
  title = {U.S. Digital Service (USDS) and 18F Initiatives},
  author = {Medium},
  year = {2022},
  journal = {Medium},
  url = {https://medium.com/the-u-s-digital-service/two-years-of-the-u-s-digital-service-e14af5ce713b},
  urldate = {2025-01-20},
  note = {Medium, Two Years of USDS | Wikipedia, 18F | FedTech, How 18F \& USDS Drive Digital Transformation},
}

@article{vaccine-roi-44-to-1,
  title = {Return on investment for vaccines},
  author = {AAF},
  year = {2011},
  journal = {AAF},
  url = {https://www.americanactionforum.org/research/vaccine-protection-and-productivity-the-economic-value-of-vaccines/},
  urldate = {2025-01-20},
  note = {AAF, Vaccine Economic Value | Health Affairs, ROI from Immunization 2011-30 | VoICE, Value of Vaccines},
}

@misc{value-captured-by-1pct-treaty,
  title = {Value captured by 1\% treaty of $27+ billion annually},
  author = {Calculated from 1% of global military spending ($2.7T × 1%)},
  year = {},
  note = {Calculated from 1\% of global military spending ($2.7T × 1\%)},
}

@article{veteran-healthcare-cost-projections,
  title = {Veteran healthcare cost projections},
  author = {VA},
  year = {2026},
  journal = {VA},
  url = {https://department.va.gov/wp-content/uploads/2025/06/2026-Budget-in-Brief.pdf},
  urldate = {2025-01-20},
  note = {VA, FY 2026 Budget Submission | CBO, Veterans' Disability Compensation | American Legion, VA budget tops $400B for 2025},
}

@article{vitamin-a-cost-per-daly,
  title = {Cost per DALY for Vitamin A Supplementation},
  author = {PLOS ONE},
  year = {2010},
  journal = {PLOS ONE: Cost-effectiveness of "Golden Mustard" for Treating Vitamin A Deficiency in India (2010)},
  url = {https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012046},
  urldate = {2025-01-20},
  note = {PLOS ONE: Cost-effectiveness of "Golden Mustard" for Treating Vitamin A Deficiency in India (2010) | PLOS ONE: Cost-effectiveness of Vitamin A supplementation in Sub-Saharan Africa (2022)},
}

@article{vsl,
  title = {\$12.5M Value of Statistical Life (VSL)},
  author = {U.S. Department of Transportation},
  year = {2023},
  journal = {U.S. Department of Transportation},
  url = {https://www.transportation.gov/office-policy/transportation-policy/revised-departmental-guidance-on-valuation-of-a-statistical-life-in-economic-analysis},
  urldate = {2025-01-20},
  note = {U.S. Department of Transportation, 2023 Guidance},
}

@article{vsl-value-statistical-life,
  title = {Value of a Statistical Life (VSL)},
  author = {U.S. Department of Transportation},
  year = {2021},
  journal = {U.S. Department of Transportation},
  url = {https://www.transportation.gov/office-policy/transportation-policy/revised-departmental-guidance-on-valuation-of-a-statistical-life-in-economic-analysis},
  urldate = {2025-01-20},
  note = {U.S. Department of Transportation, 2021, Guidance on Treatment of Economic Value of Statistical Life},
}

@article{war-deaths-indirect-14m-annually,
  title = {Annual deaths from war, including indirect causes (14 million)},
  author = {BMC Medicine},
  year = {},
  journal = {BMC Medicine},
  url = {https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-020-01708-5},
  urldate = {2025-01-20},
  note = {BMC Medicine, Estimating indirect mortality impacts of armed conflict | PMC, Armed conflict as public health problem},
}

@article{war-on-cancer-treatment-cost,
  title = {War on Cancer annual treatment costs},
  author = {NCI},
  year = {2021},
  journal = {NCI},
  url = {https://www.cancer.gov/news-events/press-releases/2021/annual-report-nation-part-2-economic-burden},
  urldate = {2025-01-20},
  note = {NCI, Annual Report to Nation Part 2 | AACR, Cancer Care Costs Projected to Exceed $245B | NCI, Budget \& Appropriations},
}

@article{war-on-drugs-cost-and-violence,
  title = {War on Drugs cost and impact on violence},
  author = {CNBC},
  year = {2021},
  journal = {CNBC},
  url = {<https://www.cnbc.com/2021/06/17/the-us-has-spent-over-a-trillion-dollars-fighting-war-on-drugs.html>},
  urldate = {2025-01-20},
  note = {CNBC, America has spent over $1 trillion fighting war on drugs | Fox News, After 40 years, $1 trillion, US War on Drugs has failed},
}

@article{war-on-poverty-cost,
  title = {War on Poverty cost},
  author = {Heritage Foundation},
  year = {2014},
  journal = {Heritage Foundation},
  url = {https://www.heritage.org/poverty-and-inequality/report/the-war-poverty-after-50-years},
  urldate = {2025-01-20},
  note = {Heritage Foundation, The War on Poverty After 50 Years | Daily Signal, We've Spent $22 Trillion on War on Poverty},
}

@article{war-on-terror-cost-blowback,
  title = {War on Terror cost and unintended consequences},
  author = {Brown University},
  year = {2021},
  journal = {Brown University},
  url = {https://www.brown.edu/news/2021-09-01/costsofwar},
  urldate = {2025-01-20},
  note = {Brown University, Costs of the 20-year war on terror | Costs of War Project, Economic Costs},
}

@article{warren-buffett-career-average-return-20-pct,
  title = {Warren Buffett's career average investment return},
  author = {CNBC},
  year = {2025},
  journal = {CNBC},
  url = {https://www.cnbc.com/2025/05/05/warren-buffetts-return-tally-after-60-years-5502284percent.html},
  urldate = {2025-01-20},
  note = {CNBC, Warren Buffett's return tally after 60 years: 5,502,284\% | SlickCharts, Berkshire Hathaway Returns by Year},
}

@article{wars-since-1945,
  title = {Number of armed conflicts since 1945},
  author = {Uppsala University},
  year = {},
  journal = {Uppsala University},
  url = {https://ucdp.uu.se/},
  urldate = {2025-01-20},
  note = {Uppsala University, UCDP Dataset | Wikipedia, Uppsala Conflict Data Program},
}

@article{wasted-spending-on-failed-experiments,
  title = {Estimated annual cost of repeating failed experiments due to non-publication of results},
  author = {Science/AAAS},
  year = {2020},
  journal = {Science/AAAS},
  url = {https://www.science.org/content/article/study-claims-28-billion-year-spent-irreproducible-biomedical-research},
  urldate = {2025-01-20},
  note = {Science/AAAS, $28 billion/year spent on irreproducible research | IDBS, $28 billion wasted every year},
}

@article{weapons-vs-cures-workforce-ratio,
  title = {Workforce size comparison for weapons vs. cures},
  author = {StartUs Insights},
  year = {2026},
  journal = {StartUs Insights},
  url = {https://www.startus-insights.com/innovators-guide/defence-industry-report/},
  urldate = {2025-01-20},
  note = {StartUs Insights, Defense Industry Report 2026 (11.6M contractors) | RUSI/Militarnyi, Russian Defense Industry Employs 4.5M | World Bank, Armed Forces Personnel (~27M active military 2020) | StartU...},
}

@article{wef-harvard-ncd-cost,
  title = {WEF/Harvard NCD Cost (\$47T, 2011-2030)},
  author = {World Economic Forum and Harvard School of Public Health},
  year = {2011},
  journal = {World Economic Forum and Harvard School of Public Health},
  url = {https://www3.weforum.org/docs/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf},
  urldate = {2025-01-20},
  note = {World Economic Forum and Harvard School of Public Health, 2011, The Global Economic Burden of Non-communicable Diseases},
}

@article{wellcome-trust-endowment-size,
  title = {Wellcome Trust Endowment Size},
  author = {Wellcome Trust},
  year = {2023},
  journal = {Wellcome Trust},
  url = {https://cms.wellcome.org/sites/default/files/2024-01/Wellcome-Trust-Annual-Report-and-Financial-Statements-2023.pdf},
  urldate = {2025-01-20},
  note = {Wellcome Trust, Annual Report 2023 | Note: £28B endowment (~$35B); spends £1.6B/year on medical research},
}

@article{who-budget-comparison,
  title = {War spending vs WHO budget},
  author = {Share the World's Resources},
  year = {},
  journal = {Share the World's Resources},
  url = {https://sharing.org/information-centre/news/world-health-organisations-annual-budget-equivalent-global-military/},
  urldate = {2025-01-20},
  note = {Share the World's Resources, WHO budget equivalent to military spending every 8 hours | PMC, Military expenditure crowds out health-care spending},
}

@article{who-choice-daly-value,
  title = {WHO-CHOICE DALY Valuation (\$1-3x$ GDP per capita)},
  author = {World Health Organization},
  year = {},
  journal = {World Health Organization},
  url = {https://www.who.int/activities/choosing-interventions-that-are-cost-effective-(who-choice},
  urldate = {2025-01-20},
  note = {World Health Organization, Cost-effectiveness thresholds/cost-effectiveness-thresholds)},
}

@article{who-clean-water-daly-costs,
  title = {WHO clean water and sanitation DALY costs},
  author = {WHO},
  year = {2004},
  journal = {WHO},
  url = {https://iris.who.int/bitstream/handle/10665/68568/WHO_SDE_WSH_04.04.pdf},
  urldate = {2025-01-20},
  note = {WHO, 2004, Water, Sanitation and Health},
}

@article{who-cost-effectiveness-threshold,
  title = {Cost-effectiveness threshold ($50,000/QALY)},
  author = {PMC},
  year = {},
  journal = {PMC},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC5193154/},
  urldate = {2025-01-20},
  note = {PMC, Country-Level Cost-Effectiveness Thresholds | WHO, WHO-CHOICE Methods Update},
}

@article{who-daily-deaths,
  title = {150,000 deaths per day from all causes},
  author = {Based on WHO Global Health Estimates showing ~55 million annual deaths / 365 days = ~150,000 per day | WHO},
  year = {2024},
  journal = {Based on WHO Global Health Estimates showing ~55 million annual deaths / 365 days = ~150},
  url = {https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death},
  urldate = {2025-01-20},
  note = {Based on WHO Global Health Estimates showing ~55 million annual deaths / 365 days = ~150,000 per day | WHO, 2024, The top 10 causes of death},
}

@article{who-generic-drug-policy,
  title = {WHO generic drug substitution policy},
  author = {WHO},
  year = {2015},
  journal = {WHO},
  url = {https://www.who.int/medicines/areas/policy/wha58_33-ENGLISH.pdf},
  urldate = {2025-01-20},
  note = {WHO, 2015, Access to New Medicines in Europe},
}

@article{who-global-health-estimates-2024,
  title = {WHO Global Health Estimates 2024},
  author = {World Health Organization},
  year = {2024},
  journal = {World Health Organization},
  url = {https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates},
  urldate = {2025-01-20},
  note = {World Health Organization, 2024, Global Health Estimates: Life expectancy and leading causes of death and disability},
}

@article{who-smallpox-eradication-commemoration,
  title = {WHO smallpox eradication commemoration (2010)},
  author = {WHO},
  year = {2010},
  journal = {WHO},
  url = {https://www.who.int/news/item/17-05-2010-statue-commemorates-smallpox-eradication},
  urldate = {2025-01-20},
  note = {WHO, 2010, Statue Commemorates Smallpox Eradication},
}

@report{who2024,
  title = {Global Health Estimates: Life expectancy and leading causes of death and disability},
  institution = {World Health Organization},
  year = {2024},
  url = {https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates},
  urldate = {2025-01-20},
}

@article{wikipedia-doge,
  title = {Department of Government Efficiency (overview)},
  author = {Wikipedia},
  year = {},
  journal = {Wikipedia},
  url = {https://en.wikipedia.org/wiki/Department_of_Government_Efficiency},
  urldate = {2025-01-20},
  note = {Wikipedia, Department of Government Efficiency},
}

@misc{wishocracy2024,
  title = {Wishocracy: A Decentralized Semi-Autonomous Todo List for Humanity},
  author = {Wishonia},
  year = {2024},
  url = {https://github.com/wishonia/wishonia},
  urldate = {2025-01-20},
  note = {Aggregated Pairwise Preference Allocation (APPA) system using pairwise comparisons to determine resource allocation; can use Bradley-Terry model to aggregate millions of pairwise comparisons into g...},
}

@article{wordpress-multi-billion-dollar-economy,
  title = {WordPress multi-billion dollar economy},
  author = {WP Engine},
  year = {},
  journal = {WP Engine},
  url = {https://wpengine.com/blog/wordpress-economy-drives-more-than-half-a-trillion-in-revenue-new-global-study/},
  urldate = {2025-01-20},
  note = {WP Engine, WordPress Economy Drives More Than Half a Trillion in Revenue | Business Wire, WordPress Economy Study},
}

@article{world-bank-poverty-eradication-cost,
  title = {World Bank cost to eradicate extreme poverty},
  author = {Global Policy Journal},
  year = {2024},
  journal = {Global Policy Journal},
  url = {https://www.globalpolicyjournal.com/blog/25/07/2024/new-estimates-cost-ending-poverty},
  urldate = {2025-01-20},
  note = {Global Policy Journal, New estimates of the cost of ending poverty | Borgen Project, How Much Does it Cost to End Poverty?},
}

@article{world-bank-trade-disruption-conflict,
  title = {World Bank trade disruption cost from conflict},
  author = {World Bank},
  year = {},
  journal = {World Bank},
  url = {https://www.worldbank.org/en/topic/trade/publication/trading-away-from-conflict},
  urldate = {2025-01-20},
  note = {World Bank, Trading Away from Conflict | NBER/World Bank, Collateral Damage: Trade Disruption | World Bank, Impacts on Global Trade of Current Trade Disputes},
}

@article{world-warheads,
  title = {World Nuclear Forces},
  author = {Federation of American Scientists},
  year = {2024},
  journal = {Federation of American Scientists},
  url = {https://fas.org/issues/nuclear-weapons/status-world-nuclear-forces/},
  urldate = {2025-01-20},
  note = {Federation of American Scientists, 2024, Status of World Nuclear Forces},
}

@article{worldcoin-scale,
  title = {Worldcoin identity verification scale},
  author = {World Foundation},
  year = {2025},
  journal = {World Foundation},
  url = {https://world.org/blog/announcements/world-year-two},
  urldate = {2025-01-20},
  note = {World Foundation, 2025, World: Year Two},
}

@article{wwii-cost-4-trillion-today,
  title = {Cost of World War II in today's dollars},
  author = {Federation of American Scientists},
  year = {},
  journal = {Federation of American Scientists},
  url = {https://fas.org/publication/costs_of_war/},
  urldate = {2025-01-20},
  note = {Federation of American Scientists, Costs of Major U.S. Wars Compared | Norwich University, The Cost of U.S. Wars Then and Now | Note: Most expensive U.S. war in history at $4.1-4.7 trillion (inflat...},
}

@article{wwii-war-bonds,
  title = {WWII War Bonds},
  author = {U.S. Treasury},
  year = {},
  journal = {U.S. Treasury},
  url = {https://en.wikipedia.org/wiki/War_bond},
  urldate = {2025-01-20},
  note = {U.S. Treasury, WWII War Bonds},
}

@article{yamanaka-factors-cellular-reprogramming,
  title = {Discovery of Induced Pluripotent Stem Cells (Yamanaka Factors)},
  author = {Nobel Prize},
  year = {2012},
  journal = {Nobel Prize},
  url = {https://www.nobelprize.org/prizes/medicine/2012/press-release/},
  urldate = {2025-01-20},
  note = {Nobel Prize, 2012 Physiology or Medicine | Wikipedia, Induced pluripotent stem cell},
}

@article{young-earth-creationism-poll,
  title = {Poll on belief in young-Earth creationism},
  author = {Gallup},
  year = {},
  journal = {Gallup},
  url = {https://news.gallup.com/poll/261680/americans-believe-creationism.aspx},
  urldate = {2025-01-20},
  note = {Gallup, 40\% of Americans Believe in Creationism | NCSE, How Many Young-Earth Creationists?},
}

@article{zinc-22-database,
  title = {ZINC-22 Database (Billions of compounds)},
  author = {ACS},
  year = {},
  journal = {ACS},
  url = {https://pubs.acs.org/doi/10.1021/acs.jcim.2c01253},
  urldate = {2025-01-20},
  note = {ACS, ZINC-22},
}
